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ABSTRACT 
     This thesis describes the synthesis and use of an N-based L-proline derived chiral 
auxiliary/directing group for selective synthesis of planar chiral and central chiral products. A 
series of planar chiral ferrocenes were prepared, and converted to chloroimidazoliums and 
complexed to palladium via oxidative addition. In addition to this, a centrally chiral Ir(I) catalyst 
was prepared for the purpose of evaluating the importance of planar chirality for the  induction of 
enantioselectivity in the Ir(I) catalyzed hydrogenations of 2-substituted quinolines. A lower 
enantioselectivity was observed, allowing the conclusion that planar chirality does contribute to the  
enantioselectivity. The pyrroloimidazolone directing group used to induce high diastereoselectivity 
in ferrocene lithiations (>95:5 dr) has been applied (with minor modifications) towards the 
diastereoselective lithiation of η6-arene chromium tricarbonyl complexes. The anti-epimer of the 
pyrroloimidazolone auxiliary undergoes pro-R lithiation in >95:5 dr. The syn-epimer of this 
auxiliary undergoes pro-S lithiation in >95:5 dr. The origin of selectivity is believed to be caused 
by a conformational bias exerted by the O-group. The selectivity of lithiations, and stereochemistry 
of all the products has been confirmed by a combination of X-ray analysis, transmetalation and 
deuteration experiments and by the preparation and comparison of solely planar chiral 
enantiomers. 
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1 .  I n t r o d u c t i o n  
     Many of the complex molecules produced by living organisms such as proteins, nucleic acids 
and carbohydrates are produced as a single enantiomer and/or diastereomer in high selectivity.
1
 In 
some cases chemists are able to selectively synthesize single enantiomers/diastereomers, but for 
the most part our arsenal of asymmetric strategies is still limited. A multitude of enantioselective 
methods have been developed by chemists to address the selective synthesis of chiral molecules. 
The focus of research in the Metallinos group can be divided into two categories: the development 
of new asymmetric transformations and, more often than not applying these transformations 
towards the development of new previously inaccesible chiral ligands for asymmetric catalysis. 
Recent efforts are focused on the development of N-based chiral auxiliaries for diastereoselective 
lithiations of prochiral ferrocenes. The most recent advancements were the development of an 
epimeric pyroloimidazolone directing group for highly diastereoselective lithiation of ferrocenes, 
providing access to both planar chiral enantiomers of 1,2-substituted aminoferrocenes.
2
 This 
strategy was then applied to the synthesis of unusual chiral imidazolinylidene (NHC) ligands 
which, when complexed to Ir(I), are capable of hydrogenating quinolines under relatively low 
pressures of hydrogen (5 atm) with good to high enantioselectivity.
3
  
     The first part of this thesis will discuss an application of this recently reported methodology
2
 
towards the synthesis of planar chiral N-substituted ferrocenyl imidazolylidene and 
imidazolinylidene ligands with the intent of preparing enantiopure bidentate ligands for the 
preparation of metal complexes to use in asymmetric catalysis. The utility of the 
pyroloimidazolone directing group was then extended to the synthesis of planar chiral N-
2 
 
substituted η6-arene chromium tricarbonely complexes. Last, the importance of the planar chirality 
of the aforementioned Ir(I) complexes
3
 will be studied by preparing solely centrally chiral 
analogues and testing their induction of enantioselectivity in the hydrogenations of previously 
studied substrates.  
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1.1 Planar Chirality  
 
     Chirality is a mathematical property of asymmetry. The word chiral is derived from the Greek 
word for hand (kheir) which was the first observation of chirality. Chirality exists when an object 
is distinguishable from its mirror image. The simplest example of this is the relationship between 
one's hands (Figure 1),
4
 which perfectly describes the relationship between two enantiomeric 
molecules. 
 
 
Mirror Plane 
 
Figure 1. The chirality of hands and molecules. 
 
     Chirality is assigned using the Cahn-Ingold-Prelog system,
5
 which is based on assigning priority 
of substituents based on a combination of the atomic number and to a lesser extent the molecular 
weight of substituents. Within the field of chemistry there are sub-classes of chirality used to 
describe different types of asymmetry depending on the dimensions in which it is asymmetric. 
Apart from central chirality, axial and planar chirality may be used to describe elements of chirality 
for molecules with sp- and sp
2
-hybridized atoms.  Axial chirality exists in a molecule that does not 
4 
 
have a stereogenic centre, but possesses an axis of chirality like those shown in Figure 2.  The most 
common form of axial chirality exists in biaryl ring systems (1), where free-rotation around the 
CAr1-CAr2 bond is restricted. This type of chirality is also observed in polysubstituted allenes (2); 
here, the central carbon atom is sp-hybridized. 
 
 
Figure 2. Axially chiral polysubstituted allenes and ortho-substituted biaryls. 
 
Planar chirality exists in cyclic systems in which there is a clearly defined inequivalence 
between the two faces of the ring. This is easily explained using metal-arene complexes as an 
example. In these compounds one face is haptically bound to a metal (Figure 3). For 
organometallics such as ferrocene, the Schlӧgl convention,6 which follows similar rules to the 
Cahn-Ingold-Prelog system,
7
 may be used to assign absolute stereochemistry. Chirality is assigned 
by looking at the molecule from a top-view of the disubstituted ring, and assigning priority based 
on atomic number (and size) as shown in Figure 3. If A > B, then a counterclockwise priority is 
assigned and denoted as SP indicating that the configuration is S, and the type of chirality is planar.
6
 
When more than one element of chirality exists within a molecule, the priority order is central > 
axial > planar > helicity.  
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Figure 3. Assignment of planar chirality. 
 
Two chemically identical compounds that possess one stereogenic centre that are opposite 
in their stereochemical assignment are referred to as enantiomers and appear as mirror images of 
one another. A molecule may possess multiple stereogenic centres or axes/planes of chirality. 
Molecules which possess one or more elements of chirality in their stereochemical assignment (but 
are not mirror images) are diastereomers. For example, tartaric acid contains two stereogenic 
centres and may exist as two unique diastereomers (Figure 4). The structures with stereochemical 
assignments 1R,2R (5) and 1S,2S (8) are mirror images of one another, and are therefore 
enantiomers. Compounds with the stereochemical assignments 1S,2R (7) and 1R,2S (6) appear to 
be enantiomers, but because both chiral centres contain the same groups, these compounds are 
equivalent, and referred to as meso compounds. The number of stereoisomers that can exist for a 
chiral molecule depends on the number of individual stereogenic components within the molecule 
and can be calculated using the equation 2
n
, where n is the number of stereogenic centres or 
planar/axial elements of chirality in the molecule. This equation does not take into account the 
equivalence of meso-structures. 
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Figure 4. Isomers of tartaric acid. 
 
 Chiral compounds exhibit the ability to rotate plane-polarized light. This observation was 
made more than 200 years ago by French physicist François Jean Dominique Arago, who noted 
that compounds that possess structures which are mirror images of one another rotate plane 
polarized light in equal magnitudes, but in opposing directions.
8
 Since this observation, the specific 
rotation of chiral molecules has been used as a physical constant for chiral molecules. The specific 
rotation can be defined as the direction and number of degrees by which plane polarized light has 
been displaced per unit distance-concentration product as the light passes through a sample of 
compound in solution. In the equation (Figure 5), α is the magnitude of displacement in degrees, l 
is the path length of the sample measured in decimeters, and   is the density (concentration of 
analyte) of the solution in g/mL. The superscript in the equation indicates the temperature at which 
the measurement was taken while the subscript D refers to wavelength of light used to obtain the 
measurement; D stands for the sodium D line which is 589 nm. Though always expressed as 
degree (°) with clockwise rotation denoted as +, and counterclockwise rotation denoted as −, the 
true units of specific rotation are: °L/dm(g). It is customary to report the wavelength of light used 
7 
 
and the temperature under which the measurement was made. Factors affecting the measured 
optical rotation include: enantiomeric/diastereomeric purity, solvent used, wavelength used, 
temperature of the sample at the time of measurement, length of the cell, and the concentration of 
the analyte studied. There exists no linear relationship between these parameters and any 
comparisons made are only valid when all the parameters are identical to those first reported in the 
literature. The instrument used to measure the specific rotation of a sample is called a polarimeter. 
Although the equation for specific rotation implies a linear relationship between rotation and 
analyte concentration, this is not always the case as non-linear effects can occur in specific rotation 
measurments.
9
 
 
[ ] 
   = 
 
   
  
Figure 5. Equation for the calculation of specific rotations. 
 
All chiral molecules rotate plane polarized light, but it is still possible for some enantiopure 
molecules to possess a specific rotation of zero.  
 
1.2 Metal-Arene Complexes 
 
A metal-arene complex is a compound which contains a transition metal bound through 
neutral or anionic haptic bonds to one or two aromatic rings.
10
 There are two main categories of 
metal-arene complexes: sandwich compounds, and half-sandwich compounds. Representative 
examples of common metal arene compounds are shown in Figure 6. Sandwich compounds, which 
contain a metal atom haptically bound between two aromatic rings, can additionally be sub-
categorized as either bent sandwich compounds, which contain additional ligands, or regular flat 
8 
 
sandwich compounds. Half-sandwich compounds contain a metal atom bound by a single aromatic 
ring and can contain one or more additional ligands coordinated in a linear fashion. Half-sandwich 
compounds with three additional ligands are commonly referred to as “piano stool complexes” 
because they adopt a morphology that resembles a three-legged stool. Metal arene complexes with 
more diverse structures have been reported but do not easily fit into these categories. 
 
 
Figure 6. Representative examples of metal-arene complexes. 
 
The aromatic rings may be neutral (benzene) or anionic (cycopentadienyl) and many 
oxidation states of metals are also observed with 0, +2 and +4 being the most common.  Metal-
arene compounds can be formed with a variety of transition metals and aromatic compounds. 
Sandwich compounds containing the formula [(η5-C5H5)2M] are referred to as metallocenes. These 
compounds generally contain a metal atom in the +2 oxidation state and are haptically bound by 
9 
 
two anionic cyclopentadienide rings. The first metallocene to be characterized was ferrocene, 
which contains a Fe
2+
 atom in the centre.
12 
 
1.2.1 Ferrocene 
The structure of bis(cyclopentadienyl)iron(II), or ferrocene (10) was initially unclear and 
thought to consist of two σ-bonded Cp rings attached to a Fe2+ (9), as shown in Figure 7. 
 
 
Figure 7. Initial (left) and correct (right) structures of ferrocene. 
 
Ferrocene was discovered simultaneously in 1951 by two independent research groups: 
Keally and Pauson
11
 (Duquesne University) and Miller, Tabboth and Tremaine (British Oxygen 
Company).
12
 The correct structure was determined the next year by Woodward and Wilkinson
13
 
and Fischer and Pfab
14
 who were later awarded the 1973 Nobel prize in Chemistry for their 
contributions towards the study of metallocenes. The evidence that led to the determination of the 
correct structure (10) was the observation that all ten C-H bonds in the molecule were equivalent, 
leading to the correct assumption that the rings are aromatic and bound to the metal through haptic 
bonds.  
10 
 
Ferrocene is the oldest known and most widely studied organometallic compound.
15
 The 
discovery of ferrocene is credited with having caused the rapid growth and emergence of 
organometallic chemistry as a separate discipline. The bonding of ferrocene, as mentioned 
previously, is haptic through the two cycopentadienide rings. The six electron pairs donated to the 
central metal by the Cp rings fill the six d
2
 sp
3
 hybrid orbitals of the ferrocene, rendering it with a 
stable 18 electron configuration. Ferrocenes are electron-rich aromatics because of the formal 
negative charges resonating on the cyclopentadienyl rings. As a result, these compounds undergo 
electrophilic aromatic substitution three million times faster than benzene, but do not undergo 
nucleophilic aromatic substitution.
16
 They are stable to strong bases and reducing agents, but 
decompose in the presence of many strong oxidizing agents such as halogens, and nitric acid. It is 
for this reason that indirect methods such as mercuration or lithiation/substitution must be used to 
incorporate certain heteroatoms onto a Cp ring.  
Lithiation is the most commonly used method for the preparation of substituted 
ferrocenes.
17
 The isolation of monosubstituted ferrocenes via lithiation is not always a simple 
endeavour due to their tendency to undergo metalation on both Cp rings. Fortunately, procedures 
have been developed for the preparation of both monolithio- and 1,1'-dilithioferrocene.
18
 In 1990, 
Kagan reported a procedure for the preparation of monolithioferrocene using t-BuLi with a short 
lithiation period (15 min), achieving nearly quantitive yields (up to 98%) of monosubstituted 
products.
19
 Methods for the isolation of lithioferrocene have been described by Bildstein who, 
using the procedure established by Kagan for the preparation of monolithioferrocene, showed the 
intermediate can be precipitated and isolated using anhydrous Schlenk filtration techniques.
20
  On 
the other hand, 1,1'-dilithioferrocene can be obtained exclusively with the use of N,N,N’,N’-
tetramethylethylenediamine (TMEDA) in combination with n-BuLi in hexane.
21
 A more 
11 
 
convenient method for monosubstitution of ferrocene with electrophiles was reported by Mueller-
Westerhoff who employed Schlosser's base (t-BuLi/t-BuOK), which allows for an in-situ 
electrophile quench.
22
 
     The major applications of ferrocenes in industry are as ligands. The thermostability and oxygen-
tolerance of ferrocene make it a good ligand choice for reactions that require harsh conditions. In 
addition to stability, the ease of rotation between the upper and lower rings allows flexibility, 
reducing steric strain. A popular ferrocene ligand, [1,1’-bis(diphenylphosphino)ferrocene] (dppf) 
was first reported in the 1960’s and is still widely used today in a number of palladium-catalyzed 
reactions.
23
 Some widely used ferrocene ligands are the planar chiral PhTrap
24
 (55), Josiphos
25
 
(56), and Xyliphos
26
 (57) ligands (Figure 10). The syntheses and applications of these ligands will 
be discussed in detail in Section 1.3.2. (vide infra). 
There are a number of other fields in which ferrocene has found niche uses. Ferrocene 
derivatives have found applications in the fuel industry as “anti-knock” agents, and are known to 
be much safer than leaded alternatives.
27
 Certain ferrocenium salts have also been shown to 
possess anticancer and antimalarial activity.
28
 In the early 2000’s, a ferrocenyl analogue of 
Tamoxifen was used as an experimental drug to treat breast cancer.
29
 In materials chemistry, the 
degradation of ferrocene has found application in the production of carbon nanotubes.
30
 The 
polymerization of vinylferrocene produces the ferrocene analogue of polystyrene which has been 
studied as a conductive polymer.
31
 Owing to the ease of its crystallization, ferrocene is also 
sometimes used as an auxiliary to induce the crystallization of otherwise non-solid compounds for 
the purpose of determining absolute stereochemistry by the heavy atom method in X-ray 
diffraction of single crystals.  
 
12 
 
1.2.2 Arene-Chromium Tricarbonyl Complexes 
Arene chromium tricarbonyl complexes have the general formula (η5-C5H5)ML3 or (η
6
-
C6H6)ML3, where η refers to the number of carbons equally participating in the haptic bonds to the 
metal and ligands L are not required to be equivalent. In (η5-C5H5)ML3 compounds there is an 
anionic donor ligand with a haptic bond to the metal, whereas in (η6-C6H6)ML3 this haptic ligand is 
a neutral donor. This class of compounds also falls under a broader category of compounds called 
half-sandwich compounds, which is used to describe any haptic metal-arene that is bound to a 
single aromatic ring. The first "piano stool" complex characterized and studied was (η6-
C6H6)Cr(CO)3 (11) (Figure 8) reported by  Fischer and Ӧfele in 1957. This compound was first 
prepared by carbonylation of bis(benzene)chromium.
32
  The crystal structure was determined two 
years later by Corradine and Allegra.
33
  Since then, a number of syntheses of these types of 
compounds have been reported, all of which involve variations of the original procedure.
34
 
Methods for complexation include refluxing the arene with metals of the type M(CO)6, or via 
transfer reactions, in which the pre-complexed Cr(CO)3 is transferred from one aromatic ring to 
another which contains a higher electron density. This second type of transfer reaction can be 
thought of as nucleophilic substitution, in which the more electron-rich ring system functions as 
the better nucleophile. Typical transfer reagents for this type of reaction include naphthalene-
Cr(CO)3 and L3Cr(CO)3 where L is a labile ligand such as acetonitrile, ammonia or pyridine.   
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Figure 8. Benzene(chromium) tricarbonyl. 
 
Despite the existence of arene-metal-tricarbonyl complexes containing a wide range of 
metals and ligands (L), only complexes based on an (η6-C6H6)Cr(CO)3 formulation will be 
discussed here and will be referred to as ArCr(CO)3. In general, the industrial applications of 
ArCr(CO)3 are somewhat limited. They are mainly used as catalysts for the large-scale preparation 
of substituted pyridines,
35
 and as anti-knock agents in the petroleum industry.
36
 In academic 
applications, they have been used as ligand scaffolds in transition-metal catalyzed reactions and as 
electrophilic arene equivalents to which nucleophiles may be added via SNAr chemistry, owing to 
their electron deficiency.
37
 
Typically, ArCr(CO)3 are bright yellow in colour due to their strong absorption in the low 
400 nm region of the electromagnetic spectrum. Compounds of the formula (η6- C6H6)Cr(CO)3 
have an octahedral coordination geometry. In terms of valence bond theory, the six electron pairs 
donated to the central metal by the ligands fill the six d
2
 sp
3
 hybrid orbitals of the chromium
0 
atom, 
rendering it an 18 electron complex. Three of these pairs of electrons are donated by the arene and 
the remaining pairs by the carbon monoxide molecules. Overlap of the full non-bonding d orbitals 
of the chromium atom with the empty anti-bonding orbitals of ligands decreases the overall 
electron density on the metal atom, contributing to the instability of these compounds.
38
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The unique reactivity of ArCr(CO)3 complexes arises from the overall net electron 
withdrawing nature of the  chromium and carbon monoxide ligands.
39
 The Cr(CO)3 moiety has an  
electron withdrawing effect similar to that of a nitro group.
40
 This diminishment of electron density 
of the aromatic ring has two major effects on the overall properties of the molecule. The first effect 
is the observation of enhanced acidity (lowered pKa) of the aromatic protons. Upon complexation, 
the pKa of an unsubstituted benzene ring drops from approximately 43 to 35.
41
 This enhanced 
acidity allows for the deprotonation of the complexed aromatics by a number of bases including 
alkyllithiums, and metal-amides.
42
 The second effect observed is an increased propensity of these 
molecules to undergo nucleophilic aromatic substitution (SNAr) and nucleophilic aromatic addition 
with nucleophiles.
38
 Under normal conditions the electron cloud of the uncomplexed benzene ring 
acts as a deterrent to nucleophilic additions by anions, and instead favours deprotonation. 
Depending on both the size and pKb of the base used, and the size and properties of substituents 
already present on the aromatic ring, different reactivities are observed.
43
 
 
 
Scheme 1. Reactivity of anions with benzene(chromium) tricarbonyl.
44 
15 
 
     In general, metalated compounds whose conjugate acids have a pKa above 35, with the 
exception of t-BuLi, tend to act as bases towards benzene chromium tricarbonyl.
44
 Metalated 
compounds with a lower pKa (22-34), such as enolates, allylic and heteroatom-stabilized anions 
tend to act as nucleophiles.
45
 A summary of the reactivities of many bases/nucleophiles is provided 
in Scheme 1. The reactivity of certain anions can in some cases be selectively modified to act as 
either a base or a nucleophile with the use of additives such as hexamethylphosphoramide (HMPA) 
or  dimethylpyrimidone (DMPU).
45
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Scheme 2. Reactivities of substituted arene-chromium tricarbonyl complexes toward nucleophilic 
addition and further manipulations. 
 
In the late 1970’s, Semmelhack et al. undertook a thorough investigation of the reactivities 
of these compounds towards metalation and nucleophilic addition. Comprehensive summaries of 
the reactivities of various mono- and di-substituted (η6- C6H6)Cr(CO)3  complexes towards 
metalating reagents and nucleophiles (Schemes 1 and 2) have been reported.
44
 In the decades since, 
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the utility of these compounds have been demonstrated through the preparation of optically pure 
synthons for the asymmetric synthesis of complex molecules and natural products such as (−)-
lausubine
46
, 11-epi-helioporin B
47
, (+)- and (−)-acetoxytubipofuran48, korupensamine49 and  
 
 
Scheme 3. Stereoselective synthesis of AB-ring system of aklavinone.
51 
 
aklavinone
50
 (20). Uemura’s synthesis of alkavinone (Scheme 3) is an example of the types of 
stereoselective transformations that are possible with ArCr(CO)3. The naphthalene derivative 18 
first undergoes nucleophilic addition from above the plane of the complexed ring. The anion 
resulting from this addition then stereoselectively adds to a coordinated carbon monoxide ligand 
from below the plane of the ring. The acyl anion generated is then trapped with methyliodide 
providing a methyl ketone (19). In one pot, a 1,2-trans substitution pattern was generated using the 
planar chirality imparted by the complexation to chromium(tricarbonyl).  
   
1.3 Synthesis and Applications of Planar Chiral Ferrocenes and η
6
-Arene Chromium 
Tricarbonyl Complexes  
The most convenient method of functionalizing metal-arene complexes is by metalation 
with strong bases followed by substitution with electrophilic reagents. The range of the pKa values 
18 
 
of the aromatic C-H bonds in metal arene complexes is between 33-40 (this is based on the 
capacity of such compounds to be deprotonated by metalating reagents such as LDA with a pKa of 
approximately 34).
51,52
 This property allows them to be deprotonated by most commercially 
available bases. The methods of preparing optically active metal-arene complexes by metalation 
can be classified into two categories that involve the use of either chiral metalating reagents 
(enantioselective), or chiral directing groups/auxiliaries (diastereoselective).  
 
1.3.1 Enantioselective Lithiation 
The use of chiral metalating reagents for the desymmetrization of prochiral metal-arenes 
was and perhaps still is the most efficient method for the generation of planar chirality in this class 
of compounds. Directed enantioselective ortho-metalation was independently developed by a 
number of research groups such as Kündig
53
, Simpkins
54
 and Uemura.
55
  Among the metal-arenes 
most easily desymmetrized are those bearing heteroatom substituents. Many heteroatom 
substituted ArCr(CO)3 and ferrocenes undergo ortho-metalation by chiral lithium amide bases 
(Figure 9), resulting in poor to excellent enantiomeric ratios (75:25 to 97:3), upon quenching with 
suitable electrophiles.
56
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Figure 9. Selected chiral lithium amide bases used in asymmetric lithiation. 
 
Arguably the simplest, most widely known and used chiral lithium amide base is the 
“Simpkins base” (21), named after Nigel Simpkins who first demonstrated its use.41 While 
desymmetrization of ArCr(CO)3 was possible by this method, these bases were for the most part 
ineffective at introducing high levels of enantioselectivity in ferrocenes (Scheme 4). Despite the 
high yields, only phosphinyl ferrocenes underwent desymmetrization (up to 75:25 er) by these 
bases.
57
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Scheme 4. Enantioselective lithiation-substitution of metal-arenes 
with Simpkin’s base.41,58 
 
Uemura and coworkers have demonstrated that enantioselective lateral lithiation of 
prochiral methylene groups of ArCr(CO)3 compounds is possible with chiral lithium amide bases 
(Scheme 5), providing products in high yields and with up to 97:3 er.
58
 This was demonstrated in 
his synthesis of atropoisomeric benzamides and anilides from prochiral starting materials. Using 
Simpkin's base (21), both planar and axial chirality may be introduced in high yields and 
enantiomeric ratios (up to 99:1).
59
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Scheme 5. Enantiotopic lateral lithiation of prochiral anilides with chiral amide  
bases inducing planar and axial chirality.
59 
 
 
Chirality can also be imparted to prochiral substrates via lithiation with achiral bases if 
chiral ligands are added to the reaction mixture. This approach effectively creates a chiral base 
upon complexation. These chiral additives commonly contain appropriate chelating atoms such as 
oxygen, or more commonly, nitrogen.
60
  The use of chiral additives towards the asymmetric 
lithiation of metal arenes was the first ever attempted enantioselective lithiation. In 1970, Nozaki 
showed that (−)-sparteine-mediated lithiation of isopropylferrocene resulted in mixtures of 
products with minor optical activity (52:48 er).
61
 Since then, Widdowson and coworkers have 
demonstrated that high levels of enantiopurity (up to 96:4 er) are observed in the products of 
heteroatom-substituted ArCr(CO)3 complexes subjected to the same conditions.
62
 The limitations 
of chiral amide bases, and chiral additives to effectively induce enantioselectivity in ferrocene 
lithiation left a major gap in the asymmetric methodology of ferrocenes that wasn’t revisited for 
two decades.  
In the latter part of the 20
th
 century, inspired by Beak
63
 and Hoppe,
64
 Snieckus 
demonstrated that (−)-sparteine-mediated directed ortho-metalation of N,N-
diisopropylferrocenecarboxamide (35) proceeded with high levels of  enantioselectivity (Scheme 
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6).
65
 The major increase in selectivity compared to the results obtained by Nozaki may be 
attributed to the coordinating capability of the heteroatom directing group present on the ring. A 
more facially-selective chiral intermediate is formed upon coordination of (−)-sparteine (37) to the 
lithiated intermediate. In essence, the major difference between the results of Nozaki and Snieckus 
was that Nozaki studied asymmetric ortho-metalation while Snieckus investigated asymmetric 
directed ortho- metalation (DoM). A not widely known fact from Nozaki’s orginal publication was 
that diastereoselectivity was observed in lithiations of ferrocenes bearing chiral nitrogen containing 
substituents.
47 
The presence of heteroatoms with coordination capability within the substrates has 
an observable effect on the enantioselectivity of lithiations. This observation is known as the 
complex-induced proximity effect, which aims to explain the differences in reactivity of lithiated 
compounds.
66
   
 
 
Scheme 6. (−)-Sparteine-mediated lithiation of N,N-diisopropyl ferrocenecarboxamide  
and electrophile quench.
66 
 
  (−)-Sparteine (37) is a natural product of the alkaloid class of compounds and is derived 
from leguminous flowers such as the Scotch Broom.
67
 Many efforts have been made towards its 
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total synthesis and many have been successful. Despite this, and its natural abundance, the 
stoichiometric use of complex natural products for the induction of enantioselectivity in lithiations 
is not considered sustainable. This urged further studies into use of chiral diamines as asymmetric 
catalysts for lithiation, which fortunately revealed that other synthetically derived chiral diamines 
could be used for the induction of chirality.
68
 Uemura demonstrated the use of chiral 1,2-
cyclohexyldiamines to induce up to 90:10 er in the lithiation-substitution of N,N-
dimethylaminoferrocene, but with low overall yields (5-49%).
69
 The next advancement in this area 
was done by Metallinos, who expanded upon the results of Kessar
70
, Harmata
71
, Vedejs
72
, and 
Simpkins
73
 who demonstrated the ease with which certain BF3- or BH3- coordinated tertiary 
amines underwent sp
3
-lithiation α to nitrogen. Applying this approach to the directed ortho-
metalation of dimethylaminoferrocene (38), 1,2-disubstituted products were obtained in higher 
yields than had been previously reported (up to 93%). In conjunction with the BF3 activation of 
dimethylaminoferrocene (38), the use of chiral diamines, both natural and synthetically derived, 
was also studied (Scheme 7). The use of (−)-sparteine (37) had very little influence on the 
selectivity of the deprotonation by isopropyllithium, but much greater selectivity was observed 
with the use of synthetically derived chiral cyclohexyldiamines (40 and 43, up to 90:10 er). Even 
more useful was the observation that the lithiation selectivity could be reversed with the use of the 
enantiomer of the chiral diamine ligand. Using this method, a rare class of enantio-enriched 1-
amino-2-phospinoferrocene ligands (45) was synthesized and coordinated to various metals (Pd, 
Pt, Ir). Each of these compounds was then investigated as ligands in asymmetric transition metal-
catalyzed reactions for their activity and induction of selectivity.
74
 The stereochemistry of 42 and 
45 was confirmed by X-ray crystallography.While this method provided access to enantiopure 
planar chiral aminoferrocenes after recrystallization, not all products were easily crystallized. The 
24 
 
lack of manipulability of the tertiary amine to a different functional group limited the utility of the 
products. 
 
 
Scheme 7. Lithiation of BF3-activated aminoferrocenes with diaminocyclohexane 
ligands/i-PrLi. 
 
1.3.2 Diastereoselective Lithiation 
1.3.2.1 Diasteroselective Lithiation of Ferrocenes 
The most widely studied method of stereoselective planar chiral induction in metal arene 
compounds involves diastereoselective lithiation with chiral directing groups or auxiliaries. This 
method relies on pre-existing chirality in the molecule to differentiate the two diastereotopic 
"ortho-" or neighbouring protons. Coordination of heteroatoms in the directing group to the base 
results in diastereoselective formation of lithiated intermediates. Chiral carbon-,
75
 phosphorous-
76
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and sulphur-based
77
 directing groups have been reported as viable auxiliaries for the 
diastereoselective lithiation of ferrocenes (Scheme 8). 
 
 
Scheme 8. Diastereoselective lithiation of ferrocene and examples of  
selected chiral directing groups. 
 
The first diastereoselective lithiation of pro-planar chiral substrates was reported by Nozaki 
in the late 1960’s.62 In this, he reported that lithiation of a chiral piperidinyl ferrocene (49, Scheme 
8) followed by electrophile quench gave 2-substituted products in low yields, but in high 
26 
 
diastereomeric ratio (up to 93:7 dr). However, the diastereoselectivity of this substrate was called 
into question shortly after by Ugi, who upon repetition of these experiments was unable to achieve 
the reported selectivity.
78
  
The next and perhaps simplest reported chiral auxiliary N,N-dimethylferrocenyl-α-
ethylamine (48) was developed by Ugi in the 1960s.
76c
 Resolution of racemates with (R)-(+)-
tartaric acid provided both enantiopure substrates. This strategy involved the directed ortho-
lithiation of N,N-dimethylferrocenyl-α-ethylamine (48, Scheme 9). The origin of selectivity in this 
reaction is thought to arise from a conformational bias induced by steric repulsion of the α-methyl 
group with the lower Cp-ring of the ferrocene core (Scheme 9). In the most stable conformation, 
(52a) the methyl group would be oriented above the plane of the ring to minimize steric interaction 
with the lower unsubstituted Cp ring. In this conformation, the nitrogen coordinates to the 
alkyllithium delivering it to the pro-Rp hydrogen atom, resulting in selective deprotonation. 
Opposite stereoselectivity is observed in the lithiation of the enantiomer, which also provides 
planar chiral products in up to 96:4 dr. 
 
 
Scheme 9. Proposed origin of lithiation selectivity of Ugi’s amine.76c 
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The attractive feature of Ugi’s amine (48) is that the substituted products can undergo 
further manipulations. For example, stereoselective SN1 reactions occur with retention of 
stereochemistry, by substitution of the dimethylamino group with other nucleophiles. This 
methodology is used for the large-scale preparation of planar chiral ferrocene compounds which 
are used as ligands in metal-catalyzed reactions. The most commonly prepared ligands are those 
mentioned previously: diphosphinylferrocenes such as PhTRAP (55), JosiPhos (56) and Xyliphos 
(57), shown in Figure 10.
79
 
 
 
Figure 10. Commercially important planar chiral ferrocene ligands derived from Ugi’s 
amine. 
 
The largest scale application of a ferrocene containing compound is in the synthesis of 
Metolachlor, an active ingredient in the herbicide Dual.
80
 A cationic iridium complex of 57 is 
employed as a hydrogenation catalyst in the late-stage reduction of an intermediate in the synthesis 
of Metolachor. This catalyst possesses very high activity, allowing it to be used at low loadings (1 
x 10
-7
 mol%). Metolachlor is produced in quantities >20 000 tonnes per year; low catalyst loadings 
makes this method viable for such large scales.  
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Reported independently by a number of groups, ferrocenes bearing chiral oxazolines (47) 
have also been shown to undergo diastereoselective lithiation with high selectivity.
81
 This directing 
group is thought to induce selective deprotonation by means of a steric interaction with the alkyl 
group of the alkyllithium reagent and the R-group substituent on the oxazoline. The extent of 
diastereoselectivity depends on the size of the base used. Directing groups that undergo selective 
deprotonation which exhibit dependence on the bases used have been referred to as "under base 
control" (Scheme 10).
2b 
 
 
Scheme 10. Proposed origin of lithiation selectivity of Kagan's oxazoline.
82a 
 
     A survey of all the chiral directing groups used for diastereoselective lithiations of ferrocene-
containing compounds revealed that there are no N-based chiral directing groups in which the 
nitrogen is attached directly to the Cp ring. The lack of ferrocenyl N-based directing groups is not 
surprising due to the difficulty associated with introducing nitrogen onto a Cp ring (Scheme 11). 
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The first method of preparing chiral aminoferrocenes was established by Togni in 1981, where he 
employed a lengthy synthesis comprised of multiple functional group conversions.
82
 Beginning 
with Kagan’s acetal (46), diastereoselective lithiation followed by electrophile quench with methyl 
iodide provided the planar chiral ferrocene (61), which was then subjected to acid-hydrolysis of the 
acetal providing the ferrocenyl aldehyde (62). This aldehyde was then oxidized to an ester (63), 
hydrolyzed (64), converted to an acyl azide (65), and then subjected to Curtius rearrangement 
conditions to provide the Cp-nitrogen bond (66). This provided the first method for the synthesis of 
planar chiral ferrocenes in which the imidazolium moiety was bound directly to the Cp ring (68). 
While this method did provide access to planar chiral aminoferrocenes that were amenable to 
further manipulation, the number of steps required to access these compounds made this 
methodology unappealing.  
 
 
Scheme 11. Togni’s synthesis of planar chiral aminoferrocenes using Kagan’s acetal.83 
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Togni was determined to find a convenient method by which these compounds could be 
prepared. His next route made use of Ugi’s amine (48) to induce planar chirality by sequential 
lithiation and quench with CO2.  Hoffman elimination of the resulting amine, followed by a Curtius 
rearrangent of an acyl azide, addition of nucleophiles across the alkene, and reduction of the N-
benzyl group provided a planar chiral aminophosphine ligand. The number of steps required to 
prepare planar chiral aminoferrocenes highlighted the need for additional methods.  
In the late 1990’s Salter employed a method for the introduction of a nitrogen ferrocene 
bond by lithiation of a ferrocenyl oxazoline (47) and electrophile quench with N2O4, followed by 
hydrolysis of the oxazoline and Pt-catalyzed reduction of the photosensitive nitroferrocene.
83
 
While feasible, there is little that can be done with the resulting aminoacid (ester). The ability to 
convert the directing group to a heteroatom or other functional group would impart utility to this 
method, unfortunately it is not applicable to non-carbon based directing groups.  
While Ugi's amine is amenable to further manipulations, additional "traceless" directing 
groups (those which can be completely removed from the final products) are desired. In this 
regard, only Kagan's sulfoxides (51) are removeable.
76a
 Treament of these sulfoxides with t-BuLi 
affords lithium-sulfoxide exchange resulting in a lithioferrocene which can then quenched with 
additional electrophiles.
84
 This method is very useful for the preparation of planar chiral 
ferrocenes, given that the initial functional group substituted onto the ring is stable to 
organolithium reagents.  
Previous work in the Metallinos group has focused on developing new chiral N-based 
auxiliaries for diastereoselective lithiation of ferrocenes. The feasibility of this type of directing 
group was established when ferrocenyl phthalimidines (71) underwent diastereoselective lithiation 
in excess of 95:5 dr (Scheme 12). This auxiliary, albeit in racemic form, could be cleaved to 
31 
 
aminoferrocenes in principle by oxidation back to the phthalimide and treatment with hydrazine. 
The substrates were prepared racemically by an Ullman coupling of iodoferrocene (78) and 
phthalimidine to produce 69, followed by reduction and silylation of the hemiaminal (70) affording 
racemic starting materials (71). When treated with LDA with an in-situ electrophile quench with 
TMSCl, a 2-substituted compound was obtained as the major product (72), in addition to an 
inseparable mixture of regioisomers and disubstituted products. The key observation of this result 
was that the 2-substituted product (72) appeared to be a single diastereomer by 
1
H and 
13
C NMR 
spectroscopy. What this meant was that each enantiomer underwent diastereoselective lithiation 
with   95:5 diastereoselectivity. This was promising because if this result could be observed with 
an optically pure starting material, a new N-based chiral auxiliary had been discovered.  
 
Scheme 12. Diastereoselective lithiation of phthalimidines.
75 
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Based on previous work done in our lab on diastereoselective sp
3 
ortho-lithiation of L-
proline derived imidazolone 75 (Scheme 13),
85
 and the current need for a homochiral imide, an L-
proline derived hydantoin (79) was chosen as a starting material. Thus, L-proline hydantoin (79), 
prepared by condensation of KOCN with L-proline (77), followed by recrystallization of the crude 
 
 
Scheme 13. Diastereoselective lithiation of L-proline derived imidazolones. 
 
product from water (Scheme 14). L-proline hydantoin (79) was then coupled to iodoferrocene (78) 
using a modified Ullman procedure using DMSO as solvent to give ferrocenyl hydantoin 80.
2a 
Stepwise hydrosilylation of 80 with Cp2ZrHCl (Schwartz reagent) followed by trapping of the 
zirconium alkoxide with TESCl gave (syn-81). Lithiation of syn-81 with t-BuLi followed by 
electrophile quench with various electrophiles (Scheme 15) gave planar chiral products in >95:5 dr 
via deprotonation of the pro-Sp hydrogen atom.
2a
 The 95:5 dr observed is comparable to what was 
observed with other directing groups such as Ugi’s amine (48), oxazolines (47), or acetals (46), 
(Scheme 8). This method represented the first example of a chiral N-based directing group used for 
the diastereselective lithiation of ferrocene.
2a
 Further studies of the lithiation behavior revealed that 
the selectivity of the deprotonation was not sensitive to the size of the base used, implying that the 
selectivity was not under base control. The selectivity of the deprotonation was established by 
obtaining a crystal structure from an X-ray diffraction of a single crystal of boronic acid derivative 
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(82h). The structure revealed that the lithiation was selective for deprotonation of the pro-Sp 
hydrogen atom.
2a  
The origin of selectivity in the lithiation of syn-81 was then studied. Based on the 
results of other chiral directing groups used in diastereoselective lithiations of ferrocene, it can be 
generalized that the origin of selectivity of directing groups with stereocentres α to the ferrocene 
core arises through steric interactions of the directing group with the lower Cp ring (Cp ring 
control, vide supra). Directing groups with stereocentres farther away from the ferrocene core (γ or 
beyond) usually operate by steric influences of the substrate with the base (base control) because 
steric interactions with the lower Cp ring at such distances are generally negligible (vide supra).
2b 
 
 
 
Scheme 14. Synthesis of L-proline derived pyrroloimidazolidine auxiliary. 
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Scheme 15. Substrate scope for lithiation of syn-81.
2a 
 
       To determine by which mode this directing group operated, the β-epimer was synthesized. It 
was reasoned that if the directing group operated by Cp-ring control, a reversal of lithiation 
selectivity would be observed.
2b
 The anti-epimer was prepared by reduction of ferrocenyl 
hydantoin (80) with Schwartz's reagent. The isolated configurationally unstable hemiaminal (83) 
mixture was then treated with n-BuLi followed by silylation, affording a nearly 1:1 mixture of syn- 
and anti- epimers (81), which were separable by flash column chromatography (Scheme 16).
2b
 As 
was anticipated, lithiation of anti-81 with t-BuLi followed by electrophile quench gave products 
(84a-c) that were single diastereomers (  95:5 dr by 1H and 13C NMR spectroscopy). Importantly, 
the products 84a-c possessed the opposite planar chirality via deprotonation of the pro-R hydrogen 
of the Cp ring.  
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Scheme 16. Synthesis and lithiation of anti-81.
2b
  
 
     The reversal of lithiation selectivity was confirmed by single-crystal X-ray diffraction of the 
anti-derived methyl derivative (84a).
2b
 Further evidence of the preferred orientations of the urea 
carbonyls in both syn- and anti-81 was obtained by nOe experiments. Irradiation of the methine at 
δ 5.44 for the syn-81 produced a 1.0% nOe for a Cp hydrogen at δ 4.30. What this meant was that 
the hydrogen located at the β-stereocentre was close to the pro-R hydrogen atom on the Cp ring. 
Therefore, the doublet at δ 4.80 was tentatively assigned at the pro-SP hydrogen of the Cp ring. In 
the case of anti-81, the doublet at δ 5.41 was tentatively assigned as the pro-RP hydrogen. This was 
assigned based on an nOe of 0.6% upon irraditation of the methine at δ 5.41. Lithiation and 
deuteration of both epimers confirmed this assignment as both of these signals are completely 
diminished in the 
1
H NMR spectra of the deuterated epimers.  
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Scheme 17. Comparison of imidazolone antipodes derived from syn and anti epimers.
2b
  
 
The stereochemistry of the products was confirmed by acid catalyzed elimination of the 
silanol to give solely planar chiral products (Scheme 17). The products obtained had opposite 
specific rotations, thus were shown to be enantiomers.  
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1.3.2.2 Diasteroselective Lithiation of η
6
-Arene Chromium Tricarbonyl Complexes 
Thus far, chiral carbon- and sulphur- based directing groups have been reported for the 
induction of planar chirality in ArCr(CO)3 by diasteroselective lithiation. Of these, α-ethylamines
86
 
(86), aminals
87
 (87), chiral acetals
88
 (88), and sulfoxides
89
 (89) are prime examples (Figure 11).  
 
 
Figure 11. Chiral directing groups used in diastereoselective lithiations of arene-chromium 
tricarbonyl complexes. 
 
The methodology developed by Ugi (chiral α-ethylamines, Scheme 9) was later applied 
towards the diastereoselective lithiation of ArCr(CO)3, in which even higher levels of 
diastereoselectivity were observed (99:1 dr).
87
 It has been established that the lithiation selectivity 
of ArCr(CO)3 with chiral centres α to the aryl ring operates under the same principle as proposed 
for ferrocenes, i.e., that selectivity arises from avoidment of steric interactions with the CO ligands 
instead of the Cp ring (Cp ring control). ArCr(CO)3 derived from α-ethylamines (86) can also be 
further manipulated via SN1 chemistry. Salzer has demonstrated that treatment with 
chloroethylchloroformate of ArCr(CO)3 bearing α-ethylamines results in substitution of the 
dimethylamine by a chlorine atom with retention of stereochemistry (Scheme 18).
90
 This chloride 
may be nucleophilically displaced in an SN1 fashion by other nucleophiles with the use of TlPF6.
91
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This method was used for the preparation of Hasiphos
91
 (92) and Daniphos
92
 (93), ArCr(CO)3 
analogues of the ferrocenyl diphosphine ligands. These ligands were shown to be useful for 
asymmetric induction in a number of transition metal-catalayzed reactions such as Suzuki-Miyaura 
couplings, allylic alkylations
93
 and Heck reactions, among many others.
94
 
 
 
Scheme 18. Conversion of α-ethylamines to other functional groups and ligands.91-93 
 
ArCr(CO)3 analogues of  chiral auxiliaries used for diastereoselective lithiations of 
ferrocene have been developed based on chiral acetals,
95
 chiral sulfoxides
96
 derived from Ellman’s 
reagent, oxazolines,
97
 aminals,
98
 sulfoximines,
99
 hydrazones,
100
 and imidazolines.
101
 Some of these 
auxiliaries are sensitive to the steric demands of the bases used for lithiation, while some are not. In 
ferrocene lithiations, the directing groups which exhibit sensitivity to the bases used are referred to 
as under base control, whereas the reactions which are unaffected by the size of the base are 
referred to as under Cp-ring control. As previously explained, classical substrates such as Ugi's 
amine (48) operate under Cp ring control (Scheme 9). Since there is no direct analogy for 
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diastereoselective lithiations of ArCr(CO)3, the terms “substrate” or “carbonyl control” will 
tentatively be assigned for directing groups whose selectivity is not sensitive to the base used 
(analogous to Cp ring control). Some of these auxiliaries allow for further manipulation of the 
directing group, while some are permanently present in the final products. It should also be noted 
that thus far, no N-based directing groups have been reported for diastereoselective lithiation of 
ArCr(CO)3.  
 
1.3.3 Applications of Planar Chiral Ferrocenes as Ligands for Asymmetric Transition-Metal 
Catalyzed Reactions 
When the diphenylmethanol adduct 82c was treated with acid an unexpected tetracyclic 
product (94) was obtained in which the alcohol had intramolecularly added to the intermediate 
imminium ion (Scheme 19).
3
 Both syn- and anti-derived adducts (82c plus its diastereomer) 
underwent annulation, the stereochemistry of the products was assigned using the coupling 
constants of the methine proton at the acetal-aminal juncture and nOe experiments. This compound 
was then converted to an NHC ligand by the methods shown in Scheme 19. This NHC was then 
trapped with [Ir(COD)Cl]2 providing 95. Treament of this compound with PPh3 then gave cationic 
Ir-complex 96a. Following the same synthetic route, 96b was prepared from anti-81.
102
 
Based on the work by Crabtree and coworkers who employed imidazolylidenes as ligands 
for the Ir-catalyzed hydrogenation of 2-substituted quinolines,
103
 chiral imidazolylidene ligands 
have been of particular interest to the Metallinos group. The use of imidazolylidene ligands 
dramatically increases the reactivity of the Ir-catalysts towards hydrogenation, allowing for high 
conversions at low H2 pressures (as low as 1 atm), with sterically demanding substrates converting 
at slightly higher pressures (5 atm).
104
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Scheme 19. Synthesis of Ir-complexes 96a-b.
3 
 
The chiral Ir-complexes 96a-b were tested for their acitivity as hydrogenation catalysts 
under similar conditions reported by Crabtree (Scheme 20).
103
  After optimization of the 
conditions, and the hydrogenation of numerous 2- and 2,6-disubstituted quinolones, it was found 
that syn-derived complex 96a was capable of hydrogenating quinolines under 5 atm of H2 at 1 
mol % catalyst loading with up to 90:10 er and good overall yields (25-94%).
3
 Anti-derived 
complex 96b was found to give high overall conversions but with low enantioselectivities (73:27 
er), and only at high pressures of H2 (45 atm). Analogues of Ir-complex 96a-b were synthesized by 
changing the carbonyl electrophiles during the lithiation step. An analogue incorporating 
benzaldehyde as the electrophile gave an annulated compound upon cyclization with a syn-
stereochemical relationship in the ligand framework, similar to the anti-derived 96b. Under the 
optimized conditions, this analogue gave good conversion of 2-methylquinoline (88%) but with 
poor enantioselectivity (59:41 er).
105
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Scheme 20. Substrate scope for the asymmetric hydrogenation of quinolines with 96a.
3 
   
      Based on the results of the 2-methylquinoline hydrogenations with complexes 96a-b, it may be 
inferred that an anti-stereochemical relationship of the ligand backbone is favourable for inducing 
high enantioselectivity. What is unclear is the role that the planar chiral ferrocene moiety plays in 
the low pressure reactivity and selectivity of the hydrogenation. This anti-relationship in the 
imidazolylidene ligand backbone is present in a number of commerically available chiral catalysts. 
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The first enantioselective Grubbs ring closing metathesis catalyst 99 (Figure 12) bears a 4,5-
diphenyl-anti-configured imidazolinylidene ligand.
106
 In Grubbs’ first report of this catalyst, he 
mentioned that the anti-substituted backbone was effective at transferring chiral information from 
 
 
Figure 12. Grubb's 1
st
 enantioselective metathesis catalyst. 
 
the backbone to the metal centre by means of a “gearing effect” imparted on the mono-ortho-
substituted aryl rings. In this ligand, the ortho-substituted aryl groups orient themselves into an 
anti-anti-configuration with respect to the 4,5-trans-diphenyl substituents, thereby relaying the 
chiral information to the metal-centre.
107
 While this gearing effect may not be present in rigid 
systems such as the annulated Ir-complexes 96a-b, the anti-configuration of the imidazolylidene 
ligand may play an important role in the transfer of chiral information to the substrates. 
      With multiple sites and elements of chirality within ligands 96a-b it can be difficult to pinpoint 
which stereocentre(s) are responsible for the observed enantioselectivity. With regards to central 
chirality, both syn- and anti- configured imidazolylidene ligands showed catalytic activity, but only 
the anti-configured ligand 96a demonstrated good enantioselectivity.
3
 The element of planar 
chirality may be too far away from the metal centre to impart any chiral information. In addition to 
that, and the variance in reactivity observed with different phosphines, a bidentate ligand with a 
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phosphine bound directly to the Cp ring was sought.
107
 In this bidentate ligand, the element of 
planar chirality would be closer to the metal centre and may impart this chiral information, thereby 
increasing the enantioselectivity.  
In the initial attempts at substituting the ferrocene with a phosphine by lithiation-quench, 
spontaneous oxidation of the resulting ferrocenylphosphine was observed (Scheme 21).
108
  To 
circumvent this problem, a less electron rich phosphine bearing electron-withdrawing 
trifluoromethyl groups was prepared by the methods reported by Casalnuovo.
109
 Unfortunately, 
every attempt at the oxidation of the aminal bearing this phosphine with various oxidizing agents 
did not provide the desired imidazolinium salt. Despite the presence of electron withdrawing 
groups, the nucleophilic nature of arylphosphines (which is exploited in their use as ligands) was 
likely the reason for which this method was not working.  
 
 
Scheme 21. Attempted synthesis of phosphino imidazolones from syn-81.
110 
 
     Another attempt at the synthesis of a bidentate phosphine-NHC ligand was attempted by 
lithiation of the annulated urea (Scheme 22). Lithiation of 100 proceeds by coordination of the urea 
oxygen to the alkyllithium base resulting in ortho-substitution upon electrophile quench providing 
the trisubstituted planar chiral ferrocene 101. To avoid the reaction of nucleophilic phosphines with 
44 
 
DIBAL-H, iodine was first installed. After reduction by DIBAL-H, 102 was subjected to metal 
halogen exchange with n-BuLi providing 103. Unfortunately, these arylphosphines are 
incompatibible with the highly electrophilic oxidants required to oxidize the aminal, resulting in 
phosphonium adducts instead of imidazolinylidenes. The use of phosphines with electron 
withdrawing groups, or protecting groups resulted in either partial recovery or decomposition of 
the starting materials.  
 
Scheme 22. Attempted synthesis/coordination of bidentate phosphine-NHC ligand. 
 
      The efforts towards a bidentate ligand were not abandoned. Instead, a more robust imidazolium 
ligand was sought, based on the work of Debono et al.
110
 Racemic and planar chiral phosphine-
imidazolylidene ligands (105) were prepared by the Ugi method (lithiation of 48) and coordinated 
to Pd-sources (Scheme 23).
112
 It was the first report of a planar chiral Pd-imidazolylidene complex 
to be used as a catalyst in asymmetric Suzuki-Miyaura couplings. The bidentate complexes 106 
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and 107 contain a 7-member coordination ring. These compounds all displayed moderate activity 
in Suzuki-Miyaura couplings of arylbromide and boronic acids with yields of up to 87%. When 
used for asymmetric couplings of 2-substituted napthylboronic acids and halides, good conversions 
(up to 95%) but poor enantioselectivities (  71:29 er) were observed.112  
 
 
Scheme 23. Synthesis of Pd-complexes bearing bidentate planar chiral ligands.
112
  
 
Secondary ureas may be converted to NHCs by an indirect method by first preparing a 
chloroimidazolium species.
113
 Treatment of the resulting chloroimidazolium with t-BuLi effects a 
metal-chlorine exchange providing the NHC, which can be trapped by electrophilic metals or other 
reagents (or it can be protonated). This methodology has previously been used by our group for the 
preparation of chiral imidazolylidenes
111
 and guanidines
86
 derived from the same L-proline 
hydantoin (79) starting material.  
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Chlorination of ureas can be accomplished by a number of reagents including oxalyl 
chloride, thionyl chloride, and chlorophosphorous reagents (PCl3, PCl5, POCl3).
112
 Depending on 
the substrate, the product may be prone to nucleophilic addition (or rehydration by water). 
Chloroimidazoliniums derived from saturated imidazolines are more susceptible to nucleophilic 
attack.
114
 This reactivity has been used for the preparation of guanidines.
86
 Stabilized 
chloroimidazoliums are those derived from unsaturated imidazolones, which are stablilized by the 
aromatic imidazolium ring. These compounds are not as susceptible to nucleophilic attack and are 
stable to moisture.
113
  
In addition to NHCs, phosphines are usually the second ligand of choice in catalytic 
systems because of their strong electron donating properties.
114
 Though popular, phosphines are 
not the only atom capable of ligation to metals for the purpose of catalyst development. Nitrogen, 
oxygen, sulphur, and selenium are also able coordinate to metals and many of such complexes are 
also catalytically active. Bidentate coordination complexes with ligands bearing imidazolylidenes 
and additional nitrogen, oxygen or sulphur atoms have been shown in some cases to possess 
similar catalytic activity as their phosphor- containing analogues.
115
 For reviews on sulfur- 
functionalized imidazolylidene ligands refer to references 116; for reviews on bidentate 
imidazolylidene ligands and complexes thereof please see references 117.  
Planar chiral thioether ligands have also been prepared and studied as ligands for 
asymmetric catalysis.
118
 The Fesulphos complex (108, Figure 13) contains a planar chiral ferrocene 
ligand with P-, S- functionality derived from Kagan’s sulfoxide (51). Standard lithiation-
substitution followed by electrophile quench with chlorophosphines provided the planar chirality 
after which the sulfoxide was reduced by silane. The Fesulphos ligand has been used in 
asymmetric allylic alkylation reactions and displayed moderate to good enantioselectivites (70:30 
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to 95:5 er).
119
 In addition, ThioclickFerrophos (109), which is also derived from Ugi's amine (48), 
displays similar catalytic activity.
106   
Bidentate planar chiral ferrocene ligands with both thioether-imidazolylidene and 
phosphine-imidazolylidene functionalities have been prepared and coordinated to palladium, 
rhodium and iridum (Figure 13).
120
 Using the approach developed by Ugi, planar chirality was 
installed via deprotonation-substitution. Quaternization of the tertiary amine followed by 
 
 
Figure 13. Planar chiral S- and P- imidazolylidene coordination  
complexes of Pd, Ir, and Rh. 
 
displacement by imidazole generated the desired ligands, which were then coordinated to both 
palladium (110), iridium (111), and rhodium (112 and 113).
123a
 Complexes 111 and 113 displayed 
no catalytic activity in asymmetric hydrogenations of numerous substrates. Rhodium complex 112 
displayed poor activity and enantioselectivity in the hydrogenation of dimethyl itaconate (44% 
yield, 59:41 er).  
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2. Objectives: 
The aims of the current work can be split into three goals, all of which are related through the use 
of the L-proline derived pyrroloimidazolone directing group.  
 
1. The first goal is to prepare solely planar chiral unsaturated imidazolylidene ligands bearing 
heteroatom substituents (85), and after conversion to imidazolylidenes (114), coordinate them to 
Pd or Ir, with the aim of preparing catalysts bearing bidentate ligands (115, Scheme 24). Pd-
complexes will be tested as catalysts for asymmetric Suzuki-Miyaura couplings to determine the 
extent of chiral induction in the axially-chiral products formed. Iridium complexes will be used for 
asymmetric hydrogenations of 2- and 2,6-substituted quinolines to determine the extent of chiral 
induction and the low-pressure activity of the catalysts. 
 
 
Scheme 24. Proposed synthesis of bidentate planar chiral transition-metal complexes. 
 
2. The second goal is to investigate the importance of planar chirality in the Ir-catalysts used for 
asymmetric hydrogenations of 2- and 2,6-substituted quinolines. The two irdium complexes 
previously investigated (96a,b) are pseudo-enantiomers, sharing only one chiral centre with the 
same configuration, the γ centre derived from L-proline. By preparing an N-phenyl analogue 
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(anti-121) of iridium complex 96a, (Scheme 25) and using it to hydrogenate previously studied 
quinoline subtstrates, the extent of chiral induction imparted by the planar chirality will be 
inferred.  
 
Scheme 25. Proposed synthesis of N-phenyl Ir(I) analogue (121). 
 
3. The final goal is to expand the utility of the epimeric imidazolone directing group towards the 
diastereoselective lithiation-substitution of η6-arene chromium tricarbonyl complexes 
(ArCr(CO)3), with the aim of preparing planar chiral products in high diasteromeric ratios. It is 
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hoped that a reversal of lithiation selectivity, as was observed when the β-stereocentre was 
epimerized in the ferrocene series,
2b
 will result in a similar reversal of lithiation selectivity in 
ArCr(CO)3 complexes (Scheme 26). 
 
 
Scheme 26. Proposed diastereselective lithiation-substitution of η6-arene chromium tricarbonyl 
compounds with L-proline derived chiral auxiliaries. 
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3. Results and Discussion 
3.1 Planar Chiral N-Substituted Ferrocenyl Imidazolones: Imidazolylidene Ligands and 
Coordination Chemistry 
     The first set of reactions studied was the chlorination/oxidation of planar chiral ferrocenyl 
imidazolones. The synthesis of these compounds began with the synthesis of iodoferrocene (78), 
via an in-situ lithiation-electrophile quench with elemental iodine. This method is an improvement 
on the previously reported synthesis of iodoferrocene which required the isolation of the 
pyrophoric intermediate lithio-ferrocene.
21
 Thus, iodoferrocene may be prepared by a 
modificiation of the procedure reported by Mueller and Westerhoff, quenching with elementa
121
 by 
lithiation of ferrocene in the presence of substoichiometric amounts of t-BuLi/KOt-Bu followed by 
quench with iodine. This procedure provides a mixture containing a small amount of ferrocene 
which need not be removed by chromatographic means.
108
 The yield can then be determined using 
1
H NMR spectroscopy integration ratios to obtain a molar ratio of FcI : Fc, which can then be 
converted to masses using the total mass of the product mixture.  
The coupling of iodoferrocene (78) to L-proline hydantoin (79) is then accomplished using 
a Cu2O-mediated procedure which is a combination of two procedures reported by Bildstein
21
 and 
Sato.
122
 Reduction of 80 using Schwartz’s reagent (Cp2ZrHCl) and in-situ protection of the 
resulting hemiaminal alkoxide provided syn-81 after recrystallization. Diastereoselective lithiation 
of syn-81 followed by electrophile quench with chlorophosphines and disulfides (dimethyl 
disulfide and diphenyl disulfide) gave products 82 in good yields and high diastereomeric purity 
(Scheme 27). Subsequent treatment of 82 with TsOH in CHCl3 at reflux led to planar-chiral 
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imidazolones 85b-g in good yields, as established previously in our group.
2b
 Syn-81 also 
underwent elimination under these conditions, providing achiral imidazolone 85g in good yield.  
 
 
 
Scheme 27. Diastereoselective lithiation of syn-81 and elimination to  
solely planar chiral imidazolones. 
 
         With planar-chiral imidazolones in hand, attempts were then made to convert them to 
bidentate imidazolylidene ligands. Initial studies of the chlorination were first performed on 
unsubstituted imidazolone 85g (E = H). There are multiple reagents reported to chlorinate ureas 
such SOCl2, oxalyl chloride, PCl3, and POCl3 among a few others.
114
 A previously established 
procedure using POCl3 was chosen as a starting point.
103
 After scanning variables such as 
temperature, solvent, reaction time and chlorinating reagent, it was found that neat POCl3 under 
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mild heating (50 °C) gave the cleanest conversion to the corresponding chloroimidazolium salts. 
Isolation of the cationic chloroimidazolium salt was accomplished by salt metathesis with KPF6, 
and precipitation of the resulting salt in a cold Et2O/ hexane solution. Once the product was 
confirmed, the chlorination of imidazolones 85b-g was carried out (Scheme 28). 
 
Scheme 28. Chlorination/oxidation of imidazolones with POCl3. 
 
All the ureas except the phosphines (85e and 85f) gave the desired chloroimidazoliums 
124a-d. Multiple attempts at the chlorination of phosphines using POCl3 and the aforementioned 
reagents resulted in the consumption of starting material and the isolation of an intractable black 
solid upon precipitation. 
31
P NMR spectroscopy revealed the presence of multiple phosphine 
containing compounds, none of which could be isolated or characterized. While no product was 
isolated, it is suspected that an addition reaction between the triarylphosphine and POCl3 had 
occurred.
123
  
Chloroimidazolium salts may be converted to imidazolylidenes by two methods: oxidative 
addition to a low-valent metal centre
115
 or metal-halogen exchange with two equivalents of 
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t-BuLi.
114,124
 A procedure for the oxidative addition of chloroimidazolium salts to a Pd
0 
source 
reported by Furstner was attempted first.
115 
For ease of preparation, the first compound studied was the achiral chloroimidazolium salt 
124a. Reflux of the chloroimidazolium salt with tetrakis(triphenylphosphine)palladium
0 
(Pd(PPh3)4) in CH2Cl2 under inert atmosphere provided, after crystallization of the crude reaction
mixture, Pd-complex 125a as bright yellow crystals in 78% yield (Scheme 29). TLC analysis could 
 
 
Scheme 29. Oxidative addition of chloroimidazolium salts to Pd(PPh3)4. 
 
not be used to follow the course of the reaction because of the ionic nature of the starting materials 
and products. When the oxidative addition procedure was established for 124a, experiments were 
carried out on both the thiomethyl and thiophenyl derivatives (124b,c). Upon crystallization of the 
crude reaction mixtures, the reaction that contained thioether 125b gave bright yellow powdery 
crystals that were confirmed by X-ray analysis to be the oxidative addition product. Unfortunately, 
despite being a potentially bidentate ligand, the sulphur atom in 125b was not bound to the Pd 
atom. This result was not entirely unexpected as it is known that phosphines are better ligands than 
sulphur atoms.
125
 The rationale used was that an intramolecular donor might have had a chance to 
55 
 
displace the phosphine, but this was not the case and cationic imidazolylidene-Pd complex 125b 
was obtained instead (Figure 14). The crystal structure of complex 125b shows an overall square 
planar coordination geometry at palladium with the chlorine atom trans to the 
pyrroloimidazolylidene ligand. The ligand is monodentate with Rp absolute configuration of the 
ferrocene moiety. The triphenylphosphines are in slightly different chemical environments, an 
observation that is consistent with the nonequivalency of the phosphines atoms by 
31
P NMR 
spectroscopy. 
 
 
Figure 14. ORTEP plot of 125b with 30% probability ellipsoids.  
Hydrogen atoms, PF6
- counterion, and 2 CHCl3 of crystallization omitted for clarity. 
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     Despite the monodentate coordination of the ligand to the metal of 125b, it was still potentially 
a viable catalyst for asymmetric Suzuki-Miyaura reactions.
113
 Under the conditions reported by 
Debono et al.,
113 
125b was tested as a catalyst for the coupling of 1-bromo-2-methyl naphthalene 
(126) and 1-naphthyl boronic acid (127). The product of the reaction (128) would bear axial 
chirality, resulting from a hindered rotation around the newly formed Ar-Ar bond. While no 
optically pure sample was available for comparison, a calibration curve (Figure 15) was prepared 
using specific rotations and % ee measurents (measured by chiral HPLC) reported by Hayashi in 
the late 1980s.
126
  
 
 
Scheme 30. Suzuki-Miyaura coupling with Pd complex 125b. 
 
      From this calibration curve a regression line was obtained with an R
2
 value of 0.9993. The 
sample prepared using complex 125b was found to have a specific rotation of −5.63 (c 1.0, 
CHCl3). Using the equation of the regression line, the calculated ee was found to be 14% or 57:43 
er. Based on the calculated rotation value it was determined that the overall selectivity of Pd-
complex 125b in the Suzuki-Miyaura coupling was very low. In the ORTEP plot (Figure 14) the 
nitrogen-ferrocene bond is rotated so that the planar chiral Cp ring is not near the Pd centre. This 
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orientation may not allow for chiral information to be transferred to the reaction centre during 
catalysis. Methods of preparing binap 128 in excesses of 95:5 er have been reported, many of 
which are discussed in Hayashis's report.
128
 Additional substrates would have been investigated 
had an enantiomeric ratio of at least 75:25 been observed. However, discouraged by these results, 
no further substrates were studied.  
     The pursuit of planar-chiral bidentate Pd- complexes was not abandoned. It was reasoned that if 
non-phosphine containing Pd-sources were used then a more labile ligand could be 
intramolecularly displaced by the sulphur atom. Unfortunately, the tendency of palladium to 
undergo oxidative addition is dramatically enhanced by strongly donating ligands such as alkyl 
phosphines, or by very polarized C-X bonds within the substrate (where X can be a halogen, a 
carbon atom, a proton or a triflate, among other groups).
127
 The cationic nature of the imidazolium     
ring may polarize the C-Cl bond sufficiently that another phosphine-free Pd
0
 could undergo 
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   -0.0253x – (9 x 10-5) 
      0253/°) (-5.632°) - (9 x 10-5)       0.142 (57:43 er) 
Figure 15. Calibration curve of specific rotation vs. ee of 2-Me-1,1'-BINAP  
and calculation of er. 
oxidative addition. Two additional palladium sources were investigated: (dba)2Pd
0
 and 
(CH3CN)4Pd
0
. No evidence of complex or crystal formation was observed in either case. It was 
decided that another method of generating the imidazolylidene was required.  
Established in the late 1930s independently by both Wittig
128
 and Gillman
129
 was a method 
of metathesis between an organolithium and an organohalide. In this reaction, treatment of alkyl, 
vinyl, allylic or aryl-halides with alkyllithium reagents results in the exchange of the halogen for 
the lithium atom. While the mechanism of exchange is still debated, it is believed to proceed 
through SN2-like addition of the anion to the halogen and displacement of the alkyl, vinyl, allylic 
or aryllithium species.
130
 Though this is a reversible process, as long as the newly generated 
lithium species is less basic than the orginal lithium species, the reaction under most conditions 
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will proceed in the forward direction. This method has been applied to haloimidazoliums (129) and 
has been shown to generate the imidazolylidene (130) in solution.
114, 125
 The imidazolylidene can 
then be coordinated in-situ to an electrophilic metal (132) or can be protonated providing an 
imidazolium salt (131, Scheme 31).  
 
 
Scheme 31. Metal-halogen exchange of chloroimidazolium salts by t-BuLi followed by trapping of 
the imidazolylidene with electrophiles.
125 
 
The oxidative addition approach, which may provide the coordinated imidazolylidene 
directly, was not giving the desired product so a step-wise approach was taken. This step-wise 
ylidene deprotonation-coordination approach, which does not proceed via oxidation addition, 
allows the use of metal salts in higher oxidation states, so that non-phosphine containing Pd-
sources can be used. THF was used as the solvent in all cases for solubility reasons and 
compatibility with alkyllithium reagents. Treatment of chloroimidazolium salt 124b with t-BuLi 
followed by quenching with electrophilic metals (Pd, Ir, Rh) in all cases yielded no isolable 
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products (Scheme 32). Attempts to isolate materials by column chromatography and/or 
crystallization of the crude or Celite filtered reaction mixtures gave no recognizable products. In 
most cases, a black solid was collected from the reaction mixture upon attempts to precipitate 
products. This black solid was insoluble in all common organic solvents, leading to the conclusion 
that it may have been Pd
0
. Investigation of the reaction mixtures soon after addition of the Pd-
source revealed the same insoluble black material.  
 
 
Scheme 32. Attempts to generate and trap imidizolylidenes with various metals. 
 
Despite no isolation of desired products, the failure of these reactions may be attributed to 
the coordination step. That is, the imidazolylidene is formed, but coordination to the metal is not 
occurring, possibly due to insolubility of the metal complexes at low temperatures, or 
decomposition of the metal complexes before coordination can take place. It is also possible that 
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coordination does take place, but isolation of the products is the issue. Formation of the 
imidazolylidene was proven by subsequent conversion of the chloroimidazolium salts 124b-c to 
imidazolium salts 134a-b by protonation of the generated imidazolylidene (Scheme 33).  
 
 
Scheme 33. Reduction of chloroimidazoliums by t-BuLi. 
 
     Following the procedure by Debono et al. for the preparation of bidentate phosphine-
imidazolylidene complexes of palladium,
113
 134a was treated with either KOt-Bu or NaH in 
CH3CN in the presence of Pd(CH3CN)2Cl2 under reflux (Scheme 34). After refluxing for 16 hours 
a new yellow coloured spot appeared on the TLC of the reaction mixture. Column chromatography 
of the reaction mixture in 90/5/5 CH2Cl2/MeOH/acetone provided a yellow solid in low quantity 
(~22%). 
1
H NMR revealed the same signals present in the starting material, minus the C3 
imidazolium proton which would be absent in the desired product. Since coordination to the metal 
provided no new proton signals, the identity of the isolated material could not be verified. Low- 
and high- resolution mass spectrometry revealed a molecular ion peak with a mass of 526.41 amu, 
while the desired product would have a mass of 515.57 amu. No fragments were observed at the 
expected mass. 
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Scheme 34. Attempted deprotonation/coordination of 134a to palladium. 
 
     Attempts to recrystallize the material for the purpose of single crystal X-ray diffraction led to 
the eventual decomposition of the material. Attempts to repeat the experiment were not successful. 
Many conditions, including variations of the Pd-source, base and solvent were attempted but no 
products were isolated.  
   
3.2 A Biferrocene Ligand Precursor 
    Focus then changed to the development of a C2-symmetric bidentate imidazolylidene ligand. 
Bis-NHC ligands have been reported to impart a number of unique properties to the metal 
complexes thereof. Among these properties are an observed trend of high thermostability and high 
catalytic performance in challenging reactions such as alkane dehydrogenation.
131
 Imidazolylidene  
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Scheme 35. Ullman coupling of imidazolone 85c and attempted chlorination with POCl3. 
 
ligands are known to be stronger σ-donors than phosphine ligands and the effect of two 
imidazolylidenes coordinated to a single metal can be additive.
132
 An Ullmann homocoupling of 
imidazolone 85c was performed (Scheme 35) using a slight excess of copper bronze, and DMSO 
as the solvent. The desired C2-symmetric biferrocene 136 was obtained in 21% yield, with partial 
recovery of deiodinated imidazolone 85g. Unfortunately, upon treatment of the product with 
POCl3, decomposition of starting material was observed with no isolation of the desired product.  
 
3.3 Attempts Towards Annulated Bidentate Imidazolinylidene Ligands and their 
Coordination Complexes  
It was previously established that ferrocenyl phosphines are incompatible with Ph3CBF4, 
resulting in phosphonium adducts.
108
 From the attempted chlorination/oxidation of phosphino and 
thioether imidazolones 85b and 85d, it is likely that phosphines, even those with electron 
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withdrawing groups, are too nucleophilic to be compatible with these electrophilic reagents.  The 
thioether imidazolones underwent chlorination with ease, suggesting that they may be stable 
towards oxidation of the aminal by Ph3CBF4. Following the procedure previously established for 
the synthesis of aminal 102,
3
 a metal-halogen exchange was used to install a thiomethyl ether upon 
electrophile quench (Scheme 36). Treatment of aminal 138 with Ph3CBF4 resulted in complete 
consumption of the starting material.  
 
 
Scheme 36. Synthesis of and attempt to oxidize 138. 
 
     Attempts were made to isolate the product by anhydrous precipitation techniques but the 
identity of the material could not be confirmed. This was most likely because of the instability of 
imidazolinium, or its tendency to rehydrate by the addition of water. To further study the oxidation, 
experiments were carried out in a Schlenk-NMR tube in acetone-d6 in the hope of observing 
evidence that the oxidation had taken place. If the sulphur atom had been oxidized by the reagent, 
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it was expected that the chemical shift (δ) of thiomethyl-singlet shown in Figure 16 would be 
downfield with respect to the chemical shift of the starting material 138 in acetone-d6 (2.37 ppm, s, 
3H). In addition, the diastereotopic aminal protons indicated on the top spectrum at 4.34 ppm (d, 
1H, J = 6.8 Hz) and 3.94 ppm (d, 1H, J = 6.8 Hz) would still be present. The resulting crude NMR 
spectrum (Figure 16, bottom) showed minimal displacement of the thiomethyl singlet, 
disappearance of the diastereotopic aminal protons, and a new 
1
H singlet at 9.22 ppm indicated in 
red. While not directly comparable, the chemical shift of the C2 protons of the imidazoliums 134 
was approximately 9.2 ppm. Two attempts to trap this intermediate were made (Scheme 36). In the 
first attempt [Ir(COD)Cl]2 dimer was used as the electrophile, and in the second attempt 
(CH3CN)2PdCl2 was used. In both cases, slight excess of KOt-Bu was employed to generate the 
ylidene by deprotonation of the imidazolinium at low temperature but no products were observed. 
1
H NMR sprectroscopy suggested that the oxidation had taken place, implying that the 
deprotonation/coordination step was problematic. Repetition of this experiment under glovebox 
condiitons is likely required for isolation of the imidazolinylidene (139) or complexes bearing this 
ligand. 
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Figure 16. 
1
H NMR spectrum of aminal 138 before (top) and after (bottom)  
treatment with Ph3CBF4 (400 MHz, 298 K, acetone-d6) 
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3.4 Chiral Annulated N-Phenyl NHCs Derived From L-Proline Hydantoin 
To determine the importance of planar chirality in iridium complex 96a, a non planar chiral 
analogue was required. The synthesis of the N-phenyl analogue (116) was undertaken by acid-
catalyzed condensation of phenyl isocyanate with L-proline (Scheme 37). Crystallization of the 
product from the reaction mixture gave 141 in high yield (95%) and enantiomeric purity (>95:5 
er). Treatment of 141 with Cp2ZrHCl followed by in-situ silylation provided the analogous 
lithiation substrate 116 in good yields and diastereomeric purity (>95:5 dr). The product was 
obtained in better diastereomeric ratio (>95:5 dr) than the ferrocenyl analogue, which was fortunate 
because the product was obtained as an oil, thus rendering crystallization impossible. While the 
lithiation-substitution reaction itself would impart no planar chirality in the molecule, it was 
expected to proceed via coordination of the urea to the alkyllithium base resulting in ortho-  
substituted products upon electrophile quench as was seen in the ferrocene analogue.
2
 Many 
lithiation conditions were investigated including the use of different alkyllithium bases, equivalents 
of bases, solvents, and diamine additives (Scheme 38).
133
 
 
 
Scheme 37. Preparation of N-phenyl analogue of syn-81. 
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Scheme 38. Attempted lithiations of N-phenyl analogue 116. 
 
 Close examination of the preceeding experiments revealed that the major product in all cases 
was the achiral elimination product 143. This result suggested that the methine on the exo-face of 
the fused-ring system α to the nitrogen was prone to abstraction with concurrent loss of TESO− 
(Figure 17). The near anti-periplanar configuration of the α to nitrogen methine and the TESO 
group in 116 may have enhanced the ease of this elimination. 
 
Figure 17. Elimination of the stereodetermining β-silyloxy group. 
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To solve this problem it was reasoned that preparation of an alkoxy analogue with anti-
stereochemistry would be less prone to E2-type anti-periplanar elimination. This modification 
would also impart the added benefit of a more basic alkoxide upon elimination, thereby inhibiting 
elimination of the leaving group under metalation conditions. Based on the results of an early 
experiment I performed investigating further manipulations of the imidazolone directing group in 
the ferrocene series, a method for substitution at the β-chiral centre with oxygen-based 
nucleophiles was chosen. Under acidic conditions in the absence of nucleophiles, compounds 
bearing the triethylsilane group undergo elimination providing achiral imidazolones.
2b
 This method 
was previously used to prepare planar-chiral enantiomers, which were used to prove the 
diasteroselectivity of the imidazolone directing group in ferrocene lithiation.
2b
 Attempts to 
eliminate the triethylsilyloxy moiety of the diphenylmethanol adduct 85c under acidic conditions 
resulted in an intramolecular nucleophilic substitution of the directing group by the alcohol group.
3
 
This result is what led to the eventual transformation of the imidazolone directing group into the 
imidazolylidene ligands. Later experiments used non-nucleophile containing starting materials, but 
instead a nucleophilic solvent (MeOH) resulted in the isolation of a single product (144) with an 
anti-configuration in good yield (Scheme 39). 
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Scheme 39. Acid-catalyzed substitution at the β-stereocentre by nucleophilic alcohols. 
 
For the N-phenyl series, an alcohol with a similar A-value to the triethylsilyloxy group was 
desired. A-values are a system used to determine the most stable orientations of atoms within a 
molecule.
134
 It is also used to compare the volume of space occupied by different functional groups 
in order to compare steric bulk. The origin of selectivity in the lithiation of 81 is due to 
unfavourable steric interactions between the triethylsilyloxy group and the lower Cp ring (Cp 
control).
2b
 To achieve a similar lithiation selectivity, a functional group which could impart a 
similar steric bulk to the pyrroloimidazolone was necessary. In the end, isopropanol was chosen as 
the nucleophile because it possesses a similar A-value to that of the triethylsilyloxy group. The A-
value of the isoproxy (Oi-Pr) group is 2.15, and while there is no measured A-value for a 
triethylsilyloxy (OSiEt3) group, trimethylsilyloxy (OSiMe3) has a value of 0.74, and an isopentyl 
group (CH2C(CH3)3) has a value of 2.
135
 The A-value of the triethylsilyloxy moiety can be 
approximated somewhere between that of the trimethylsilyloxy and isopentyl groups in the range 
of 0.74 < AOSiEt3 <<2.  
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The acid catalyzed substitution reaction was applied to the 116 and a similar substitution 
product (anti-145) was obtained in low yield, along with the eliminated imidazolone 143 (Scheme 
39). However, this route was low yielding, and not efficient due to the sacrificial use of the silane 
group. Instead, this method was applied to the hemiaminal 146 obtained after Schwartz reduction 
of hydantoin 141 (Scheme 40). Initially, the isolation of this intermediate was arduous owing to the 
water-solubility of the product and the need to use water for the work-up procedure. Very low 
yields were obtained (30-40%) due to the aqueous work-up involved. Modifications of the work-up 
procedure allowed this compound to be obtained in higher yields (Scheme 40). Instead of aqueous 
work-up/ extraction after the reaction was complete as shown by TLC, a small amount of a sat. 
NaHCO3 solution was added to the reaction mixture and stirred for 5 minutes. To this was then 
added dry silica gel and the solvent was removed under reduced pressure. This silica was then 
filtered in a fritted funnel eluting with 50:50 EtOAc/hexanes, providing 146 in good yield and 
purity. Compound 146 was then submitted to the acetalization conditions (Scheme 40).  Three 
products were observed: the expected anti-145, and the elimination product 143, but this time a 
syn- epimer (syn-145) was also observed. This result suggests that under acidic conditions an 
imminium intermediate is formed, and is then quenched by predominant nucleophilic addition 
from the exo-face of the fused ring system and minor addition from the endo-face.  
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Scheme 40. Preparation of the epimeric isopropoxy-imidazolones anti and syn-145. 
 
     With the desired lithiation substrates in hand, both epimers were subjected to the lithiation 
conditions established with ferrocenes 81 and quenched with benzophenone. Though both 
expected products were formed (147), they were obtained in low yields with complete recovery of 
starting material. Optimization revealed that a higher temperature during lithiation was all that was 
required for complete lithiation of the starting materials (Scheme 41). Despite these not being 
asymmetric lithiations, it was established that ortho-substituted products could be prepared in good 
yields. 
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Scheme 41. Ortho-lithiation of isopropoxy-modified imidazolones anti and syn-145. 
 
Following the same methodology used to prepare Ir-catalysts 96,
3 
these compounds were 
then subjected to acid-induced annulation. Under the conditions shown in Scheme 19, both 
products (118) were formed in less than 4 minutes and in excellent yields (Scheme 42). In both 
cases a single product was isolated, which by 
1
H and 
13
C NMR spectroscopy appears to be a single 
diastereomer. The reaction proceeds through an imminium intermediate, and cyclizes through 
addition of the alcohol to the imminium with inversion of stereochemistry. The stereochemistry of 
the products were determined by the coupling constants of the methine hydrogen atom located on 
the hemiaminal carbon. Compounds 118 bearing syn-stereochemistry at the methine give a doublet 
with coupling constants of 6.8 Hz. Compounds bearing anti-stereochemistry give a doublet with a 
coupling constant of 1.6 Hz because of the near-90° angle between the methine and the 
neighbouring proton. As a side note, syn-118 undergoes lithiation with t-BuLi to provide ortho-
substituted products via coordination of the urea to t-BuLi, as is seen in the annulated ferrocenyl 
urea 100. Only one experiment was performed, quenching with ClPPh2 providing the 
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arylphosphine in 83% yield. This product was prepared to show that ortho-lithiation of syn-118 
was possible. The product does not serve as a NHC precursor because the methods by which the 
urea may be converted to a NHC ligand are not compatible with phopshines. Anti-118 was then 
treated with DIBAL-H using a cosolvent system of THF/CH2Cl2 to allow for a more concentrated 
reaction mixture, leading to faster conversion (Scheme 43). 
 
 
 
Scheme 42. Acid-catalyzed annulation of diphenylmethanol adducts. 
 
       Despite the inherent instability of these compounds, aminal anti-119 was isolable by column 
chromatography in 95% yield and recrystallized in acetone. Anti-119 was then treated with 
tritylium tetrafluoroborate in THF at −78 °C and stirred for 5 hours; to this solution was then added 
KOtBu and [Ir(COD)Cl]2. Treatment of the intermediate imidazolinium with KOtBu generated the 
imidazolylidene, which was immediately trapped with [Ir(COD)Cl]2, providing anti-120 which was 
isolated by column chromatography in 34% over two steps (Scheme 43). The neutral complex was 
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then treated with one equivalent of PPh3. The initially yellow solution turned red immediately upon 
addition of the PPh3 solution. After 3h, TLC analysis revealed that the starting material had been  
 
 
 
Scheme 43. Conversion of annulated urea to cationic Ir-complex anti-121. 
 
 
 consumed, at which time the solvent was removed under reduced pressure and salt metathesis was 
performed using a KPF6 solution in CH3CN. After 1 h, the solvent was removed and the red solid 
was treated with pentane, affording a bright red powdery solid which was collected on a Hirsch 
funnel, providing anti-121 in 97% yield. 
1
H NMR spectroscopy of both the neutral and cationic Ir 
complexes revealed a doublet appearing much further upfield than is generally seen with aromatic 
protons (9.64 ppm in the neutral complex, and 9.10 ppm in th cationic complex. 
1
H-
13
C HSQC 
experiments of the neutral complex showed that this signal corresponds to the proton ortho- to the 
imidazolylidene nitrogen of the disubstituted phenyl ring. Upon comparing the 
1
H NMR spectrum 
of the ferrocenyl analogue (96a),
107 
an unusually high chemical shift was also observed for the 
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neighbouring Cp proton. The crystal structure of 96a revealed that this proton is oriented towards 
the apical position of the square planar Ir atom, and it is therefore believed to be deshielded by the 
electron cloud of the Ir atom. If this is the case, then a decrease in electron density at the metal 
should shield this proton to some extent. Upon treatment with triphenyl phosphine, rendering the Ir 
cationic, a downfield shift from 9.64 ppm to 9.09 ppm was observed. This suggests that this proton 
is interacting with the metal in some way. Further experiments, which add electron density to the 
metal are required to make a definitive statement. From this observation arises two additional 
questions: (1) to what extent is this proton affected by the electron density of the metal; and (2)  is 
it possible that this proton may undergo C-H activation? If this is possible, the installation of  
nucleophiles at this position may provide a new method of preparing bidentate complexes.  
      With the desired catalyst in hand, we then performed hydrogenations on substrates which gave 
the best results when using the ferrocene analogue 96a. 2-Methylquinoline (97a) and 6-fluoro-2-
methylquinoline (97b) were subjected to hydrogenation under the same conditions used 
previously.
83
 Low conversions at 5 atm of pressure necessitated the need to apply higher pressures 
of H2 (45 atm) for conversions (Scheme 44). This indicates that the N-phenyl analogue is less 
reactive than the ferrocene containing catalysts. In the ferrocene containing catalysts, the anionic 
nature of the cyclopentadienide ring may contribute to an overall higher electron density on the Ir 
atom compared to the phenyl analogue because the nitrogen on the phenyl ring can donate electron 
density into the ring and not just to the ylidene. However, the lower reactivity of catalyst 121 
cannot exclusively be explained by a lower electron density at the Ir centre. In 2008 Nolan et al. 
studied the electronic and steric parameters of a number of imidazolylidene and imidazolinylidene 
ligands by comparing the CO stretch frequencies of carbonylated Ir-complexes bearing these 
imidazolylidene ligands.
137
 By comparing these frequencies they were able to correlate the amount 
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of d → π* (imidazolylidene) back donation of the metal and the d → π* (CO). Assuming that the 
extent of d → π* (imidazolylidene) back donation is directly related to the overall electron density 
on the metal they were able to compare the donating capacity of each imidazolylidene ligand.  
What they observed was that the overall reactivity of these complexes was not proportional to the 
electron density on the metal, suggesting that other factors, such as sterics, play a more important 
role.
135
 
 
 
Scheme 44. Asymmetric hydrogenation of quinolines with catalyst anti-114.  
 
     Under these conditions quinolines 97a-b were both converted to their tetrahydroquinoline 
derivatives in 98a-b in 72% and 80% yields respectively. CSP HPLC analysis (CHIRALCEL OD-
H column, eluting with 2:94:4 EtOAc/hexanes/Et3N) determined that the major product in both 
cases was the (S)-configured enantiomer, the same result as obtained with ferrocene analogue 96a. 
The enantiomeric ratio of the products was determined to be 65:35 and 71:29 for 
tetrahydroquinoline and 6-fluorotetrahydroquinoline, respectively. These results suggest that the 
planar chirality of 96a is important for inducing high enantioselectivity in hydrogenations of 
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substrates of this type. It has been postulated that hydrogenations with ylidene-Ir complexes 
proceed via an outer-sphere mechanism. What this means is that each species remains separate and 
intact before, during and after the reaction has taken place.
136
 While it is sometimes possible to 
explain the selectivity by invoking hydrogen bonding, this is not always possible or obvious. From 
these results, it is evident that to achieve higher enantioselectivity additional derivatives or 
analogues of the planar chiral Ir-complex (96a) should be investigated.   
3.5 Selective Synthesis of Enantiomeric η
6
-Arene Chromium Tricarbonyl Complexes with 
Epimeric Pyrroloimidazolones 
 
Disubstituted ArCr(CO)3 possess planar chirality just like ferrocenes. Chemical reactions of 
both ferrocenes and ArCr(CO)3 in many cases occur selectively by approach of reaction partners 
from above or below the plane of the aromatic rings so as to avoid steric interactions with other 
parts of the molecule. Examples of this include stereoretentetive SN1 reactions of both Ugi's 
amine
137
 and chiral α-chloroethyl substituted ArCr(CO)3
91
 and directed nucleophilic additions by 
nucleophiles to ArCr(CO)3.
47-51
 Thus far, many of the stereoselective transformations possible with 
ferrocenes have analogous transformations with ArCr(CO)3, such as those just mentioned. The 
diastereoselective lithiation of both Ugi's amine and ArCr(CO)3 bearing the same α-ethylamine 
group are believed to undergo selective lithiation by this same priniciple (Cp control and 
substrate/carbonyl control).
87
 Given that the epimeric pyrroloimidazolone directing group on 
ferrocenes induce selective lithiation of the pro-R or pro-S positions of the Cp ring,
2b
 it should also 
be possible to differentiate the pro-chiral ortho- positions of ArCr(CO)3 . 
     Since it was established that isopropoxy-modified imidazolones 145 were stable to lithiation 
conditions, methods for the complexation of these compounds to chromium were sought. After 
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trying a few different methods for the complexation of aromatics to Cr(CO)6, including refluxing
138
 
or exposure of the two reagents to UV light in high-boiling hydrocarbons, it was concluded that 
solubility of the arenes in these solvents was too low even at elevated temperatures. In the early 
1990s, Hudeĉek et al. observed that with the use of esters and ketones as cosolvents the rates of 
complexation of arenes to Cr(CO)6 could be dramatically enhanced.
139
 Particularly, n-BuOAc was 
found to be the best cosolvent for the preparation of ArCr(CO)3.  In the original procedure by 
Hudeĉek, he reports results using decalin as the solvent. It was decided that decalin (bp 190 °C) 
was not necessary and instead octane (bp 125 °C) was used (Scheme 45). The use of n-BuOAc 
improved the solubility of the starting material and enhanced the rate of reaction. The 
stoichiometric ratio of ligand to Cr(CO)6 in most reported syntheses of these compounds is quite 
high at around 4:1; a near stoichiometric ratio with a slight excess of Cr(CO)6 (1.1 equiv) provided 
products in good yields. The products (148) of the reaction were bright yellow in colour, so to 
some extent the progress of the reaction could be followed colourimetrically. The reaction was 
stopped once evidence of decomposition was observed (insoluble black particles). Both products 
were obtained as thick yellow oils but could be crystallized in a number of oxygen containing 
solvents (acetone, EtOAc, Et2O, EtOH). It was found that these compounds slowly decompose if 
left in oxygenated solutions for extended periods of time. 
1
H NMR results are best when taken in 
degassed NMR solvents.  
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Scheme 45. Complexation of anti and syn-145 to Cr(CO)6. 
 
     Lithiation of anti-148 under the same conditions as ferrocene 81 (using 2.2 equiv t-BuLi), 
followed by quench with iodomethane, gave 149a as a single diastereomer according to NMR 
spectroscopy, indicating that the product had been formed in >95:5 dr.  Further optimization of the 
reaction revealed that only 1.5 equivalents of base was necessary for high conversion of products 
(Scheme 46). 
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Scheme 46. Electrophile scope for the lithiation of anti-145. 
 
     With good initial results, the task of proving that all the products obtained possess the same 
relative strereochemistry was undertaken. Repetition of this experiment and quenching with 
several other carbon and heteroatom electrophiles gave ortho-substituted products in equally good 
yields and levels of diastereomeric purity (Scheme 46). No evidence of additional diastereomers 
was observed by TLC or NMR spectroscopy. That the lithiation-substitution of anti-145 proceeded 
with high levels of diastereomeric selectivity was undeniable, however the absolute 
stereochemistry of the product was yet to be proven. Single-crystal X-ray diffraction of sulfide 
149g confirmed that the pro-Rp aryl hydrogen had been deprotonated during lithiation (Figure 18), 
which matches the lithiation stereochemistry observed for ferrocene anti-81.
2b
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Figure 18. ORTEP plot of 149g with 30% probability ellipsoids.  
Most hydrogen atoms omitted for clarity. 
 
     To prove that the anion of anti-145 has configurational stability, and that all the products 
obtained from the lithiation of anti-145 have the same relative stereochemistry, a transmetalation 
experiment with stannane 149i was performed (Scheme 47). Stannane 149i was treated with n-
BuLi at −78 °C in THF for 1 hr and quenched with dimethyldisulfide. The sulfide product obtained 
from the transmetalation was physically (melting point and Rf) and spectroscopically (
1
H and 
13
C 
NMR, specific rotation) identical to sulfide 149g, obtained by direct lithiation of anti-145.
 
Since an 
identical product was formed indirectly by transmetalation, this result proves that the stannane 
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derivative also possesses the same relative stereochemistry as 149g obtained by direct lithiation-
quench. Furthermore it can be tentatively stated that all the products derived from lithiation of anti-
145 possess the same relative stereochemistry.
140
  
 
 
Scheme 47. Transmetalation of stannane 149i. 
 
Attention was then turned to syn-145. If products with opposite planar chirality could be 
obtained in equally high levels of diastereomeric purity then it could be concluded that the 
imidazolone directing group is also applicable towards the diastereoselective lithiation-substitution 
of N-substituted η6-arene chromium tricarbonyl compounds providing both planar-chiral products. 
Under the same conditions as the anti-epimer, syn-145 underwent lithiation-substitution in equally 
high yields and levels of diastereomeric purity. Again, repetition of this experiment and quenching 
with several other carbon and heteroatom electrophiles gave ortho-substituted products in equally 
good levels of diastereomeric purity (Scheme 48).  
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Scheme 48. Electrophile scope for lithiation of syn-145. 
    
     The highly diastereoselective nature of the deprotonation step was investigated in deuteration 
experiments by quenching the reaction mixture with methanol-d4 to give 149j and 150f. A 
comparison of the 
1
H NMR spectra of starting material and products revealed selective loss of one 
of the aryl hydrogen atoms (Figures 19 and 20). In both starting materials the signal that was lost 
upon deuteration was the most downfield signal (inidicated with a red arrow), which appeared as a 
doublet in both cases. This was the exact same observation made from deuteration experiments 
with the ferocenyl epimers.
85
 This proves that the pro-RP ortho-proton is the most deshielded 
proton in anti-145. This is believed to be caused by its close proximity to the urea oxygen in the 
minimum energy state, as was previously established with the ferrocene analogues. 
     Though the absolute stereochemistry of anti-derived products (149a-j) can be assigned with 
confidence, the absolute stereochemistry of the syn-derived products (150a-f) could not yet be 
assigned. To prove the stereochemistry of the syn-derived products, they were then subjected to  
85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. 
1
H NMR spectra of anti-148 (top) and deuterated 149j (top) 
(400 MHz, 298 K, acetone-d6) 
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Figure 20. 
1
H NMR spectra of syn-148 (top) and deuterated 150f (bottom) 
(400 MHz, 298 K, acetone-d6) 
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acid-induced elimination of the L-proline derived central chirality providing solely planar-chiral 
products. Upon elimination of the methyl and thiomethyl adducts of both series (149a, 149g, and 
150a, 150d) two sets of planar chiral enantiomers would be obtained (Scheme 49). As anticipated, 
products 151a/ent-151a, and 151b/ent-151b had equal but opposite specific rotations, thus 
verifying that the pro-Sp hydrogen of syn-148 had been selectively removed during lithiation with 
t-BuLi.  
 
 
 
Scheme 49. Preparation of planar-chiral enantiomers.   
 
 
Now that it had been proven that both planar chiral products were accessible by lithiation, 
attempts were then made to increase the ratio of the syn- : anti- alkoxy-modified epimers. The acid 
catalyzed substitution reaction was then attempted with ethanol, a smaller more nucleophilic 
alcohol. Under the same conditions as before, using EtOH the reaction was complete in under 5 
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min with full conversion of starting material (Scheme 50). No elimination byproduct was observed, 
but the ratio of syn- to anti- was for the most part unchanged (15:85 as opposed to 15:65). The 
ethoxy products obtained (syn- and anti-152) were more easily separated by chromatography than 
their isopropoxy counterparts. The syn-epimer co-eluted with an unknown impurity and required 
multiple recrystallizations. Complexation of anti-152 with Cr(CO)6 was then performed under the 
same conditions as before, providing anti-153 in 42% yield. The reaction did not go to completion 
because evidence of decomposition was observed after 16 h, at which point the reaction was 
suspended. The product was obtained as a bright yellow solid and was shown to be a single 
diastereomer by NMR.  
 
 
Scheme 50. Synthesis and of ethoxy modified piano stool complexes. 
 
To gain more insight into the selectivity of the directing group, anti-153 was then subjected 
to lithiation with both n-BuLi and t-BuLi, quenching with dimethyl disulfide (Scheme 51). Both 
reactions yielded the same thioether adduct 154 in 63% and 96% yields, respectively. These results 
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suggest that the size of the O-alkyl group has little to no effect on the diastereoselectivity of the 
lithiation. The difference in yields is in accordance with previous optimization reactions which 
revealed that t-BuLi is the ideal base for lithiating these compounds.  The relative stereochemistry 
of thioether 154 is tentatively assigned to be the same as all the products derived from the lithiation 
of the isopropoxy congener anti-145. 
 
 
Scheme 51. Lithiation of anti-142 by n-BuLi and t-BuLi. 
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4. Conclusions and Future Work 
 A cationic Pd-complex (125b) of a planar chiral ferrocene ligand bearing a pyrroloimidizolylidene 
has been prepared by oxidative addition to Pd(PPh3)4.  Xray analysis reveals a mondentate 
complex coordinated to the palladium through the imidazolylidene. Although a bidentate complex 
was desired, it was established that sulfur atoms are stable towards treatment with POCl3. 
Ferrocenyl phsophines were not stable to these conditions, resulting in the decomposition of 
starting materials. If thioether donor atoms are used, non-phosphine containing Pd
0 
sources are 
required to obtain bidentate complexes because intramolecular thioethers are not capable of 
displacing phosphine ligands. Towards this end, Pd
0
 sources with strong electron donating ligands 
are required to facilitate oxidative addition, and yet must be labile enough to be displaced by 
heteroatoms such as thioethers. Methods for the conversion of 2-chloroimidazolium species to 
imidazolium species has also been established by treatment with n-BuLi, followed by protonation 
by water. In the future, methods of installing phosphines are necessary after conversion of the urea 
to chloroimidazolium. A double metal-halogen exchange approach may give the desired product 
(Scheme 52). Treatment of 85c with POCl3 followed by addition of n-BuLi and quench with 
chlorophosphines and electrophilic metals should be investigated. After treatment with n-BuLi a 
ferrocenyl anion and the imidazolylidene should be produced (155). The anion could then be 
quenched with chlorophosphines, and while nucleophilic, the imidazolylidene is unlikely to react 
with the chlorophosphine because it is a neutral donor. The imidazolylidene could then be trapped 
by addition of electrophilic metals.  
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Scheme 52. Proposed double metal-halogen exchange approach towards bidentate ligand-metal 
complexes. 
 
    Two new arene chromium tricarbonyl complexes (145) bearing epimeric imidazolone directing 
groups have been prepared and shown to undergo diastereoselective lithiation in excess of 95:5 dr. 
Compounds with syn- and anti- stereochemistries undergo lithiation with opposite selectivity 
leading to planar chiral enantiomers (151 and ent-151) upon treatment with acid. Anti- configured 
imidazolones undergo deprotonation of pro-R hydrogen atom and syn- undergoes pro-S 
deprotonation. The size of the O-alkyl group has little to no effect on the stereoselectivity of the 
lithiations. The stereochemistry of the products was proven by a combination of X-ray analysis, 
transmetalation and deuteration experiments. These results are in accordance with previously 
reported results obtained with ferrocene.
84-85
 In future, two additional aspects of this chemistry 
should be explored. Efforts towards maximizing the yield of syn-configured products should be 
made. A possible method for this would be an in-situ electrophile quench of the zirconium 
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alkoxide generated from the Schwartz reagent with a suitable electrophile other than TESCl. 
Experiments showing that the size of the O-group has little to no effect on the selectivity of the 
lithiations suggest that larger O-groups should not be a problem. The second aspect is the removal 
of the chiral auxiliary to provide planar chiral ArCr(CO)3 of aniline derivatives. While this method 
is capable of providing planar chiral products in high diastereomeric ratios, the utility of the 
products is limited until methods for removal of the auxiliary are established. Removal of the 
auxiliary from the ferrocene containing compounds was accomplished by base catalyzed removal 
of the silane, reduction of the heminal (aldehyde equivalent) by NaBH4 and hydrolysis of the urea 
by refluxing in KOH. To achieve this, the use of an alcohol with a masked reactivity must be used. 
If the trimethylsilylalcohol shown in Scheme 53 is used as the initial O-group, after lithiation, 
treatment of the products with F
-
 sources such as TBAF should provide the hemiaminal which can 
then be removed by the methods previously reported and discussed.
85 
 
 
Scheme 53. A proposed method for the removal of the pyrroloimidazolone auxiliary. 
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     Additional aspects of the N-phenyl Ir complex that require further experimentation include the 
synthesis and evaluation of the complex derived from the annulated aminal with syn-
stereochemistry in the backbone (syn-121). While the ferrocene analogue did not provide high 
enantioselectivity, only experimentation will reveal if the same trend will be observed. In addition, 
treatment of the neutral Ir-complexes with anionic nucleophiles such as MeLi, which would result 
in an increase of electron density at the Ir atom, should be investigated. If a further deshielding of 
the upfield doublet is observed then this methodology may provide access to C-H activation 
products, possibly providing access to bidentate complexes after installation of nucleophilic atoms.  
   
5. Experimental  
 
General. All reagents were purchased from Aldrich, Fisher Scientific, Acros, Strem or Oakwood 
chemicals and used as received unless otherwise indicated. Tetrahydrofuran and diethyl ether were 
freshly distilled from sodium/benzophenone ketyl under an atmosphere of nitrogen. 
Dichloromethane was distilled from calcium hydride under nitrogen. All alkyllithiums were 
titrated against N-benzylbenzamide to a blue endpoint.
141
 All reactions were performed under 
nitrogen or argon in flame- or oven-dried glassware using syringe-septum cap techniques unless 
otherwise indicated. All reactions were run in round-bottom flasks with magnetic stir bars unless 
otherwise noted. The size/volume of the glassware used in all reactions was dictated by the amount 
of solvent required, such that each reaction vessel was no more than half-full.  TLC was performed 
on silica gel. Column chromatography was performed on silica gel 60 (70-230 mesh). Schwartz’s 
reagent was prepared according to a literature procedure.
142
 NMR spectra were obtained at room 
temperature, unless otherwise stated, on a Bruker Avance 300, 400 or 600 MHz instrument and are 
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referenced to the residual proton signal of the deuterated solvent for 
1
H spectra, and to the carbon 
multiplet of the deuterated solvent for 
13
C spectra according to published values.  FT-IR spectra 
were obtained on Bruker ALPHA platinum ATR spectrometer as neat materials. Specific rotations 
of diastereomerically and enantiomerically pure materials were measured on a Rudolph Research 
Autopol III automatic polarimeter. Mass spectra were obtained on a Micromass GCT 
spectrometer. Combustion analyses were performed by Atlantic Microlab Inc., Norcross, GA, 
USA. Melting points were determined on a Kofler hot-stage apparatus and are uncorrected.  
 
(+)-2-[(2Sp-Thiophenyl)ferrocenyl]-1R-triethylsilyloxy-7aS-hexahydropyrrolo[1,2-c]imidazol-
3-one) (82i). A solution of syn-81 (500 mg, 1.13 mmol) in THF (15 mL) at 
−78 ° C was treated with t-BuLi (2.1 mL, 1.25 M, 2.49 mmol). After 30 min, 
phenyl disulfide (617 mg, 0.93 mmol) in THF (5 mL) was added via cannula, 
and the reaction mixture was allowed to warm to room temperature (ca. 25 min). Water (10 mL) 
was added and the reaction mixture was extracted with EtOAc (10 mL). The organic extract was 
washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced 
pressure. Flash column chromatography (70:30 hexane/EtOAc Rf = 0.31) gave 82i (620 mg, 95%) 
as a red oil; [ ] 
   +43.7 (c 1.0, acetone); IR (ATR, oil) νmax 2953, 2875, 1713, 1475, 1402,1087 
cm
-1
; 7.14 (d, 2H, J = 6 Hz), 7.11 (t, 1H, J = 6 Hz), 7.04 (t, 1H, J = 6Hz), 5.55 (d, 1H, J = 6.8 Hz), 
4.42 (s, 1H), 4.38 (s, 5H), 4.18 (s, 1H), 3.81 (q, 1H, J = 7.2 Hz), 3.72 (td, 1H, J = 7.2, 4.4 Hz), 
3.15-3.09 (m, 1H), 1.92-1.89 (m, 1H), 1.80-1.73 (m, 2H), 1.65-1.60 (m, 1H), 0.86 (t, 9H, J = 8 
Hz), 0.56 (q, 6H, J = 8 Hz);
 13
C NMR (100 MHz, CDCl3) δ 158.9, 140.0, 128.24, 128.23, 125.1, 
94.9, 83.0, 77.3, 71.2, 66.4, 65.5, 62.5, 46.7, 25.5, 25.3, 6.8, 4.8; EI-MS [m/z (%)] 548 (M
+
, 87),  
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440(32), (416, 100), 335(55), 227(31), 103(30);  HR-MS (EI) calcd. for C28H36FeN2O2SSi: 
548.1616; found: 548.1621.  
 
(+)-2-[2Rp-(4-bis(Trifluoromethyl)diphenylphosphino)ferrocenyl]-2,5,6,7-tetrahydropyrrolo 
[1,2-c]imidazol-3-one (82j). To a solution of syn-81  (760 mg, 
1.00 mmol) in CHCl3 (30 mL) was added p-toluenesulfonic acid 
(760 mg, 4.0 mmol). The solution was heated to reflux and stirred 
for approximately 20 min. The acid was neutralized by addition of 
a sat. aq. NaHCO3 solution (10 mL). The reaction mixture was 
extracted with EtOAc (3 x 10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(EtOAc:Et3N 99/1, Rf = 0.34) provided 82j (501 mg, 79%) as a yellow glassy solid; [ ] 
   +101.2 
(c 0.5, CHCl3); IR (ATR, solid) νmax 3087, 2974, 2909, 2881, 1735, 1475, 1319, 1057 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.68-7.63 (m, 4H), 7.47 (d, 2H, J = 7.6 Hz), 7.28-7.24 (m, 3H), 6.56 (s, 
1H), 5.06 (s, 1H), 4.37 (t, 1H, J = 2.0 Hz), 4.15 (s, 5H), 3.66-3.57 (m, 3H), 2.74-2.62 (m, 2H), 
2.39-2.29 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 150.14, 143.2 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 
141.5 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 135.4 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 132.3 (d, 1C, 
1
J 
13
C-
31
P = 13.0 
Hz), 131.7 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz) 130.3 ((d, 1C, 
1
J 
13
C-
31
P = 33.0 Hz), 126.3, 125.4 (d, 1C, 
1
J 
13
C-
31
P = 15.0 Hz), 125.2 (d, 1C, 
1
J 
13
C-
31
P = 4.0 Hz), 125.1 (d, 1C, 
1
J 
13
C-
31
P = 3.0 Hz), 124.9 (d, 1C, 
1
J 
13
C-
31
P = 6.0 Hz), 122.6 (d, 1C, 
1
J 
13
C-
31
P = 15.0 Hz), 104.9 (d, 1C, 
1
J 
13
C-
31
P = 9.0 Hz), 98.9 (q, 
1C, 
1
J 
13
C-
19
F = 13.0 Hz), 70.6, 70.5, 70.4, 68.7, 68.67, 68.4, 67.7, 67.6, 42.3, 27.8, 22.8; 
31
P NMR 
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(162 MHz, CDCl3) δ −21.62; EI-MS [m/z (%)] 628 (M
+
, 100), 563 (23), 483 (17), 387 (44), 368 
(16), 217 (4); HR-MS (EI) calcd. for C30H23FeN2PF6: 628.0802, found 628.0811.  
 
(+)-2-[2Sp-(Thiophenyl)ferrocenyl]-2,5,6,7-tetra-hydropyrrolo[1,2-c]imidazol-3-one (85d). To 
a solution of 82i (613 mg, 1.12 mmol) in CHCl3 (10 mL) was added p-
toluenesulfonic acid (850 mg, 4.47 mmol). The solution was heated to reflux 
and stirred for approximately 30 min. The acid was neutralized by addition of 
a sat. aq. NaHCO3 solution (10 mL). The reaction mixture was extracted with EtOAc (10 mL). The 
organic extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated 
under reduced pressure. Flash column chromatography (50:50 acetone/hexanes Rf = 0.25) provided 
85d (440 mg, 94%) as a yellow solid which can be recrystallized from EtOAc to provide small, 
yellow cuboidal crystals; mp 165 °C (EtOAc); [ ] 
   +23.2 (c 0.6, acetone); IR (ATR, solid) νmax 
3367, 3156, 3091, 2980, 2901, 2887, 1682, 1635, 1477, 1080 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
7.18 (t, 2H, J = 7.2 Hz), 7.08-7.02 (m, 3H), 6.63 (s, 1H), 5.20 (s, 1H), 4.38 (s, 1H), 4.36 (s, 1H), 
4.35 (s, 1H), 3.73 (m, 2H), 2.78-2.63 (m, 2H) 2.38 (m, 2H);
 13
C NMR (100 MHz, CDCl3) δ 149.63, 
139.8, 128.7, 125.8, 125.7, 125.0, 103.9, 97.1, 72.2, 70.7, 68.3, 68.0, 66.5, 41.8, 27.6, 22.3; EI-MS 
[m/z (%)] 416(M
+
, 100), 351(18), 308(17), 243(15), 229(11), 171(6), 110(11), 56(8); HR-MS (EI) 
calcd. for C22H20FeN2OS: 416.0646; found: 416.0640.  
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(+)-2-[2Sp-(4-bis(Trifluoromethyl)diphenylphosphino)-2,5,6,7-tetra-hydropyrrolo[1,2-
c]imidazol-3-one (85e). To a solution of 82j (613 mg, 1.12 mmol) 
in CHCl3 (10 mL) was added p-toluenesulfonic acid (850 mg, 4.47 
mmol). The solution was heated to reflux and stirred for 
approximately 30 min. The acid was neutralized by addition of a sat. 
aq. NaHCO3 solution  (10 mL). The reaction mixture was extracted 
with EtOAc (10 mL). The organic extract was washed with water, brine, dried over anhyd. 
Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(EtOAc:Et3N 99/1, Rf = 0.34) provided 85e (501 mg, 79%) as a yellow glassy solid; [ ] 
   +101.2 
(c 0.5, CHCl3); IR (ATR, solid) νmax 3087, 2974, 2909, 2881, 1735, 1475, 1319, 1057 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.68-7.63 (m, 4H), 7.47 (d, 2H, J = 7.6 Hz), 7.28-7.24 (m, 3H), 6.56 (s, 
1H), 5.06 (s, 1H), 4.37 (t, 1H, J = 2.0 Hz), 4.15 (s, 5H), 3.66-3.57 (m, 3H), 2.74-2.62 (m, 2H), 
2.39-2.29 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 150.14, 143.2 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 
141.5 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 135.4 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz), 132.3 (d, 1C, 
1
J 
13
C-
31
P = 13.0 
Hz), 131.7 (d, 1C, 
1
J 
13
C-
31
P = 13.0 Hz) 130.3 ((d, 1C, 
1
J 
13
C-
31
P = 33.0 Hz), 126.3, 125.4 (d, 1C, 
1
J 
13
C-
31
P = 15.0 Hz), 125.2 (d, 1C, 
1
J 
13
C-
31
P = 4.0 Hz), 125.1 (d, 1C, 
1
J 
13
C-
31
P = 3.0 Hz), 124.9 (d, 1C, 
1
J 
13
C-
31
P = 6.0 Hz), 122.6 (d, 1C, 
1
J 
13
C-
31
P = 15.0 Hz), 104.9 (d, 1C, 
1
J 
13
C-
31
P = 9.0 Hz), 98.9 (q, 
1C, 
1
J 
13
C-
19
F = 13.0 Hz), 70.6, 70.5, 70.4, 68.7, 68.67, 68.4, 67.7, 67.6, 42.3, 27.8, 22.8; 
31
P NMR 
(162 MHz, CDCl3) δ −21.62; EI-MS [m/z (%)] 628 (M
+
, 100), 563 (23), 483 (17), 387 (44), 368 
(16), 217 (4); HR-MS (EI) calcd. for C30H23FeN2PF6: 628.0802, found 628.0811.  
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[3-Chloro-2-ferrocenyl-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-ium] hexafluorophosphate 
(124a). A mixture of imidazolone 85h (100 mg, 0.32 mmol) in neat POCl3 
(0.5 mL, 5.36 mmol) was heated at 50 °C for 16 hours. The resulting solution 
progressively changed from orange to black during this period. After cooling 
to room temperature, the volatiles were removed under high vacuum. The black residue was 
dissolved in CH2Cl2 (10 mL) and  treated with a sat. solution of KPF6 in H2O/MeOH (2 mL). The 
mixture was stirred for 15 min at room temperature resulting in a colour change from black to deep 
red. Water was added (10 mL) resulting in a biphasic mixture from which the organic layer was 
isolated, washed with water, dried over anhyd. Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was taken up in CH2Cl2 (2 mL) and added to an ice-cooled Et2O 
solution in an ice bath. The precipitate was collected by Hirsch funnel filtration and washed with 
cold Et2O to give a gold/beige powder 124a (134 mg, 89%); mp 220 °C (Et2O); IR (ATR, solid) 
νmax 3169, 3104, 3089, 2957, 1710, 1623, 1525, 831, cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.91 
(s, 1H), 4.93 (s, 2H), 4.49 (m, 9H),  3.19 (t, 2H, J = 7.6 Hz), 2.81(quintet, 2H, J =7.2 Hz); 
13
C 
NMR (100 MHz, acetone-d6) δ 139.3, 127.0, 118.2, 92.4, 70.5, 67.6, 64.8, 48.4, 27.2, 23.6; 
31
P 
NMR (162 MHz, acetone-d6) δ -144.3 (sept, 1P, J = 706 Hz); EI-MS [m/z (%)] 327 (M
+
, 77), 307 
(9), 206 (11), 154 (27), 136 (28), 107 (21), 77 (20), 69 (100), 50 (22); HR-MS (FAB) calcd. for 
C16H16ClFeN2
+
: 327.0346, found 327.0358.  
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(+)-[3-Chloro-2-[(2Sp-thiomethyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-
ium]hexafluorophosphate (124b).  A mixture of imidazolone 85b (147 mg, 
0.42 mmol) in neat POCl3 (0.5 mL, 5.36 mmol) was heated at 50 °C for 16 
hours. The resulting solution progressively changed from orange to black 
during this period. After cooling to room temperature, the volatiles were removed under high 
vacuum. The black residue was dissolved in CH2Cl2 (10 mL) and  treated with a sat. solution of 
KPF6 in H2O/MeOH (2 mL). The mixture was stirred for 15 min at room temperature resulting in a 
colour change from black to deep red. Water was added (10 mL) resulting in a biphasic mixture 
from which the organic layer was isolated, washed with water, dried over anhyd. Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was taken up in CH2Cl2 (2 mL) and 
added to an ice-cooled Et2O solution in an ice bath. The precipitate was collected by Hirsch funnel 
filtration and washed with cold Et2O to give a gold/beige powder 124b  (161 mg, 77%) as a 
gold/beige powder; mp 96 °C (Et2O); [ ] 
   +30.2 (c 1.0, CHCl3); IR (ATR, solid) νmax 3152, 2977, 
2923, 2875, 2858, 2851, 1650, 1537, 827 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 8.04 (s, 1H), 
4.96 (s, 1H), 4.75 (s, 1H), 4.61 (s, 1H), 4.51 (bs, 7H), 3.23 (s, 2H), 2.80 (s, 2H), 2.21 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) δ 138.4, 128.1, 120.2, 93.9, 79.1, 72.3, 72.0, 68.1, 67.4, 48.6, 27.2, 24.0, 
20.9; ESI-MS [m/z (%)] 373 (M
+
, 100), 217 (5); HR-MS (ESI) calcd for C17H18N2SClFe: 
373.0229; found: 373.0222. 
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(+)-[3-Chloro-2-[(2Sp-thiophenyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-
ium]hexafluorophosphate (124c). A mixture of imidazolone 85d (100 mg, 
0.24 mmol) in neat POCl3 (0.5 mL, 5.36 mmol) was heated at 50 °C for 16 
hours. The resulting solution progressively changed from orange to black 
during this period. After cooling to room temperature, the volatiles were removed under high 
vacuum. The black residue was dissolved in CH2Cl2 (10 mL) and  treated with a sat. solution of 
KPF6 in H2O/MeOH (2 mL). The mixture was stirred for 15 min at room temperature resulting in a 
colour change from black to deep red. Water was added (10 mL) resulting in a biphasic mixture 
from which the organic layer was isolated, washed with water, dried over anhyd. Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was taken up in CH2Cl2 (2 mL) and 
added to an ice-cooled Et2O solution in an ice bath. The precipitate was collected by Hirsch funnel 
filtration and washed with cold Et2O to give a gold/beige powder 124c (101 mg, 73%) as a 
gold/beige powder; mp >230 °C (Et2O); [ ] 
   +28.0 (c 1.0, CHCl3);  IR (ATR, solid) νmax 3154, 
2967, 2919, 2873, 2858, 1608, 1547, 824 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 8.10 (s, 1H), 
7.25 (t, 2H, J = 6.8 Hz), 7.18 (t, 1H, J = 6.8 Hz), 7.04 (d, 2H, J = 7.2 Hz), 5.14 (s, 1H), 4.88 (s, 
1H), 4.82 (t, 1H, J = 2.8 Hz), 4.61 (s, 5H), 4.42-4.29 (m, 2H), 3.23 (t, 2H, J = 7.6 Hz), 2.79 (quin, 
2H, J = 7.2 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 138.7, 137.3, 129.1, 128.7, 127.5, 126.4, 
120.8, 95.4, 74.8, 74.2, 72.2, 69.2, 68.4, 48.5, 27.2, 23.5; 
31
P NMR (162 MHz, acetone-d6) δ -144.3 
(sept, 1P, J = 706 Hz);
 31
P NMR (162 MHz, acetone-d6) δ -144.3 (sept, 1P, J = 706 Hz); ESI-MS 
[m/z (%)] 435 (M
+
, 100), 433 (8), 241 (5), 157 (5); HR-MS (ESI) calcd for C22H20N2SClFe: 
435.0385; found: 435.0396. 
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 (-)-[3-Chloro-2-[(2Rp-iodo)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-
ium]hexafluorophosphate (124d) A mixture of imidazolone 85c (472 mg, 
1.09 mmol) in neat POCl3 (0.5 mL, 5.36 mmol) was heated at 50 °C for 16 
hours. The resulting solution progressively changed from orange to black 
during this period. After cooling to room temperature, the volatiles were removed under high 
vacuum. The black residue was dissolved in CH2Cl2 (10 mL) and  treated with a sat. solution of 
KPF6 in H2O/MeOH (2 mL). The mixture was stirred for 15 min at room temperature resulting in a 
colour change from black to deep red. Water was added (10 mL) resulting in a biphasic mixture 
from which the organic layer was isolated, washed with water, dried over anhyd. Na2SO4, filtered 
and concentrated under reduced pressure. The crude product was taken up in CH2Cl2 (2 mL) and 
added to an ice-cooled Et2O solution in an ice bath. The precipitate was collected by Hirsch funnel 
filtration and washed with cold Et2O to give a gold/beige powder 124d  (474 mg, 73%) was 
obtained as an  iridescent brown powder; mp >220 °C (Et2O); [ ] 
   −46.8 (c 0.5, CHCl3); IR 
(ATR, solid) νmax 3181, 3108, 2921, 2852, 1701, 1614, 1524, 1487, 1225, 1109, 828 cm
-1
; 
1
H NMR 
(400 MHz, acetone-d6) δ 8.10 (s, 1H), 4.94 (s, 1H), 4.87 (s, 1H), 4.70 (s, 1H), 4.53 (m, 7H), 3.28 
(s, 2H), 2.79 (s, 2H); 
13C NMR (100 MHz, acetone) δ 139.0, 129.4, 120.6, 95.5, 74.8, 73.3, 69.2, 
67.3, 48.9, 37.3, 27.3, 23.8; 
31
P NMR (162 MHz, acetone-d6) δ -144.3 (sept, 1P, J = 706 Hz); 
FAB-MS [m/z (%)] 453 (M
+
, 63), 332(15), 149 (22), 123 (54), 111 (63), 109 (100); HR-MS (FAB) 
calcd. for C16H15ClFeIN2
+
: 452.9318, found 452.9297. 
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1-[Ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-ylidine-[trans-(bis 
(triphenylphosphine))]palladium(II)chloride}hexafluorophosphate 
(125a). A solution of 124a (60 mg, 0.13 mmol) and Pd(PPh3)4 (147 mg, 
0.13 mmol) in CH2Cl2 (3.0 mL) was refluxed for 16 h. After cooling the 
solution was filtered through celite, evaporated to dryness and allowed to crystallize in 
CHCl3/pentane producing 125a as bright yellow powdery crystals (76 mg, 62%); mp193-195 °C 
(CHCl3); IR (ATR, solid) νmax 3076, 3056, 1702, 1618, 1586, 1573, 1498, 1481, 1435, 1413, 1388, 
1185, 1159, 832, 690, 491, 424 cm
-1
 
1
H NMR (400 MHz, acetone-d6) δ 7.49-7.44 (m, 7H), 7.31-
7.29 (m, 23 H), 7.18 (s, 1H), 5.91 (s, 1H), 4.83 (s, 1H), 4.53(q, 1H, J = 11.6 Hz), 4.45 (s, 1H), 4.3 
(s, 5H), 4.28 (s, 1H), 4.20 (q, 1H, J = 11.6 Hz), 2.99-2.91 (m, 1H), 2.72-2.60 (m, 2H), 2.56-2.50 
(m, 1H); 
13
C NMR (100 MHz, acetone-d6) δ 139.4, 134.8, 134.7, 134.2, 133.5, 131.8, 131.4, 130.9, 
129.7, 129.3, 130.0, 128.9, 128.4, 128.3, 117.8, 117.7, 97.3, 70.0, 69.7, 68.0, 67.2, 66.1, 64.4, 47.6, 
27.1, 22.3; 
31
P NMR (162 MHz, acetone-d6) δ 30.3 (s, 1P), 20.8 (s, 1P) -144.2 (sept, 1P, J = 708 
Hz); FAB-MS [m/z (%)] 957 (M
+
, 100), 956 (66), 695 (32), 538 (41), 293 (51), 154 (90), 137 (58); 
HR-MS (FAB) calcd. for C52H46ClFeN2P2Pd: 955.1210, found 955.1373.  
 
(+)-{2-[(2Rp-Thiomethyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-ylidine-
[trans-(bis(triphenylphosphine))]palladium(II) chloride} 
hexafluorophosphate (125b). A solution of 124b (150 mg, 0.29 mmol) 
and Pd(PPh3)4 (334 mg, 0.13 mmol) in CH2Cl2 (25 mL) was refluxed for 
16 h. After cooling the solution was filtered through celite, evaporated to 
dryness and allowed to crystallize in CHCl3/pentane producing 125b as bright yellow powdery 
crystals (246 mg, 67%); mp >230 °C (CHCl3); [ ] 
   +25.1 (c 1.0, CHCl3);X-ray diffraction data 
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was collected on single yellow crystal (0.300 x 0.190 x 0.090 mm3) obtained by crystallization in 
CHCl3/ pentane: C55H50C17F6FeN2P3PdS: M = 1388.34, orthorhombic, P212121, a = 11.2517(5) Å, 
b =16.424(1) Å, c = 31.1181(18) Å, V = 5750.6(5) Å
3, α = 90°, β = 90°, γ = 90°, Z = 4, Dc = 1.604 
g/cm
3
, F(000) = 2800, T = 147(2) K; 30535 data were collected. The structure was solved by 
Direct Methods (SHELXTL) and refined by full-matrix least squares on F
2
 resulting in final R, Rw, 
and GOF [for 13109 data with F > 2α(F)] of 0.0444, 0.0697 and 0.980 respectively. Flack 
parameter = -0.011(13); IR (ATR, solid) νmax 3054, 1708, 1480, 1362 cm
-1
; 
1
H NMR (400 MHz, 
acetone-d6) δ 7.73 (s, 1H), 7.68-7.41 (m, 30H), 5.41 (s, 1H), 4.53 (s, 1H), 4.42 (t, 1H, J = 2.8 Hz), 
4.17 (s, 5H), 3.18-3.12 (m, 1H), 3.03-2.97 (m, 1H), 2.36 (t, 2H, J = 7.2 Hz), 1.89 (s, 3H), 1.57 
(quin, 2H, J = 7.6 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 140.6, 134.2, 134.1, 131.7, 131.2, 
129.2, 129.1, 128.7, 128.6, 120.5, 95.3, 79.0, 78.3, 71.3, 70.4, 66.1, 65.9, 46.8, 25.9, 22.3, 18.7; 
31
P 
NMR (162 MHz, acetone-d6) δ 30.1 (s, 1P), 20.6 (s, 1P) -144.5 (sept, 1P, J = 708 Hz); ESI-
MS[m/z (%)] 1095 (M+
+
, 100), 1003 (18), 833 (82), 743 (17), 659 (6), 389 (48), 263 (23); HR-MS 
(ESI) calcd for C53H48N2PdFeClSP2: 1003.1086; found: 1003.1126. Anal. Calcd for 
C53H48N2PdFeF6ClSP3·CHCl3: C,55.37; H, 4.21. Found: C, 55.60; H, 4.33. 
 
(+)-[2-[(2Rp-thiomethyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-
ium]hexafluorophosphate (134a). A solution of 124b (175 mg, 0.34 mmol) 
in THF (8 mL) at −78 ° C was treated with t-BuLi (0.88 mL, 0.77 M, 0.67 
mmol). After 1 hour water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. The residue is then dissolved in 
CH2Cl2 (2 mL) and this solution is added dropwise to a cold solution of Et2O in a tared flask within 
an ice bath. The resulting solution is put into the freezer for 16 hours, after decanting the colourless 
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solution and washing with cold Et2O the residue is dried under reduced pressure to give 134a (130 
mg, 80%) as a brown residue; mp 128 °C (Et2O); [ ] 
   +31.6 (c 1.0, CHCl3); IR (ATR, solid) νmax 
3162, 2980, 2924, 1702, 1608, 1547, 824 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 9.33 (s, 1H), 
7.77 (s, 1H), 4.99 (s, 1H), 4.69 (s, 1H), 4.54 (bs, 3H), 4.43 (s, 5H), 3.16 (s, 2H), 2.80 (s, 2H), 2.23 
(s, 3H); 
13
C NMR (100 MHz, acetone-d6) δ 139.5, 131.6, 116.7, 94.6, 72.9, 72.0, 67.3, 65.8, 30.9, 
27.8, 23.0, 21.2; 
31
P NMR (162 MHz, acetone-d6) δ -144.5 (sept, 1P, J = 708 Hz), ESI-MS[m/z 
(%)]373(18), 339 (M
+
, 100); HR-MS (ESI) calcd for C17H19N2FeS: 339.0613; found: 339.0601.  
 
(+)-[2-[(2Rp-Thiophenyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-4-
ium]hexafluorophosphate (134b). A solution of 124c (352 mg, 0.60 mmol) 
in THF (15 mL) at −78 ° C was treated with t-BuLi (2.4 mL, 0.50 M, 1.2 
mmol). After 1 hour water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. The residue is then dissolved in 
CH2Cl2 (2 mL) and this solution is added dropwise to a cold solution of Et2O in a tared flask within 
an ice bath. The resulting solution is put into the freezer for 16 hours, after decanting the colourless 
solution and washing with cold Et2O the residue is dried under reduced pressure to give 134b (277 
mg, 85%) as a brown oily residue; [ ] 
   +30.3 (c 1.0, CHCl3); IR (ATR, oil) νmax 3150, 2966, 
1696, 1608, 1477, 825 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 9.24 (s, 1H), 7.59 (s, 1H), 7.23 (t, 
2H, J = 7.6 Hz), 7.14 (t, 1H, J = 7.6 Hz), 7.03 (d, 2H, J = 7.6 Hz), 5.17 (s, 1H), 4.77 (s, 1H), 4.72 
(s, 1H), 4.53 (s, 5H), 4.45 (t, 2H, J = 6.8 Hz), 3.05 (t, 2H, J = 7.2 Hz), 2.70 (t, 2H, J = 7.2 Hz), 
13
C 
NMR (100 MHz, acetone-d6) δ 139.7, 138.0, 132.5, 129.2, 126.5, 126.1, 117.1, 96.1, 74.8, 72.3, 
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72.1, 68.5, 67.5, 48.5, 27.6, 22.5; 
31
P NMR (162 MHz, acetone-d6) δ -144.3 (sept, 1P, J = 708 Hz), 
ESI-MS[m/z (%)] 401 (M
+
, 100); HR-MS (ESI) calcd for C22H21N2FeS: 401.0769; found: 
401.0768.  
 
2-[2Rp-(bis)Ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-c]imidazol-3-one (136). To a stirred 
solution of 85c (200 mg, 0.46 mmol) in DMSO (3.5 mL) was added 
copper bronze (35 mg, 0.55 mmol) and heated at 50 °C for 8 hours. To 
the resulting dark solution was added water (10 mL) and the reaction 
mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, brine, 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
chromatography (Acetone: MeOH 95/5 Rf = 0.17) gave 136 (52 mg, 18%) as a bright red solid 
which was recrystallized from acetone to give bright red cuboidal crystals; mp >230 °C (acetone); 
IR (ATR, solid) νmax 3142, 3088, 2970, 2953, 2897, 2853, 1696, 1643, 1522, 1483, 1403, 1080 cm
-
1
; 
1
H NMR (400 MHz, CDCl3) δ 5.87 (s, 2H), 5.01 (s, 2H), 4.53 (s, 2H), 4.22 (s, 2H), 4.14 (s, 
10H), 3.66-3.62 (m, 2H), 3.46-3.40 (m, 2H), 2.75-2.69 (m, 2H), 2.58-2.52 (m, 2H), 2.34 (t, 4H, J = 
7.2 Hz); 
13C NMR (100 MHz, acetone) δ 149.4 (s, 2C), 126.0 (s, 2C), 103.9 (s, 2C), 93.8 (s, 2C), 
73.7 (s, 2C), 70.5 (s, 10C), 69.2 (s, 2C), 66.7 (s, 2C), 64.9 (s, 2C), 42.2 (s, 2C), 27.9 (s, 2C), 22.6 
(s, 2C); EI-MS [m/z (%)] 614 (M
+
, 32), 549 (100), 547 (54), 427 (17), 274 (33), 194 (4), 56 (5); 
HR-MS (EI) calcd for C32H30Fe2N4O2: 614.1068, found 614.1061.  
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 (+)-2-[2Sp-1-(Thiomethyl)-5,5-diphenyl-ferrocenyl](6aS,6bS)-6a,6b,7,8,9,11-hexahydro-5H-
pyrrolo[1',2':3,4]imidazo[5,1-b][1,3]oxazine (138). A solution of aminal 
102 (139 mg, 0.23 mmol) in THF (10 mL) at −78 ° C was treated with n-
BuLi (0.15 mL, 2.42 M, 0.35 mmol). After 30 min, dimethyl disulfide (0.05 
mL, 0.46 mmol) was added via syringe, and the reaction mixture was allowed to warm to room 
temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was extracted with 
EtOAc (10 mL). The organic extract was washed with water, brine, dried over anhyd. Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (90:10 CH2Cl2/ 
acetone Rf = 0.27) gave 138 (77 mg, 73%) as a yellow oil; [ ] 
   +201.8 (c 1.0, CHCl3); IR (ATR, 
oil) νmax 3088, 3059, 2960, 2938, 2917, 2864, 2838, 1599, 1491, 987 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.69 (d, 2H, J = 7.2 Hz), 7.48 (t, 2H, J = 7.2 Hz), 7.38 (t, 1H, J = 7.2 Hz), 7.14-7.12 (m, 
3H), 6.95-6.93 (m, 2H), 4.96 (s, 1H), 4.34 (d, 1H), 4.24 (d, 1H, J = 2.0 Hz), 3.94-3.92 (m, 2H), 
3.89-3.88 (m, 1H), 3.69 (s, 5H), 3.34 (m, 1H), 2.99-2.97 (m, 1H), 2.38 (s, 3H), 2.32 (m, 1H), 1.96-
1.92 (m, 1H), 1.89-1.87 (m, 2H); 
13
C NMR (100 MHz, CHCl3) δ 147.3, 145.8, 127.7, 127.68, 
127.6, 127.3, 127.2, 126.5, 91.6, 82.5, 81.2, 73.0, 71.5, 69.9, 68.5, 63.9, 56.1, 30.6, 26.7, 20.7; EI-
MS[m/z (%)] 522 (M
+
, 100), 439 (30), 330 (17), 121 (4), 83 (21); HR-MS (EI) calcd for 
C30H30N2OFeS: 542.1428; found: 542.1427.  
 
(–)-(S)-2-Phenyltetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione (141).  A solution of L-
proline (1.00 g, 8.68 mmol) and phenylisocyanate (0.95 mL, 8.68 mmol) in 
THF (20 mL) was heated to reflux for 3 hours. Aqueous HCl (10 mL, 8 M) 
was added and the mixture was left to reflux for an additional 16 hours. Once 
cooled to room temperature, 20 mL of CH2Cl2 was added and the solution was neutralized with an 
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excess of saturated NaHCO3 in water. The organic extract was washed with water, brine, dried 
over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (35:65 EtOAc/hexane Rf = 0.25) gave 141 (1.74 g, 93%) as a colorless solid that 
was recrystallized from EtOAc to give colourless needle crystals mp 147-149 °C (EtOAc); [ ] 
   
−49.2 (c 1.0, CHCl3); IR (ATR, solid) νmax 3463, 2969, 2360, 1708, 1494, 1353 cm
-1
; 
1
H (400 
MHz, CDCl3) δ 7.4-7.3 (m, 4H), 4.3-4.2 (m, 1H), 3.85-3.76 (m, 1H), 3.39-3.33 (m, 1H), 2.38-2.34 
(m, 1H), 2.39-2.34 (m, 2H), 1.93-1.83 (m, 1H), 1.56 (s, 1H); 
13
C NMR (100 MHz, CDCl3) δ 159.9, 
140.7, 128.7, 126.5, 125.9, 82.1, 62.3, 45.6, 26.45, 25.1, 6.5, 4.6; EI-MS [m/z (%)] 216 (M
+
 100), 
188 (17), 119 (31), 91 (4); HR-MS (EI) calcd. for C12H13N2O2: 216.0899; found: 216.0895. 
 
(–)-(1R,7aS)-2-phenyl-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one  
(116).  To a foil-wrapped flask containing 141 (2.00 g, 9.26 mmol) and 
Cp2ZrHCl (Schwartz’s reagent, 2.90 g, 11.1 mmol) was added warm THF (20 
mL) and the mixture was allowed to stir for 15 min.  Imidazole (1.45 g, 21.3 
mmol) and 4-dimethylaminopyridine (102 mg, 0.83 mmol) were added by temporarily removing 
the septum and adding the solids. Chlorotriethylsilane (1.53 mL, 12.0 mmol) was then added by 
syringe. The solution was left to stir at room temperature for 16 hours, diluted with Et2O (20 mL) 
and water (10 mL), and stirred for a further 10 min. The organic phase was then filtered through 
Celite, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 30:70 EtOAc/ hexanes Rf = 0.23) gave 116 (757 mg, 89%) as a 
colourless oil; [ ] 
   −66.2 (c 0.95, acetone); IR (ATR, solid) νmax 3061, 3042, 2952, 2901, 2876, 
1705, 1599, 1500, 1402, 1106, 1035 cm
-1
;
 1
H (400 MHz, CDCl3) δ 7.39-7.32 (m, 4H), 7.20 (t, 1H, 
J = 5.6 Hz), 5.65 (d, 1H, J = 6.4 Hz), 4.00 (q, 1H, J = 7.2 Hz), 3.70-3.67 (m, 1H), 3.20-3.14 (m, 
1H), 2.07-2.00 (m, 2H), 1.93-1.91 (m, 1H), 1.79-1.77 (m, 1H), 0.79 (t, 9H, J = 8.0 Hz), 0.49-0.34 
(m, 9H) ;
13
C NMR (100 MHz, CDCl3) δ 159.8, 137.7, 128.8, 126.1, 126.0, 82.2, 62.0, 46.0, 26.5, 
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25.1, 6.6, 4.6; EI-MS (m/z[%]) 332 (M
+
, 61), 303 (74), 259 (19), 201 (56), 184 (50), 146 (42), 93 
(100), 76 (91), 74 (90); HR-MS (EI) calcd. for C18H28N2O2Si: 332.1920; found: 332.1921. 
 
2-Phenyl-6,7-dihydro-2H-pyrrolo[1,2-c]imidazol-3(5H)-one (143). To a solution of 116 (200 
mg, 0.69 mmol) in CH2Cl2 (10 mL) was added p-toluenesulfonic acid (261 
mg, 1.37 mmol). The solution was stirred for 20 min at room temperature and 
the acid was then quenched by the addition of a saturated aqueous NaHCO3 solution (20 mL). The 
reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, 
brine, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (EtOAc Rf = 0.30) gave 143 (117 mg, 85%) as colorless solid that was 
recrystallized from Et2O to colorless needles; mp 163 °C (Et2O); IR (ATR, solid) νmax 3118, 3063, 
3047, 2986, 2965, 2945, 2889. 1673, 1639, 1595, 1503, 1420, 1345 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.58 (d, 2H, J = 10.4 Hz), 7.39 (t, 2H, J = 10.0 Hz), 7.19 (t, 1H, J = 10.0 Hz), 6.27 (s, 
1H), 3.77 (t, 2H, J = 9.2 Hz), 2.78 (t, 2H, J = 9.6 Hz), 2.46 (quin, 2H, J = 9.6 Hz); 
13
C NMR (100 
MHz, CDCl3) δ 149.0, 138.0, 129.1, 127.7, 125.3, 121.5, 101.4, 42.6, 27.9, 22.9; EI-MS [m/z (%)] 
200 (M
+
, 100), 171 (89), 157 (11), 127 (5), 104 (8); HR-MS (EI) calcd. for C12H14N2O: 200.0944; 
found: 200.0934. 
 
 (–)-2-Ferrocenyl-1S-methoxy-7aS-hexahydropyrrolo[1,2-c]imidazol-3-one (144). To a 
solution of syn-81 (100 mg, 0.23 mmol) in MeOH (2 mL) was added p-
toluenesulfonic acid (173 mg, 0.9 mmol). The solution was stirred for 4 min. 
The acid was neutralized by addition of a sat. aq. NaHCO3 solution (10 mL). 
The reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with 
water, brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (74:25:1 hexanes/EtOAc/Et3N, Rf = 0.24) gave 133 (68 mg, 88%) as a 
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yellow solid which was recrystallized from EtOAc providing yellow needle shaped crystals;  mp 
122 °C (EtOAc); [ ] 
   −45.9 (c 1.7, CHCl3); IR (ATR, solid) νmax 2991, 2952, 2937, 2873, 2830, 
1706, 1498, 1458, 1068 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.20 (s, 1H), 5.02 (s, 1H), 4.50 (s, 
1H), 4.18 (s, 5H), 4.07 (s, 1H), 4.02 (s, 1H), 3.72 (q, 1H, J = 8.0 Hz), 3.52 (q, 1H, J = 8.0 Hz), 3.29 
(s, 3H), 3.17-3.11 (m, 1H), 2.13-2.07 (m, 2H), 2.04-2.03 (m, 1H), 1.30 (quin, 1H, J = 9.6 Hz); 
13
C 
NMR (100 MHz, CDCl3) δ 161.0, 89.3, 69.0, 64.6, 64.4, 62.1, 61.7, 59.1, 50.1, 45.6, 29.2, 24.8; 
EI-MS [m/z (%)] 340 (M
+
, 100), 308 (26), 243 (64), 227 (51), 121 (11), 56 (9); HR-MS (EI) calcd 
for C17H20N2O2Fe: 340.0874; found: 340.0888.  
 
(–)-(1R,7aS)-1-Hydroxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (146). To a 
foil-wrapped flask containing 141 (2.0 g, 9.26 mmol) and Cp2ZrHCl 
(Schwartz’s reagent, 2.90 g, 11.1 mmol) was added warm THF (20 mL) and 
the mixture was allowed to stir for 15 min.  A sat. aqueous NaHCO3 solution 
(4 mL) and dry silica (2 g) was then added to flask and the mixture was stirred for a further 5 min. 
This slurry was then evaporated to dryness under reduced pressure. Flash chromatography (50:50 
EtOAc/hexane Rf = 0.30) gave 146 (1.76 g, 87%) as a colorless solid that was recrystallized from 
EtOH, EtOAc or Et2O to give colourless needles; mp 177-179 °C (EtOAc); [ ] 
   −35.0 (c 0.8, 
MeOH); IR (ATR, solid) νmax 3251, 3108, 3080, 3066, 3047, 2978, 2961, 2939, 2909, 2875, 1659,  
1597, 1416, 1328, 1292, 1088, 1067 cm
-1 
;
 1
H NMR (400 MHz, acetone-d6) δ 7.73 (d, 2H, J = 10.8 
Hz), 7.33 (t, 2H, J = 10.8 Hz), 7.07 (t, 1H, J = 10.8 Hz), 5.73 (d, 1H, J = 10.0 Hz), 5.53 (d, 1H, J = 
10.8 Hz), 3.67-3.55 (m, 2H), 3.10-3.02 (m, 1H), 2.12-2.10 (m, 1H), 1.98-1.86 (m, 2H), 1.46-1.39 
(p, 1H, J = 12.4 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 160.3, 139.3, 128.4, 123.0, 120.1, 82.2, 
66.1, 45.2, 28.3, 24.5; EI-MS [m/z (%)] 200 (M
+
, 100), 218 (51), 171 (90), 146 (18), 119 (14), 93 
(22), 77 (28), 70 (27), 51 (9); HR-MS (EI) calcd. for C12H14N2O2: 218.1055; found 218.1059. 
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(+)-(1S,7aS)-1-Isopropoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (anti-
145) and (–)-(1R,7aS)-1-isopropoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one 
(syn-145). To a stirred solution of hemiaminal 146 (300 mg, 1.39 mmol) in i-PrOH (5 mL) and 
CH2Cl2 (5 mL) was added p-toluenesulfonic acid (264 mg, 1.39 mmol). After stirring for 30 
minutes at room temperature, the acid was neutralized with sat. aq. NaHCO3 solution (20 mL) and 
the reaction mixture was extracted with EtOAc (15 mL). The organic extract was washed with 
water, brin, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (35:65 EtOAc/hexane Rf = 0.30) gave, sequentially, anti-145 (235 mg, 65 
%) and syn-145 (55 mg, 15%, Rf = 0.23) both of which were recrystallized from either EtOH, 
EtOAc or Et2O to colorless needles.  
 
 (anti-145). mp 100-101 °C (EtOH); [ ] 
   +23.2 (c 0.6, acetone); IR (ATR, solid) νmax 3061, 3044, 
2969, 2933, 2906, 1687, 1597, 1499, 1456, 1410, 1396, 1278, 1040 cm
-1
; 
1
H 
NMR (400 MHz acetone-d6) δ 7.63 (d, 2H, J = 7.6 Hz), 7.34 (t, 2H, J = 8.0 
Hz), 7.08 (t, 1H, J = 8.0 Hz), 5.58 (s, 1H), 3.97-3.86 (m, 1H), 3.64-3.59 (m, 
2H), 3.09-3.03 (m, 1H) 2.15-2.06 (m, 1H) 1.96-1.85 (m, 2H), 1.49-1.41 (s, 1H, J = 9.2 Hz), 1.107 
(d, 6H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 161, 139.7, 128.7, 123.9, 121.2, 87.6, 69.4, 
64.5, 45.6, 24.8, 23.1, 22.5; EI-MS [m/z (%)] 260 (M
+
, 60) 217 (57), 201 (79), 146 (46), 121 (56), 
70 (100);  HR-MS (EI) calcd. for C15H20N2O2: 260.1525; found 260.1523.  
 
 (syn-145). mp 76-77 °C (Et2O); [ ] 
   −102.2 (c 1.0, acetone); IR (ATR, solid) νmax 3051, 2971, 
2953, 2875, 1679, 1500, 1486, 1454, 1416, 1160cm
-1
; 
1
H NMR (400 MHz, 
acetone-d6) δ 7.57-7.55 (d, 2H, J = 8.0 Hz), 7.35-7.31 ( t, 2H, J = 8.0 Hz), 
7.13-7.09 (t, 1H, J = 8.0 Hz), 5.66-5.64 (d, 1H, J = 6.8 Hz), 4.09-4.08 (q, 1H, 
J = 6.0 Hz), 3.79-3.77 (m, 1H), 3.54-3.49 (m, 1H), 3.08-3.03 (m, 1H) 2.02- 1.85 (m, 4H), 1.55-
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1.40 (d, 3H, J = 6.0 Hz), 1.04-1.02 (d, 3H, J = 6.0 Hz); 
13
C NMR ( 100 MHz, acetone-d6) δ 158.5, 
139.4, 128.3, 124.0, 122.5, 85.8, 71.2, 60.7, 45.4, 25.9, 25.5, 22.4, 21.4; EI-MS [m/z (%)] 260 (M
+
, 
62), 217 (45), 201 (57), 146 (38), 121 (49), 119 (26), 77 (29), 70 (100); HR-MS (EI) calcd. for 
C15H20N2O2: 260.1525; found 260.1528.  
 
(–)-(1S,7aS)-2-(2-(Hydroxydiphenylmethyl)phenyl)-1-isopropoxytetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one (anti-147). A solution of anti-145 (500 mg, 1.92 mmol) in THF (10 mL) at 
−78 °C was treated with t-BuLi (2.8 mL, 1.5 M, 4.20 mmol). The solution 
turned yellow upon addition and progressively darkened to red.  After 15 
min the reaction mixture was warmed to −40 ° C by switching cold baths, 
and stirred at that temperature for an additional 15 min. A solution of 
benzophenone (734 mg, 4.03 mmol) in THF (10 mL) was added by cannula. The solution turned 
green upon addition of the electrophile, and the reaction was then allowed to warm to room 
temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was extracted with 
EtOAc (10 mL). The organic extract was washed with water, brine, dried over anhyd Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (50:50 
EtOAc/hexane Rf = 0.46) gave anti-147 (757 mg, 89%) as a colorless oil that crystallized upon 
standing; mp 120-122 °C (EtOAc/hexane); [ ] 
   −16.8 (c 1.2, acetone); IR (ATR, solid) νmax 
3325, 3058, 3023, 2971, 2894, 2877, 1679, 1417, 1327, 1261, 1054 cm
-1
; 
1
H NMR (400 MHz, 
acetone-d6) : δ 7.50 (d, 1H, J = 8.0 Hz), 7.44-7.36 (m, 7H), 7.32-7.23 (m, 5H), 6.78 (d, 1H, J = 8.0 
Hz) 6.015 (d, 1H, J = 4.0 Hz), 3.89 (s, 1H), 3.50-3.44 (m, 1H) 3.39-.3.33 (m, 2H), 2.95-2.88 (m, 
1H), 1.79-1.69 (m, 2H), 1.64-1.56 (m, 1H), 1.01 – 0.97 (m, 6H), 0.62- 0.57 (s, 1H, J = 4.0 Hz); 13C 
NMR (100 MHz, acetone-d6) δ 164.3, 148.9, 147.2, 146.9, 135.5, 134.7, 130.6, 128.4, 128.2, 
128.1, 127.9, 127.6, 126.9, 126.9, 126,7, 88.8, 80.6, 71.1, 66.0, 45.5, 27.3, 24.8, 22.0, 21.8; EI-MS 
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[m/z (%)] 442 (M
+
, 7), 382 (54), 349 (23), 260 (30), 201 (51), 121 (36), 105 (68), 77 (53), 70 
(100); HR-MS (EI) calcd. for C28H30N2O3: 442.2251; found 442.2256. 
 
(–)-(1R,7aS)-2-(2-(Hydroxydiphenylmethyl)phenyl)-1-isopropoxytetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one  (syn-147). A solution of syn-145 (170 mg, 0.65 
mmol) in THF (5 mL) at −78 ° C was treated with t-BuLi (0.90 mL, 1.45 M, 
1.31 mmol). The solution turned yellow initially and progressively darkened 
to red.  After 15 min the reaction mixture was warmed to −40 ° C bath by 
switching cold baths, and stirred at that temperature for an additional 15 min. A solution of 
benzophenone (263 mg, 1.44 mmol) in THF (3 mL) was added by cannula. The solution turned 
green upon anddition of the electrophile, and the reaction mixture was allowed to warm to room 
temperature (ca. 25 min). Water (10 mL) was then added and the mixture was extracted with 
EtOAc (10 mL). The organic extract was washed with water, brine, dried over anhyd Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (50:50 
EtOAc/hexanes Rf = 0.40) gave syn-147 (174 mg, 60%) as a colorless oil that was recrystallized 
from acetone/hexane to cuboidal crystals; mp 151-153 °C (acetone/hexane); [ ] 
   −114.3 (c 1.0, 
acetone); IR (ATR, solid) νmax 3303, 3089, 3067, 3028, 2968, 2930, 2909, 2875, 1958, 1945, 1882, 
1848, 1666, 1450,  1084 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.55-7.24 (m, 13H), 6.94 (d, 1H, 
J = 8.0 Hz), 5.59 (s, 1H), 3.78 (d, 1H, J = 6.8 Hz), 3.38-3.35 (m, 1H), 3.28-3.20 (m, 2H), 2.95 
(quin, 1H, J = 4.4 Hz), 1.88-1.81 (m, 3H), 1.63-1.60 (m, 1H), 0.96 (t, 6H, 6.4 Hz); 
13
C NMR (100 
MHz, acetone-d6) δ 161.6, 148.7, 146.7, 146.5, 135.9, 133.9, 130.3, 128.1, 128.0, 127.8, 127.5, 
127.47, 126.6, 26.55, 86.7, 80.3, 71.2, 61.6, 45.0, 26.3, 24.9, 21.7, 21.5; EI-MS [m/z (%)] 382 (M
+
, 
100), 442 (5), 349 (50), 305 (31) 285 (59), 256 (61), 217 (26), 201 (27), 164 (26), 104 (24); HR-
MS (EI) calcd for C28H30N2O3: 442.2256; found: 442.2233. 
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(+)-(6aR,6bS)-5,5-Diphenyl-6b,7,8,9-tetrahydro-5H-benzo[d]pyrrolo[1',2':3,4]imidazo[5,1-b] 
[1,3]oxazin-11(6aH)-one (syn-118). To a solution of anti-147 (145 mg, 0.33 
mmol) in CHCl3 (15 mL) was added p-toluenesulfonic acid (250 mg, 1.3 
mmol) and stirred for 4 min. The acid was neutralized by addition of a sat. aq. 
NaHCO3 solution (10 mL). The reaction mixture was extracted with EtOAc (15 mL). The organic 
extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated under 
reduced pressure. Flash column chromatography (50:50 hexanes/EtOAc, Rf = 0.50) gave syn-118 
(123 mg, 97%) as a white solid which was recrystallized from Et2O providing needle shaped 
crystals; mp 187-189 °C (Et2O); [ ] 
   + 391.3 (c 1.0, acetone); IR (ATR, solid) νmax 3059, 3033, 
2947, 2931, 2894, 1710, 1601, 1490, 1403 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.90 (dd, 1H, J 
= 8.4, 1.2 Hz), 7.46-7.41 (m, 3H), 7.32-7.26 (m, 6H), 7.22-7.19 (m, 2H), 6.99 (td, 1H, J = 8.4, 1.2 
Hz), 6.89 (dd, 1H, J = 6.4, 1.2 Hz), 5.23 (d, 1H, J = 6.8 Hz), 4.01 (q, 1H, J = 6.8 Hz), 3.73 (dt, 1H, 
J = 5.6, 1.6 Hz), 3.09 (dt, 1H, J = 5.6, 1.2 Hz), 2.29-2.24 (m, 1H), 2.04-1.98 (m, 1H), 1.97-1.93 (m, 
2H); 
13
C NMR (100 MHz, acetone-d6) δ 159.1, 146.5, 143.8, 134.9, 129.6, 129.2, 128.3, 128.2, 
127.8, 127.5, 127.4, 127.3, 122.0, 120.7, 85.1, 78.5, 59.3, 45.5, 25.8, 24.2; EI-MS[m/z (%)] 382 
(M
+
, 100), 305 (41), 285 (32), 284 (21), 256 (35), 254 (17), 165 (22), 105 (44), 77 (12), 70 (36); 
HR-MS (EI) calcd for: C25H22N2O2: 382.1676; found: 382.1692. 
 
(+)-(6aR,6bS)-1-(diphenylphosphino)-5,5-diphenyl-6b,7,8,9-tetrahydro-5H-benzo[d]pyrrolo 
[1',2':3,4]imidazo[5,1-b][1,3]oxazin-11(6aH)-one (syn-118b). A solution 
of syn-118 (382 mg, 1.00 mmol) in THF (15 mL) at −78 ° C was treated with 
t-BuLi (1.42 mL, 1.55 M, 2.20 mmol). After 30 min, chlorodiphenyl 
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phosphine (0.44 mL, 2.40 mmol) was added by syringe, and the reaction mixture was allowed to 
warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(80:18:2 hexane/EtOAc/CH2Cl2 Rf = 0.34) gave 118b (470 mg, 83%) as a white oily residue; 
[ ] 
   +372.5 (c 1, acetone); IR (ATR, oil) νmax 3054, 2035, 2978, 2952, 2887, 1722, 1572, 1432, 
695 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.52-7.48 (m, 2H), 7.42-7.41 (m, 3H), 7.36-7.25 (m, 
11H), 7.20-7.11 (m, 5H), 7.09-7.06 (m, 1H), 6.93 (d, 1H, J = 7.6 Hz), 5.03 (d, 2H, J = 5.6 Hz), 
3.72 (quin, 1H, J = 5.6 Hz), 3.05-3.01 (m, 1H), 2.34-2.30 (m, 1H), 1.98-1.94 (m, 2H), 1.85-1.83 
(m, 1H); 
13
C NMR (100 MHz, acetone-d6) δ 160.8, 146.4, 143.8, 139.8 (d, 1C, J 
13
C-
31
P = 16.0 Hz), 
139.6, 139.3, 138.7 (d, 1C, 
1
J 
13
C-
31
P = 14.0 Hz), 135.2, 134.4 (d, 1C, 
1
J 
13
C-
31
P = 17.0 Hz), 133.4 (d, 
1C, 
1
J 
13
C-
31
P = 18.0 Hz), 132.9 (d, 1C, J 
13
C-
31
P = 17.0 Hz), 130.8, 130.6 (d, 1C, J 
13
C-
31
P = 0.5 Hz), 
129.1, 128.3, 128.26, 128.2, 128.1, 128.0, 127.9, 127.6, 124.2; 
31
P NMR (162 MHz, acetone-d6) δ 
−16.31(s, 1P); EI-MS[m/z (%)] 566 (M+, 61), 490 (33), 489 (100), 469 (44), 392 (17), 362 (12), 
104 (5); HR-MS (EI) cald for: C37H31N2O2P: 566.2118; found: 566.2129.  
 
(−)-(6aS,6bS)-5,5-Diphenyl-6b,7,8,9-tetrahydro-5H-benzo[d]pyrrolo[1',2':3,4]imidazo[5,1-
b][1,3]oxazin-11(6aH)-one (anti-118). To a solution of syn-136 (275 mg, 
0.62 mmol) in CH2Cl2 (10 mL) was added p-toluenesulfonic acid (235 mg, 
1.24 mmol) and stirred for 2 min. The acid was neutralized by addition of 
a sat. aq. NaHCO3 solution (10 mL). The reaction mixture was extracted with EtOAc (15 mL). The 
organic extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated 
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under reduced pressure. Flash column chromatography (50:50 hexanes/EtOAc, Rf = 0.70) gave 
anti-118 (123 mg, 96%) as a white solid which was recrystallized from EtOAc/CH2Cl2/hexanes 
providing needle shaped crystals; mp >230 °C (EtOAc/CH2Cl2/hexanes); [ ] 
   −467.4 ° (c 1.0, 
CH2Cl2); IR (ATR, solid) νmax 3057, 3033, 2971, 2898, 1716, 1601, 1489, 1307 cm
-1
; 
1
H NMR 
(400 MHz, acetone-d6) δ 8.07 (dd, 1H, J = 8.0, 0.8 Hz), 7.44-7.41 (3H, m), 7.34-7.25 (m, 6H), 
7.20-7.18 (m, 2H), 7.03 (t, 1H, J = 6.8 Hz), 6.89 (dd, 1H, J = 6.8, 1.2 Hz), 5.04 (d, 1H, J = 1.6 Hz), 
3.84-3.80 (m, 1H), 3.62-3.56 (m, 1H), 3.18-3.11 (m, 1H), 2.02-1.90 (m, 3H)m 1.43-1.38 (m, 1H); 
13
C NMR (100 MHz, acetone-d6) δ 159.1, 146.4, 143.7, 134.6, 129.8, 129.2, 128.3, 128.25, 128.2, 
128.14, 127.8, 127.54, 127.5, 122.4, 120.3, 85.4, 81.7, 62.5, 45.5, 28.1, 25.18; EI-MS[m/z (%)] 382 
(M
+
, 100), 313 (12), 285 (68), 256 (49), 132 (43), 85 (64), 83 (94), 69 (30); HR-MS (EI) calcd for: 
C25H22N2O2: 382.1676; found: 382.1672. 
 
(−)-(6aS,6bS)-5,5-diphenyl-6a,6b,7,8,9,11-hexahydro-5H-benzo[d]pyrrolo[1',2':3,4] 
imidazo[5,1-b][1,3]oxazine (anti-119). To a solution of (anti-118) (202 mg, 
0.53 mmol) in THF (4 mL) and CH2Cl2 (2 mL) at −78 °C was added 
dropwise a solution of DIBAL-H in hexane (2.18 mL, 2.11 mmol, 0.97 M). 
The cold bath was removed and the solution was allowed to warm to room temperature (ca. 25 
min) and stirred for an additional hour. To the solution was then added a sat. aq. solution of 
Rochelle’s salt, diluted with EtOAc (10 mL) and stirred for an additional ten minutes. The reaction 
mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, brine, 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (50:50 hexanes/EtOAc, Rf = 0.24) gave anti-119 (185 mg, 95%) as a white solid 
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which was recrystallized from acetone to give colourless needle shaped crystals; mp 168-170 °C 
(acetone); [ ] 
   −384.6 ° (c 1.0, CH2Cl2); IR (ATR, solid) νmax 3082, 3060, 3025, 2966, 2911, 
2879, 2829, 2815, 1601, 1575, 1485, 1449, 1320 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.41-
7.37 (m, 3H), 7.31-7.29 (m, 2H), 7.26-7.22 (m, 3H), 7.17-7.13 (m, 3H), 6.90 (d, 1H, J = 8.0 Hz), 
6.74-6.72 (d, 2H, J = 3.6 Hz), 4.59 (d, 1H, J = 7.6 Hz), 4.38 (d, 1H, J = 3.2 Hz), 4.28 (d, 1H, J = 
7.6 Hz), 3.65 (q, 1H, J = 4.0 Hz), 3.11 (q, 1H, J = 4.0 Hz), 2.73-2.71 (m, 1H), 2.09-2.07 (m, 1H), 
1.75-1.63 (m, 3H); 
13
C NMR (100 MHz, acetone-d6) δ 147.1, 144.4, 141.8, 129.6, 129.0, 128.3, 
128.2, 128.0, 127.8, 127.7, 127.5, 127.1, 118.8, 87.5, 84.4, 74.6, 70.7, 54.7, 28.7, 25.3; EI-MS[m/z 
(%)] 368 (8), 356 (7), 270 (14), 255 (11), 194 (19), 132 (13), 85 (28), 83 (100), 82 (8); HR-MS 
(EI) calcd for: C25H24N2O: 368.1833; found: 368.1877. 
 
120a and 120b. A solution of anti-119 (95 mg, 0.26 mmol) and tritylium tetrafluoroborate (94 mg, 
0.28 mmol) in CH2Cl2 (2 mL) was stirred in a Schlenk flask at room temperature covered from 
light. After 5 h, solvent was removed in vacuo and the crude solid was washed with dry diethyl 
ether (3 x 5 mL) and dried in vacuo. To this was added Ir(μ-Cl)(COD)]2 (87 mg, 0.13 mmol) and 
degassed THF (7 mL) in glovebox. The solution was cooled to –78 °C and with increased flow of 
argon, KOtBu (32 mg, 0.29 mmol) was added at –78 °C. After 1 h, the cold bath was removed and 
the volatiles were removed under reduced pressure. Purification of the residue by flash column 
chromatography (silica gel, 2:8 EtOAc/hexanes, Rf = 0.45 and 0.21) afforded 120a (60 mg, 34%) 
and 113b (24 mg, 12%).  
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 (–)-Chloro[η
4
-1,5-cyclooctadiene]2-(6aS,6bS)-5,5-diphenyl-6a,6b,7,8,9,11-hexahydro-5H- 
benzo[d]pyrrolo[1',2':3,4]imidazo-2-ylidene]iridium (120a). Major 
coordination isomer; mp >230 °C (acetone); [ ] 
   −213.63 ° (c 0.5, CHCl3); 
IR (ATR, solid) νmax 3069, 3063, 3022, 2960, 2944, 2884, 2862, 2855, 2846, 
1610, 1558, 1440, 1366, 755, 694; 
1
H NMR (600 MHz,  CDCl3) δ 9.64 (d, 
1H, J = 8.4 Hz), 7.36-7.27 (m, 4H), 7.25-7.24 (m, 5H), 7.15 (d, 2H, J = 2.4 Hz), 7.08 (t, 1H, J = 
8.4 Hz), 6.82 (d, 1H, J = 8.4 Hz), 5.15 (d, 1H, J = 3.0 Hz), 4.85 (dt, 1H, J = 6.2, 4.8 Hz), 4.71-4.65 
(m, 2H), 4.00-3.99 (m, 1H), 3.63-3.59 (m, 1H), 3.33 (t, 1H, J = 6.2 Hz), 2.62-2.61 (m, 1H), 2.32-
2.29 (m, 1H), 2.25-2.15 (m, 3H), 1.97-193 (m, 2H), 1.82-1.76 (m, 4H), 1.46-1.39 (m, 2H); 
13
C 
NMR (150 MHz, CDCl3) δ 210.6, 146.0, 143.1, 135.4, 129.6, 129.5, 128.6, 128.4, 128.2, 128.0, 
127.7, 127.3, 123.8, 123.7, 86.7, 86.3, 86.25, 86.1, 69.5, 56.1, 51.1, 46.8, 34.1, 32.6, 29.6, 29.0, 
27.7, 25.1, EI-MS[m/z (%)] 667 (M
+
-Cl, 100), 665 (83), 663 (25), 591 (6), 320 (9); HR-MS (FAB) 
calcd for C33H30ON2Ir: 663.1982; found : 663.1969 NOTE: compound unstable, easily loses Cl 
and 4H atoms. ESI at two different voltages: 128.5 V and 241.0 V shows this compound loses 4 
additional H atoms. Anal. Calcd for C33H30ON2Ir: C, 56.44; H, 4.88. Found: C, 56.70; H, 5.06. 
 
MINOR: [ ] 
   −163.82 ° (c 0.5, CHCl3); IR (ATR, solid) νmax 3060, 3044, 3022, 2961, 2946, 
2920, 2885, 2835, 1714, 1704, 1599, 1327, 750, 699 cm
-1
; 
1
H NMR (400 MHz,  CDCl3) δ 10.00 
(d, 1H, J = 8.4 Hz), 7.47-7.37 (m, 4H), 7.33-7.28 (m, 5H), 7.17-7.15 (m, 2H), 7.00 (t, 1H, J = 8.0 
Hz), 6.80 (dd, 1H, J = 8.4 Hz 7.6, 1.2 Hz), 5.28 (d, 1H, J = 7.6 Hz), 4.68-4.66 (m, 1H), 4.61-4.59 
(m, 1H), 4.33-4.25 (m, 2H), 3.75-3.68 (m, 1H), 2.33-2.11 (m, 9H), 1.90-1.87 (m, 1H), 1.76-1.72 
(m, 2H), 1.57 (quint, 2H, J = 7.2 Hz); 
13
C NMR was not legible; EI-MS[m/z (%)] 667 (M
+
-Cl, 
100), 665 (95), 664 (13), 663 (35); HR-MS (FAB) calcd for: C33H30ON2Ir: 663.1982; found : 
663.1931. NOTE: compound unstable, easily loses Cl and 4H atoms. ESI at two different voltages: 
128.5 V and 241.0 V shows this compound loses 4 additional H atoms, after the Cl is lost. Anal. 
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Calcd for C33H30ON2Ir: C, 56.44; H, 4.88. Found: C, 56.65; H, 5.59. Sample's identity still cannot 
be assigned with confidence.  
 
(–)-[η
4
-1,5-cyclooctadiene][triphenylphosphine]2-(6aS,6bS)-5,5-diphenyl-6a,6b,7,8,9,11-
hexahydro-5H- benzo[d]pyrrolo[1',2':3,4]imidazo-2-ylidene]iridium 
hexafluorophosphate (121). To a solution of 120a (44 mg, 0.06 mmol) in 
CH2Cl2 (1 mL) was added a solution of triphenylphosphine (16 mg, 0.06 
mmol) in CH2Cl2 (1 mL) and resulting red solution was stirred for 3 h at 
room temperature and then concentrated. The residue was dissolved in 
minimum amount of CH3CN and KPF6 (15 mg, 0.08 mmol) in CH3CN was added and stirred at 
room temperature for another hour, passed through Celite and washed with CH2Cl2. Volatiles were 
removed under reduced pressure and resulting red solid was triturated with pentane to afford 121 
as red crystalline solid (68 mg, 97%). mp 189-190 °C; [ ] 
   −261.15 ° (c 0.5, CHCl3); IR (ATR, 
solid) νmax 3058, 2953, 2921, 2883, 2837, 1731, 1601, 1573, 1236, 1092, 832, 695 cm
-1
; 
1
H NMR 
(400 MHz,  CDCl3) δ 9.10 (d, 1H, J = 8.0 Hz), 7.47-7.41 (m, 8H), 7.36-7.31 (m, 9H), 7.30-7.23 
(m, 7H), 7.15-7.11 (m, 3H), 6.91 (d, 1H, J = 8.0 Hz), 4.99 (quint, 1H, J = 3.2 Hz), 4.58 (d, 1H, J = 
7.2 Hz), 4.13-4.01 (m, 4H), 3.82 (t, 1H, J = 8.8 Hz), 3.36 (q, 1H, J = 11.2 Hz), 2.65-2.61 (m, 1H), 
2.42-2.39 (m, 1H), 2.28-2.25 (m, 1H), 2.17-2.04 (m, 6H), 1.79-1.75 (m, 2H), 0.31 (quint, 1H, J = 
8.4 Hz), 
13
C NMR (100 MHz, CDCl3) δ 201.6 (d, 1C, 
1
J 
13
C-
31
P = 8.0 Hz), 145.0, 143.0, 134.3, 
133.8, 132.3, 132.2, 131.6, 131.2, 130.7, 129.2, 129.1, 129.0, 128.9, 128.8. 128.7, 128.6, 128.4, 
128.3, 128.2, 128.1, 127.8, 127.4, 123.8, 121.0, 91.3, 91.2, 88.3, 86.4, 83.3, 81.8, 69.7, 46.7, 32.2, 
31.4, 30.5, 30.2, 27.0, 26.0; ESI-MS[m/z (%)] 929 (M
+
, 100), 407 (8), 267 (4); HR-MS (FAB) 
calcd for C51H49ON2IrP: 929.3206; found: 929.3205. Anal. Calcd for C51H49 F6IrN2OP2: C, 57.03; 
H, 4.60. Found: C, 54.68; H, 4.81. Compound likely failed CH analysis because chromatography 
could not be used for isolation, it was precipitated out of solution.  
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(S)-2-Methyl-l,2,3,4-tetrahydroquinoline (98a). A solution of 2-methyl quinoline 97a (0.07 mL, 
0.51 mmol), triphenyl phosphine (1 mg, 1 mol%) and iridium catalyst 121 (6 mg, 1 
mol%) in toluene (2 mL) in a vial was sealed in an autoclave. The autoclave was 
evacuated and back-filled with hydrogen three times, pressurized to 45 atm, and the mixture was 
stirred for 72 h at room temperature. The solvent was removed under reduced pressure and the 
crude reaction mixture was passed through a plug of silica gel, eluting with 2:94:4 
EtOAc/hexanes/Et3N to give 98a (54 mg, 72%) as colorless oil; [ ] 
   –42 (c 1.25, CHCl3) [lit 
143
 
(R)-98a [ ] 
   +84 (c 0.2, CHCl3, 99% ee)]. CSP HPLC analysis (Chiralcel OD-H; eluent: 98:2 
hexanes/i-PrOH, 0.5 mL/min) determined 65:35 er, 30% ee [tR(minor) = 12.91 min, tR(major) = 
14.78 min]; 
1
H NMR (400 MHz, CDCl3) δ 7.01-6.97 (m, 2H), 6.63 (t, 1H, J = 7.6 Hz), 6.51-6.48 
(m, 1H), 3.45-3.39 (m, 1H), 2.90-2.71 (m, 2H), 1.99-1.91 (m, 1H), 1.68-1.55 (m, 1H), 1.23 (d, 3H, 
J = 6.3 Hz); 
13
C NMR (100 MHz, CDCl3) δ 144.7, 129.2, 126.6, 121.0, 116.9, 113.9, 47.1, 30.0, 
26.5, 22.5.  
 
(S)-6-Fluoro-2-methyl-1,2,3,4-tetrahydroquinoline (98b). A solution of 6-fluoro-2-methyl 
quinoline 97b (81 mg, 0.51 mmol), triphenyl phosphine (1 mg, 1 mol%) and 
iridium catalyst 121 (6 mg, 1 mol%) in toluene (2 mL) in a vial was sealed in 
an autoclave. The autoclave was evacuated and back-filled with hydrogen three times, pressurized 
to 45 atm, and the mixture was stirred for 72 h at room temperature. The solvent was removed 
under reduced pressure and the crude reaction mixture was passed through a plug of silica gel, 
eluting with 2:94:4 EtOAc/hexanes/Et3N to give 92b (66 mg, 80%) as a white solid; [ ] 
   –37 (c 
2.55, CHCl3), [lit
122 
(R)-92b + 80 (c 0.2, CHCl3, 98% ee)]; CSP HPLC analysis (Chiralcel OD-H; 
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eluent: 98:2 hexanes/i-PrOH, 0.5 mL/min) determined 71 : 29 er, 42% ee [tR(minor) = 11.84 min, 
tR(major) = 14.63 min]; 
1
H NMR (400 MHz, CDCl3) δ 6.71-6.65 (m, 2H), 6.43-6.38 (m, 1H), 
3.40-3.32 (bm, 2H), 2.83 2.67 (m, 2H), 1.95-1.88 (m, 1H), 1.63-1.50 (m, 1H), 1.21 (d, 3H, J = 6.3 
Hz); 
13
C NMR (100 MHz, CDCl3) δ 157.0, 153.9, 140.9, 122.5, 122.4, 115.5, 115.2, 114.7, 114.6, 
113.3, 113.0, 47.3, 29.8, 26.7, 22.4. 
 
(+)-Tricarbonyl[(1S,7aS)-1-isopropoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-
3(2H)-one]chromium(0) (anti-148). A solution of anti-145 (500 mg, 
1.92 mmol), Cr(CO)6 (465 mg, 2.11 mmol) and n-BuOAc (1.77 mL, 
13.4 mmol) in octane (13 mL) was heated in a round bottomed flask 
equipped under nitrogen at 145 °C for 24 hours. The sublimed solids 
were mechanically pushed back into the solution periodically using a needle for the first 8 hours. 
The reaction mixture was cooled to room temperature, filtered through Celite with EtOAc, and 
concentrated under reduced pressure. Flash column chromatography (70:20:10 
CH2Cl2/EtOAc/hexane Rf = 0.25) gave anti-148 (608 mg, 80%) as a bright yellow oil that 
crystallizes upon standing; mp 171-174 °C (Et2O/hexane); [ ] 
   +37.7 (c 1.0, acetone); IR (ATR, 
solid) νmax  3121, 2973, 2933, 2902, 2880, 1952, 1855, 1710, 1529, 1466, 1381, 1070 cm
-1
; 
1
H 
NMR (400 MHz, acetone-d6) δ 6.687 (dd, 1H, J = 6.8, 2.8 Hz), 5.87 (t, 2H, J = 6.4 Hz), 5.74 (d, 
1H, J = 6.0 Hz), 5.37 (s, 1H), 5.28 (t, 1H, J = 6.0 Hz), 4.08 (sept, 1H, J = 6.4 Hz), 3.66-3.61 (m, 
2H), 3.09 (td, 1H, J = 4.4, 2.0 Hz), 2.14 (quin, 1H, J = 6.4 Hz), 1.97-1.91 (m, 2H), 1.29 (d, 3H, J = 
6.4 Hz), 1.205 (d, 3H, J = 6.4 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 234.2, 159.7, 120.7, 95.8, 
95.7, 88.4, 86.7, 84.1, 82.4, 69.0, 63.6, 34.4, 27.9, 24.3, 23.0, 22.1; EI-MS [m/z (%)] 396 (M
+
, 25), 
340 (65), 313 (56), 312 (95), 260 (38), 253 (77), 252 (100), 201 (84), 200 (45), 77 (47), 70 (70), 52 
(57); HR-MS (EI) calcd. for C18H20CrN2O5: 396.0772; found 396.0781. Anal. Calcd for 
C18H20CrN2O5: C, 54.55; H, 5.09. Found: C, 54.56; H, 5.12. 
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(+)-Tricarbonyl[(1S,7aS)-1-isopropoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-
3(2H)-one]chromium(0)  (syn-148). A solution of syn-145 (500 mg, 
1.92 mmol), Cr(CO)6 (465 mg, 2.11 mmol) and n-BuOAc (1.77 mL, 
13.4 mmol) in octane (13 mL) was heated in a round bottomed  under 
nitrogen at 145 °C for 24 hours. The sublimed solids were mechanically 
pushed back into solution periodically using a needle for the first 8 hours. The reaction mixture 
was cooled to room temperature, filtered through Celite with EtOAc, and concentrated under 
reduced pressure. Flash column chromatography (80:10:10 CH2Cl2/EtOAc/hexane Rf = 0.40) gave 
syn-148 (602 mg, 78%) as a bright yellow solid that was recrystallized from Et2O/hexane to bright 
yellow crystals; mp 163-165 °C (Et2O/hexane); [ ] 
   −135.6 (c 1.0, acetone); IR (ATR, solid) νmax  
3126, 3102, 2980, 2915, 2891, 2860, 1972, 1951, 1878, 1839, 1700, 1529, 1469, 1090 cm
-1
; 
1
H 
NMR (400 MHz, acetone-d6) δ 6.40 (d, 1H, J = 6.0 Hz), 5.85 (t, 2h, J = 6.8 Hz), 5.74 (d, 1H, J = 
8.4 Hz), 5.495 (d, 1H, J = 6.8 Hz), 5.28 (t, 1H, J = 6.0 Hz), 4.11 (q, 1H, J =  2.4 Hz), 4.01 (sept, 
1H, J = 6.0 Hz), 3.44 (q, 1H, J = 6. 8 Hz), 3.14-3.11 (m, 1H), 2.09-2.07 (m, 1H), 2.00-1.89 (m, 
3H), 1.32 (d, 3H, J = 6.0 Hz), 1.24 (d, 3H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 234.1, 
156.6, 121.2, 95.5, 95.4, 88.5, 85.2, 82.3, 70.8, 60.9, 44.4, 25.9, 25.6, 22.5, 21.2; FAB-MS [m/z 
(%)] 419 (M+Na, 100) 397 (M+H, 28), 337 (12), 306 (4), 283 (10), 261 (11) 252 (100), 201 (4); 
HR-MS (EI) calcd. for C18H21CrN2O5: 397.0850; found 397.0855. Anal. Calcd for C18H20CrN2O5: 
C, 54.55; H, 5.09. Found: C, 54.59; H, 5.08. 
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Rp-(methyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149a). A solution of 
anti-148 (163 mg, 0.41 mmol) in THF (10 mL) at −78 °C was treated 
with t-BuLi (0.39 mL, 1.57 M, 0.62 mmol). After 30 min, methyl iodide 
(0.70 mmol) was added by syringe, and the reaction was allowed to 
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warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(50:50 EtOAc/hexane Rf = 0.46) gave 149a (168 mg, 93%) as a bright yellow oil; [ ] 
   −86.3 (c 
1.0, acetone); IR (ATR, solid) νmax  3085, 2972, 2935, 2902, 1952, 1854, 1710, 1462, 1376, 1029 
cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 5.90 (d, 1H, J = 6.4 Hz), 5.71 (t, 1H, J = 6.0 Hz), 5.56 (d, 
1H, J = 6.0 Hz), 5.52 (t, 1H, J = 6.4 Hz), 5.11 (s, 1H), 4.05 (sept, 1H, J = 6.4 Hz), 3.65-3.59 (m, 
2H), 3.08-3.03 (m, 1H), 2.18-1.25 (m, 1H), 2.11 (s, 3H), 2.00-1.88 (m, 2H), 1.48 (quin, 1H, J = 6.0 
Hz); 
13
C NMR (100 MHz, acetone-d6) δ 233.7, 160.7, 113.5, 112.7, 95.3, 94.8, 93.2, 90.9, 90.6, 
70.3, 65.4, 45.9, 27.5, 24.8, 22.7, 22.0, 18.0; EI-MS [m/z (%)] 410 (M
+
, 2), 354 (20),  326 (67), 
231 (52), 135 (43), 91 (32), 70 (85); HR-MS (FAB) calcd. for C19H22CrN2O5: 411.1007; found 
411.1016.  
   
(–)-Tricarbonyl[(1S,7aS)-2-(2Rp-(hydroxydiphenylmethyl)-η
6
-phenyl)-1-isopropoxy 
tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-  one]chromium(0) 
(149b). A solution of anti-148 (126 mg, 0.32 mmol) in THF (10 mL) 
at −78 ° C was treated with t-BuLi (0.31 mL, 1.57 M, 0.48 mmol). 
After 30 min, a solution of benzophenone (99 mg, 0.54 mmol) in THF (2mL) was added by 
cannula, and the reaction mixture was allowed to warm to room temperature (ca. 25 min). Water 
(10 mL) was added and the reaction mixture was extracted with EtOAc (10 mL). The organic 
extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated under 
reduced pressure. Flash column chromatography (50:50 EtOAc/hexane Rf = 0.23) gave 149b (154 
mg, 83%) as a yellow powdery solid; mp 183-185 °C (THF); [ ] 
   −36.9 (c 1.0, THF); IR (ATR, 
solid) νmax 3200, 2970, 2926, 2873, 2854, 1957, 1875, 1682, 1489, 1444, 1421, 1376, 1036 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 10.86, (s, 1H), 7.33-7.23 (m, 10H), 6.30 (s, 1H), 5.62-5.60 (m, 
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2H), 5.51 (d, 1H, J = 6.4 Hz), 5.38 (t, 1H, J = 6.4 Hz), 4.52 (d, 1H, J = 6.4 Hz), 4.24 (sept, 1H, J = 
6.0 Hz), 3.38 (q, 1H, J = 4.0 Hz), 2.77-2.73 (m, 2H), 1.70-1.67 (m, 1H), 1.58-1.52 (m, 2H), 1.40-
1.33 (m, 5H), 1.24 (d, 3H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 233.5, 162.1, 146.0, 
144.8, 128.4, 127.8, 127.5, 127.1, 126.5, 120.1, 113.3, 101.1, 96.1, 92.8, 91.8, 88.9, 81.0, 69.22, 
67.2, 65.5, 25.4, 25.2, 22.9, 22.3; ESI-MS [m/z (%)] 601 (M+Na,40), 561 (100), 538 (21), 456 
(93), 425 (22), 402 (3), 320 (33), 261 (3), 227 (5), 201 (3); HR-MS (FAB) calcd. for 
C31H31CrN2O6: 579.1582; found 579.1603. 
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Rp-(formyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-pyrrolo 
[1,2-c]imidazol-3(2H)-one]chromium(0) (149c). A solution of anti-148 
(162 mg, 0.41 mmol) in THF (10 mL) at −78 °C was treated with t-BuLi 
(0.40 mL, 1.56 M, 0.61 mmol). After 30 min, dimethylformamide (0.06 
mL, 0.73 mmol) was added by syringe, and the reaction was allowed to 
warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(70:10:20 CH2Cl2:EtOAc:hexanes Rf = 0.15) gave 149c (148 mg, 85%) as a bright red solid which 
was recrystallized from EtOAc to bright red powdery crystals; mp 158-160 °C (EtOAc/hexane); 
[ ] 
   −330.9 (c 1.0, acetone); IR (ATR, solid) νmax 3102, 2977, 2941, 2898, 2878, 1974, 1963, 
1914, 1873, 1707, 1688, 1522, 1379, 1028 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 9.36 (s, 1H), 
6.28 (d, 1H, J = 6.0 Hz), 6.15 (t, 1H, J = 5.6 Hz), 6.03 (d, 1H, J = 6.4 Hz), 5.66 (t, 1H, J = 6.8 Hz), 
5.41 (s, 1H), 4.09 (sept, 1H, J = 6.0 Hz), 3.75-3.64 (m, 2H), 3.14 (dt, 1H, J = 5.6 Hz, 1.6 Hz), 2.19-
2.10 (m, 2H), 1.98-1.97 (m, 1H), 1.55 (quin, 1H, J = 5.2 Hz), 1.35 (d, 3H, J = 6.0 Hz), 1.28 (d, 3H, 
J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 231.8, 183.9, 161.3, 119.4, 97.7, 96.0, 92.9, 90.3, 
88.4, 85.6, 69.6, 65.3, 45.9, 24.9, 22.7, 21,4; ESI-MS [m/z (%)] 447 (M+Na, 100), 365 (38), 311 
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(32), 283 (23), 261 (7), 229 (13), 202 (2); HR-MS (FAB) calcd. for C19H21CrN2O6: 425.0799; 
found 425.0766. Anal. Calcd for C19H20CrN2O6: C,53.78; H, 4.71. Found: C, 53.60; H, 4.7. 
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Rp-(N-phenylcarboxamido)-η
6
-phenyl)-1-isopropoxytetrahydro 
-1H-pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149d). A 
solution of anti-148 (167 mg, 0.42 mmol) in THF (10 mL) at −78 °C 
was treated with t-BuLi (0.40 mL, 1.57 M, 0.63 mmol). After 30 min, 
phenyl isocyanate (0.08 mL, 0.72 mmol) was added by syringe, which 
turned the reaction mixture red. The reaction mixture was allowed to warm to room temperature 
(ca. 25 min). Water (10 mL) was added and the reaction mixture was extracted with EtOAc (10 
mL). The organic extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and 
concentrated under reduced pressure. Flash column chromatography (50:50 EtOAc/hexane Rf = 
0.18) gave 149d (216 mg, 88%) as a bright yellow solid that was recrystallized from EtOAc to 
bright yellow needles; mp 140 °C (EtOAc/hexane); [ ] 
   −43.5 (c 1, acetone); IR (ATR, solid) 
νmax 3116, 3098, 3079, 2971, 2924, 2897, 1956, 1868, 1715, 1461, 1432, 1376, 1362, 1028 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 9.51 (bs, 1H), 7.68 (d, 2H, J = 8.0 Hz), 7.30 (t, 2H, J = 7.6 Hz), 
7.08 (t, 1H, J = 7.2 Hz), 6.07 (d, 1H, J = 6.4 Hz), 5.87 (d, 1H, J = 6.4 Hz), 5.74 (t, 1H, J = 6.4 Hz), 
5.61 (t, 1H, J = 6.4 Hz), 5.37 (s, 1H), 4.09 (sept, 1H, J = 6.0 Hz), 3.63 (t, 1H, J = 6.8 Hz), 3.46 (t, 
1H, J = 4.0 Hz), 2.96-2.95 (m, 1H), 2.08-2.07 (m, 1H), 1.95-1.81 (m, 3H), 1.31 (d, 3H, J = 6.4 Hz), 
1.27 (d, 3H, J = 6.4 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 232.4, 162.2, 161.0, 139.2, 128.5, 
123.8, 119.8, 114.2, 107.5, 92.9, 92.2, 91.5, 90.5, 90.2, 70.2, 65.6, 59.7, 45.8, 27.4, 24.7, 22.8, 
21.8; ESI-MS [m/z (%)] 538 (M+Na, 22), 456 (100), 402 (6), 320 (44), 227 (11); HR-MS (FAB) 
calcd. for C25H25CrN3O6Na: 538.1041; found 538.1055. 
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(–)-Tricarbonyl[(1S,7aS)-2-(2Sp-(trimethylsilyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149e). A solution of 
anti-148 (190 mg, 0.48 mmol) in THF (10 mL) at −78 ° C was treated 
with t-BuLi (0.46 mL, 1.56 M, 0.72 mmol). After 30 min, 
chlorotrimethylsilane (0.10 mL, 0.82 mmol) was added by syringe, and 
the reaction was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added and 
the reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with 
water, brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (70:25:5 CH2Cl2/hexane/EtOAc Rf = 0.26) gave 149e (186 mg, 83%) as a 
bright yellow solid that was recrystallized from Et2O/hexane to bright yellow needles; mp 162 °C 
(decomp), (EtOAc/hexane); [ ] 
   = −27.9 (c 1.0, acetone); IR (ATR, solid) νmax 3122, 3099, 2967, 
2944, 2894, 2880, 1959, 1912, 1862, 1704, 1505, 1461, 1021 cm
-1
; 
1
H NMR (400 MHz, acetone-
d6) δ 5.97 (d, 1H, J = 5.6 Hz), 5.89 (t, 1H, J = 5.6 Hz), 5.745 (d, 1H, J = 4.8 Hz), 5.57 (t, 1H, J = 
4.8 Hz), 5.24 (s, 1H), 4.05 (m, 1H), 3.64-3.60 (m, 2H), 3.12 (m, 1H), 2.14 (m, 1H), 1.99 (m, 1H), 
1.58 (m, 1H), 1.32 (d, 3H, J = 4.8 Hz), 1.25 (d, 3H, J = 4.8 Hz), −0.31 (s, 9H); 13C NMR (100 
MHz, acetone-d6) δ 234.0, 160.9, 120.3, 104.3, 100.8, 95.6, 92.8, 92.1, 89.4, 70.3, 65.9, 44.9, 27.1, 
24.9, 22.7, 21.6, −0.2; ESI-MS [m/z (%)] 491 (M+H, 100), 469 (30), 409 (4), 355 (7), 333 (4); HR-
MS (FAB) calcd. for C21H29CrN2O6: 469.1245; found 469.1221. 
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Sp-(diphenylphosphino)-η
6
-phenyl)-1-isopropoxytetrahydro-
1H-pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149f). A solution 
of anti-148 (400 mg, 1.01 mmol) in THF (15 mL) at −78 °C was treated 
with t-BuLi (1.50 mL, 1.55 M, 1.50 mmol). After 30 min, 
chlorodiphenylphosphine (0.36 mL, 1.50 mmol) was added by syringe, 
and the reaction was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added 
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and the reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with 
water, brine, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (50:50 EtOAc/hexane Rf = 0.28) gave 149f (470 mg, 81%) as a bright 
yellow oil; [ ] 
   −242.3 (c 1.0, acetone); IR (ATR, solid) νmax 3055, 2971, 2934, 2896, 2874, 
1959, 1871, 1713, 1571, 1423, 1027 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 7.42-7.38 (m, 10H), 
5.79-5.76 (m, 2H), 5.66 (t, 1H, J = 5.6 Hz), 5.57 (d, 1H, J = 2.0 Hz), 4.95 (d, 1H, J = 6.4 Hz), 4.17 
(sept, 1H, J = 6.0 Hz), 3.58 (t, 1H, J = 6.0 Hz), 2.97 (q, 1H, J = 6.4 Hz), 2.85-2.81 (m, 1H), 1.70-
1.62 (m, 3H), 1.35 (d, 3H, J = 6.0 Hz), 1.26 (d, 3H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) 
δ 232.78, 232.75, 162.3, 135.2, 135.1, 134.9, 134.87, 134.7, 133.7, 133.5, 131.0, 129.8, 128.8, 
128.7, 128.6, 128.4, 128.37, 128.2, 128.16, 118.4, 118.2, 107.7, 107.5, 97.7, 96.43, 96.40, 94.0, 
93.3, 88.8, 88.7, 69.5, 65.5, 45.9, 26.9, 26.89, 24.5, 22.9, 22.1; ESI -MS [m/z (%)] 603 (M+Na, 
13), 581 (M+H, 100), 537 (13), 483 (12), 445 (26), 401 (68), 387 (22), 359 (5); HR-MS (FAB) 
calcd. for C30H30CrN2O5P: 581.1292; found 581.1340. 
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Sp-(thiomethyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149g). A solution 
of anti-148 (137 mg, 0.34 mmol) in THF (10 mL) at −78 ° C was 
treated with t-BuLi (0.29 mL, 1.55 M, 0.48 mmol). After 30 min, 
dimethyl disulfide (0.07 mL, 0.52 mmol) was added by syringe, and 
the reaction mixture was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was 
added and the reaction mixture was extracted with EtOAc (10 mL). The organic extract was 
washed with water, brine, dried over anhyd Na2SO4, filtered and concentrated under reduced 
pressure. Flash column chromatography (50:50 EtOAc/hexane Rf = 0.20) gave 149g (150 mg, 
86%) as a bright yellow solid that was recrystallized from Et2O/hexane to bright yellow needles; 
mp 165 °C (decomp), (EtOAc/hexane); [ ] 
   −239.5 (c 1.0, acetone); X-ray diffraction data was 
127 
 
collected on single yellow crystal (0.230 x 0.110 x 0.070 mm
3
), obtained by crystallization from 
Et2O/hexanes: C19H22CrN2O5S: M = 442.44, orthorhombic, P212121, a = 8.1257(5) Å, b = 
8.1602(5) Å, c = 30.1139(19) Å, V = 1996.8(2) Å
3, α = 90°, β = 90°, γ = 90°, Z = 4, Dc = 1.472 
g/cm
3
, F(000) = 920, T = 147(2) K; 40891 data were collected. The structure was solved by Direct 
Methods (SHELXTL) and refined by full-matrix least squares on F
2
 resulting in final R, Rw and 
GOF [for 4612 data with F > 2σ(F)] of 0.0233, 0.0592 , and 1.086 respectively, Flack parameter = 
0.003(4); IR (ATR, solid) νmax 3079, 2972, 2925, 2898, 1956, 1866, 1714, 1462, 1432, 1028 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 5.94 (d, 1H, J = 6.4 Hz), 5.82 (t, 1H, J = 6.4 Hz), 5.63 (d, 1H, J 
= 6.4 Hz), 5.46 (t, 1H, J = 6.0 Hz), 5.14 (s, 1H), 4.10 (sept, 1H, J = 6.0 Hz), 3.66-3.60 (m, 2H), 
3.06-3.03 (m, 1H), 2.43 (s, 3H), 2.14-2.11 (m, 1H), 1.99-1.90 (m, 2H), 1.64 (quin, 1H, J = 10.0 
Hz), 1.313 (d, 3H, J = 6.0 Hz), 1.247 (d, 3H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 
233.2, 161.3, 119.9, 112.4, 97.2, 95.1, 90.0, 88.9, 88.1, 69.8, 65.5, 45.9, 27.4, 24.8, 22.8, 21.9, 
15.5; ESI-MS [m/z (%)] 465(M+Na, 24), 443 (M+H, 57), 383 (100); HR-MS (FAB) calcd. for 
C19H22CrN2O5S+Na: 465.0547; found 465.0511. Anal. Calcd for C19H22CrN2O5S: C,51.58; H, 
5.01. Found: C, 51.23; H, 5.00. 
 
(+)-Tricarbonyl[(1S,7aS)-2-(2Rp-(bromo)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149h)  A solution 
of anti-148 (160 mg, 0.40 mmol) in THF (7 mL) at −78 °C was treated 
with t-BuLi (0.62 mL, 0.97 M, 0.60 mmol). After 30 min, 1,1,2,2-
tetrabromoethane (0.08 mL, 0.69 mmol) was added by syringe, and the reaction was allowed to 
warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(50:50 EtOAc/hexanes Rf = 0.25) gave 149h (148 mg, 85%) as a bright yellow solid which was 
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recrystallized from EtOAc to bright yellow crystals; mp 116-118 °C (EtOAc/hexane); [ ] 
   +61.2 
(c 0.85, acetone); IR (ATR, solid) νmax 3082, 2971, 2936, 2899, 2879, 1963, 1874, 1712, 1504, 
1029, 616 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 5.98 (d, 1H, J = 6.4 Hz), 5.95 (d, 1H, J = 6.4 
Hz), 5.84 (t, 1H, J = 6.0 Hz), 5.50 (t, 1H, J = 6.4 Hz), 5.18 (s, 1), 4.08 (sept, 1H, J = 6.0), 3.68-3.59 
(m, 2H), 3.09-3.02 (m, 1H), 2.18-2.13 (m, 1H), 2.01-1.96 (m, 1H), 1.92-1.89 (m, 1H), 1.62 (quin, 
1H, J = 9.6 Hz), 1.30 (d, 3H, J = 6.0 Hz), 1.25 (d, 3H, J = 6.0 Hz); 
13
C NMR (150 MHz, acetone-
d6) δ 232.2, 160.8, 111.0, 103.6, 97.0, 95.7, 94.0, 90.3, 89.6, 69.9, 65.3, 45.8, 27.6, 24.7, 22.7, 
21.84; ESI-MS [m/z (%)] 498 (M+Na, 100), 496 (M+Na, 98), 363 (62), 265 (7); HR-MS (FAB+) 
calcd for C18H20BrCrN2O5: 474.9955; found: 474.9915.  
 
(–)-Tricarbonyl[(1S,7aS)-2-(2Sp-(trimethylstannyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149i). A solution of 
anti-148 (261 mg, 0.66 mmol) in THF (10 mL) at −78 ° C was treated 
with t-BuLi (0.65 mL, 1.52 M, 0.99 mmol). After 30 min, 
chlorotrimethylstannane (1.12 mL, 1.12 mmol) was added by syringe, 
and the reaction was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added 
and the reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with 
water, brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash 
column chromatography (80:10:10 hexane/CH2Cl2 /EtOAc Rf = 0.23) gave 149i (263 mg, 70%) as 
a bright yellow solid that was recrystallized from EtOAc to bright yellow needles; mp 180 °C 
(EtOAc/hexane); [ ] 
   −81.9 (c 1.02, acetone); IR (ATR, solid) νmax 3104, 2972, 2920, 2892, 
2361, 2342, 2361, 2342, 1951, 1882, 1859, 1696, 1500, 1460, 1375, 1033 cm
-1
; 
1
H NMR (400 
MHz, acetone-d6) δ 6.05 (s, 1H), 5.82 (s, 1H), 5.66 (s, 1H), 5.47 (s, 1H), 5.31 (s, 1H), 4.03 (s, 1H), 
3.64 (s, 2H), 3.12 (s, 1H), 2.07 (m, 1H), 1.99 (m, 1H), 1.52 (m, 1H), 1.31 (s, 3H), 1.25 (s, 3H), 
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0.29 (s, 1H); 
13
C NMR (100 MHz, acetone-d6) δ 234.5, 160.6, 122.6, 103.1, 102.4, 95.1, 92.8, 
88.5, 87.9, 69.6, 65.1, 44.7, 27.1, 24.6, 22.6, 21.6, −5.9; 119Sn NMR (149 MHz, acetone-d6) δ 
−13.7; ESI -MS [m/z (%)] 583 (M+Na, 100), 561 (8), 508 (7), 447 (43), 339 (5); HR-MS (FAB) 
calcd. for C21H28CrN2O5Sn:561.0498; found 561.0504. 
 
(+)-Tricarbonyl[(1S,7aS)-2-(2Rp-(deutero)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (149j). A solution of 
anti-148 (167 mg, 0.42 mmol) in THF (10 mL) at −78 ° C was treated 
with t-BuLi (0.40 mL, 1.56 M, 0.63 mmol). After 30 min, methanol-d4 
(0.05 mL, mmol) was added by syringe, and the reaction was allowed to 
warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(75:25 hexane/EtOAc Rf = 0.20) gave 149j (148 mg, 88%) as a bright yellow oil; [ ] 
   +35.4 (c 
1.3, acetone); IR (ATR, solid) νmax 2970, 2931, 2874, 1954, 1859, 1714, 1521, 1381, 1040 cm
-1
; 
1
H 
NMR (400 MHz, acetone-d6) δ 5.87 (s, 2H), 5.74 (bs, 1H), 5.37 (s,1H) 5.28 (s, 1H), 4.08 (bs, 1H) 
3.64 (bs, 2H), 3.09 (bs, 1H), 2.13-2.09 (m, 1H), 1.97-1.91 (m, 2H), 1.45 (t, 1H, J = 9.6 Hz), 1.288 
(d, 3H, J = 3.2 Hz), 1.235 (d, 3H, J = 3.6 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 234.2, 159.7, 
120.6, 95.7, 95.68, 88.4, 86.7, 83.9 (t, 
1
J
13
C-
2
H = 28.2 Hz), 82.4, 69.0, 63.6, 45.4, 27.9, 24.3, 23.0, 
22.1; ESI-MS [m/z (%)] 420 (M+Na, 100), 398 (M+H, 7), 338 (14), 284 (10), 262 (8), 202 (6); 
HR-MS (FAB) calcd. for C18H20DCrN2O5: 398.0913; found 398.0944. 
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(+)-Tricarbonyl[(1R,7aS)-2-(2Sp-(methyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-pyrrolo 
[1,2-c]imidazol-3(2H)-one]chromium(0) (150a). A solution of syn-
148 (203 mg, 0.51 mmol) in THF (10 mL) at −78 °C was treated 
with t-BuLi (0.53 mL, 1.45 M, 0.77 mmol). After 30 min, methyl 
iodide (0.05 mL, 0.87 mmol) was added by syringe, and the reaction 
was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added and the 
reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, 
brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (50:50 hexane/EtOAc Rf = 0.32) gave 150a (183 mg, 87%) as a bright yellow 
solid that was crystallized from Et2O/hexane to yellow powdery crystals; mp 146-148 °C 
(Et2O/hexane); [ ] 
   +86.9 (c 1.0, acetone); IR (ATR, solid) νmax 3093, 3073, 2973 2937, 2900, 
1946, 1891, 1845, 1713, 1528, 1482, 1460, 1380, 1089 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 
5.89 (d, 1H, J = 6.8 Hz), 5.63-5.62 (m, 2H), 5.50 (t, 1H, J = 4.8 Hz), 5.29 (d, 1H, J = 6.4 Hz), 
4.21 (q, 1H, J = 7.2 Hz), 4.04-4.00 (m, 1H), 3.41-3.36 (m, 1H), 3.12-3.07 (m, 1H), 2.12 (s, 3H), 
2.00-1.88 (m, 4H), 1.285 (d, 3H, J = 5.6 Hz), 1.217 (d, 3H, J = 5.6 Hz); 
13
C NMR (100 MHz, 
acetone-d6) δ 233.9, 157.7, 111.7, 94.2, 94.0, 92.6, 91.4, 89.2, 89.1, 71.0, 62.1, 44.8, 26.44, 25.5, 
22.35, 21.68, 17.9; ESI-MS [m/z (%)] 449 (M+K, 10), 433 (M+Na, 100), 411 (M+H, 13), 351 
(6), 297 (18), 275 (6), 203 (4); HRMS (FAB+) calcd for  C19H22CrN2O5+H: 411.1007; found: 
411.0973. 
 
(+)-Tricarbonyl[(1R,7aS)-2-(2Sp-(formyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-pyrrolo 
[1,2-c]imidazol-3(2H)-one]chromium(0) (150b). A solution of syn-
148 (203 mg, 0.51 mmol) in THF (10 mL) at −78 °C was treated with t-
BuLi (0.50 mL, 1.50 M, 0.76 mmol). After 30 min, dimethylformamide 
(0.07 mL, 0.86 mmol) was added by syringe, and the reaction was 
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allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction 
mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, brine, 
dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (70:20:10 CH2Cl2/hexane/EtOAc Rf = 0.19) gave 139b (202 mg, 94%) as a bright 
red solid that was recrystallized from EtOAc/hexane; mp 146-148 °C (EtOAc/hexane); [ ] 
   
+195.0 (c 1.0, acetone); IR (ATR, solid) νmax 3121, 3084, 2971, 2933, 2898, 1971, 1910, 1879, 
1708, 1680, 1520, 1074 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 9.47 (s, 1H), 6.28 (d, 1H, J = 5.6 
Hz), 6.17 (bt, 1H), 5.88 (d, 1H, J = 6.0 Hz), 5.61-5.60 (m, 2H), 4.30-4.28 (m, 2H, J = 6.4 Hz), 3.99 
(t, 1H, J = 5.2 Hz), 3.40-3.38 (m, 1H, J = 8.0 Hz), 3.18 (m, 1H), 2.12-2.10 (m, 1H), 2.00-1.99 (m, 
2H), 1.353 (d, 3H, J = 5.2 Hz), 1.27 (d, 3H, J = 5.2 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 231.9, 
184.2, 157.7, 121.3, 96.5, 96.3, 93.2, 89.4, 87.5, 84.0, 70.7, 62.1, 44.1, 26.5, 25.1, 22.2, 21.0; ESI-
MS [m/z (%)] 870 (2M+Na, 8), 447(M+Na, 100), 381(23), 311(9), 284(3), 229(3); HRMS (FAB+) 
calcd for C19H20CrN206+H: 425.0799; found 425.0767. Anal. Calcd for C19H20CrN2O6: C, 53.78; 
H, 4.71. Found: C, 53.84; H, 4.73. 
 
(+)-Tricarbonyl[(1R,7aS)-2-(2Sp-(N-phenylcarboxamido)-η
6
-phenyl)-1-isopropoxytetrahydro 
-1H-pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (150c). A 
solution of of syn-148 (217 mg, 0.55 mmol) in THF (10 mL) at −78 ° C 
was treated with t-BuLi (0.55 mL, 1.50 M, 0.82 mmol). After 30 min, 
phenyl isocyanate (0.10 mL, 0.93 mmol) was added by syringe, and the 
reaction mixture was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was 
added and the reaction mixture was extracted with EtOAc (10 mL). The organic extract was 
washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced 
pressure. Flash column chromatography (50:50 hexane/EtOAc Rf = 0.24) gave 150c (256 mg, 
91%) as a bright yellow solid; mp 151-152 °C; [ ] 
   +196.1 (c 1.0, acetone); IR (ATR, solid) νmax 
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3292, 3273, 3076, 2969, 2978, 2894, 2881, 1967, 1879, 1709, 1685, 1063 cm
-1
; 
1
H NMR (400 
MHz, acetone-d6) δ 9.45 (s, 1H), 7.65 (dd, 2H, J = 8.8, 1.2 Hz), 7.34-7.30 (m, 2H), 7.09 (t, 1H, J = 
7.2 Hz), 5.99 (dd, 1H, J = 6.4, 1.2 Hz), 5.92 (dd, 1H, J = 6.4, 1.2 Hz), 5.71 (td, 1H, J = 6.4, 1.2 
Hz), 5.67-5.65 (m, 2H), 4.19 (q, 1H, J = 6.8 Hz), 3.93 (sept, 1H, J = 6.0 Hz), 3.16-3.10 (m, 1H), 
2.96-2.93 (m, 1H), 1.92-1.80 (m, 3H), 1.75-1.71 (m, 1H), 1.24 (d, 3H, J = 6.0 Hz), 1.18 (d, 3H, J = 
6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 232.2, 162.1, 157.5, 138.9, 128.6, 123.8, 119.6, 105.3, 
92.8, 92.7, 91.5, 90.5, 89.1, 72.1, 61.3, 45.1, 26.1, 25.0, 22.2, 21.5; ESI-MS [m/z (%)] 538 (M+Na, 
100), 456 (14), 425 (2), 402 (38), 320 (4), 203 (3); HRMS (FAB+) calcd. for C25H25CRN3O6+H: 
516.1221; found: 516.1173. 
  
(+)-Tricarbonyl[(1R,7aS)-2-(2Rp-(thiomethyl)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one]chromium(0) (150d). A solution of 
syn-148 (154 mg, 0.39 mmol) in THF (10 mL) at −78 °C was treated 
with t-BuLi (0.38 mL, 1.55 M, 0.58 mmol). After 30 min, dimethyl 
disulfide (0.06 mL, 0.67 mmol) was added by syringe, and the reaction 
was allowed to warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction 
mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, brine, 
dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (50:50 hexane/EtOAc Rf = 0.24) gave 150d (161 mg, 94%) as a bright yellow 
solid that was recrystallized from EtOAc/hexane to bright yellow needles; mp 154-155 °C 
(EtOAc/hexane); [ ] 
   +94.7 (c 1.0, acetone); IR (ATR, solid) νmax 3098, 2977, 2959, 2892, 2869, 
1956, 1873, 1713, 1511, 1068, 1011 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 5.95 (dd, 1H, J = 6.4, 
0.8 Hz), 5.72 (dt, 2H, J = 6.4, 0.8 Hz), 5.55 (td, 1H, J = 6.4, 0.8 Hz), 5.29 (d, 1H, J = 6.4 Hz), 4.20 
(q, 1H, J = 6.8 Hz), 4.09 (sept, 1H, J = 6.4 Hz), 3.37 (dt, 1H, J = 6.4, 2.8 Hz), 3.12-3.07 (m, 1H), 
2.43 (s, 3H), 2.02-1.88 (m, 3H), 1.32 (d, 3H, J =  6.4 Hz), 1.22 (d, H, J =  6.4 Hz); 
13
C NMR (100 
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MHz, acetone-d6) δ 233.4, 158.1, 118.1, 115.8, 93.9, 93.6, 90.8, 90.4, 88.5, 70.9, 62.3, 44.7, 26.4, 
25.6, 22.4, 21.8, 16.3; ESI-MS [m/z (%)] 465 (M+Na, 100), 443 (M+H, 20), 383 (20), 329 (4); 
HR-MS (FAB+) calcd. for C19H23CrN2O5S: 443.0727; found 398.0720. Anal. Calcd for 
C19H22CrN2O5S: C,51.58; H, 5.01. Found: C, 51.61; H, 5.04. 
 
(−)-Tricarbonyl[(1R,7aS)-2-(2Sp-(bromo)-η
6
-phenyl)-1-isopropoxytetrahydro-1H-pyrrolo 
[1,2-c]imidazol-3(2H)-one]chromium(0) (150e). A solution of syn-
148 (182 mg, 0.46 mmol) in THF (6 mL) at −78 °C was treated with 
t-BuLi (0.72 mL, 0.96 M, 0.69 mmol). After 30 min, 1,1,2,2-
tetrabromoethane (0.09 mL, 0.78 mmol) was added by syringe, and the reaction was allowed to 
warm to room temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was 
extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(50:50 EtOAc/hexanes Rf = 0.20) gave 150e (181 mg, 83%) as a bright yellow solid which was 
recrystallized from EtOAc to bright yellow crystals; mp 140-142 °C (EtOAc/hexane); [ ] 
   −71.1 
(c 0.94, acetone); IR (ATR, solid) νmax 3084, 2978, 2893, 1966, 1893, 1713, 1429, 658 cm
-1
; 
1
H 
NMR (400 MHz, acetone-d6) δ 6.04 (d, 1H, J = 6.4 Hz), 5.93 (d, 1H, J = 6.4 Hz), 5.74 (t, 1H, J = 
6.4 Hz), 5.57 (t, 1H, J = 6.4 Hz), 5.34 (d, 1H, J = 6.4 Hz), 4.22 (q, 1H, J = 6.0 Hz), 4.08-4.02 (q, 
1H, J = 6.0 Hz), 3.42-3.38 (m, 1H), 3.12-3.07 (m, 1H), 2.02-1.90 (m, 4H), 1.30 (d, 3H, J = 6.0 Hz), 
1.23 (d, 3H, J = 6.0 Hz); 
13
C NMR (150 MHz, acetone-d6) δ 232.4, 157.7, 113.9, 101.9, 95.7, 94.2, 
94.0, 90.9, 88.6, 71.1, 62.3, 44.9, 26.3, 25.6, 22.4, 21.7; ESI-MS [m/z (%)] 499 (M+Na, 83), 497 
(M+Na, 81), 477 (M+H, 48), 475 (M+H, 56), 363 (90), 361 (100), 341 (76), 339 (71), 283 (19); 
HR-MS (ESI) calcd. for C18H20CrN2O5: 474.9973; found 474.9955. 
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(–)-Tricarbonyl[(1R,7aS)-2-(2Sp-(deutero)-η
6
-phenyl)-1-isopropoxytetrahydro-1H- pyrrolo 
[1,2-c]imidazol-3(2H)-one]chromium(0) (150f). A solution of syn-148 
(86 mg, 0.22 mmol) in THF (10 mL) at −78 °C was treated with t-BuLi 
(0.22 mL, 1.50 M, 0.32 mmol). After 30 min, methanol-d4 (0.05 mL) 
was added by syringe, and the reaction was allowed to warm to room 
temperature (ca. 25 min). Water (10 mL) was added and the reaction mixture was extracted with 
EtOAc (10 mL). The organic extract was washed with water, brine and dried over anhyd. Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (50:50 
hexane/EtOAc Rf = 0.24) gave 150f (74 mg, 86%) as a bright yellow crystalline solid; mp 155-156 
°C (CH2Cl2/hexane); [ ] 
   −131.8 (c 1.0, acetone); IR (ATR, solid) νmax 3121, 3101, 2980, 2959, 
2916, 2892, 2631, 1952, 1877, 1845, 1701, 1524, 1454, 1084,1018 cm
-1
; 
1
H NMR (400 MHz, 
acetone-d6) δ 5.85-5.83 (m, 2H), 5.73 (d, 1H, J = 7.2 Hz), 5.50 (d, 1H, J = 6.8 Hz), 5.28 (t, 1H, J = 
6.4 Hz), 4.11 (dt, 1H, J = 6.8, 2.4 Hz), 4.01 (sept, 1H, J = 6.0 Hz), 3.44 (dt, 1H, J = 7.6 Hz), 3.14 
(m, 1H), 2.13-2.09 (m, 1H), 2.01-1.84 (m, 3H), 1.26 (d, 3H, J = 6.0 Hz), 1.24 (d, 3H, J = 6.0 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 234.2, 156.6, 121.2, 95.5, 95.4, 88.4, 85.2, 85.0 (t, 
1
J
13
C-
2
H = 
27.2 Hz), 82.2, 70.8, 60.9, 44.4, 25.9, 25.6, 22.5, 21.2; ESI-MS [m/z (%)] 420 (M+Na 100), 398 
(M+H, 4), 384 (4), 362 (6), 284 (8), 243 (4), 202 (13), 184 (10), 140 (3); HR-MS (FAB+) calcd. 
for C18H19DCrN2O5+H: 398.0913; found: 398.0929.  
 
(–)-Tricarbonyl[(2Rp-(methyl)-η
6
-phenyl)-6,7-dihydro-2H-pyrrolo[1,2-c]imidazol-3(5H)-one] 
chromium(0) (151a).  To a solution of 149a (90 mg, 0.22 mmol) in 
CH2Cl2 (6 mL) was added p-toluenesulfonic acid (83 mg, 0.44 mmol). 
The solution was stirred at reflux for approximately 3-5 min. The acid 
was neutralized by addition of a sat. aq. NaHCO3 solution (10 mL). The 
reaction mixture was extracted with EtOAc (10 mL). The organic extract was washed with water, 
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brine, dried over anhyd. Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (EtOAc Rf = 0.08) gave 151a (66 mg, 86%) as a yellow oil; [ ] 
   −131.6 (c 1.0, 
acetone); IR (ATR, solid) νmax 3139, 3101, 3068, 2980, 2953, 2904, 2886, 1950, 1857, 1680, 1630, 
1404 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 6.17 (s, 1H), 5.895 (d, 1H, J = 6.4 Hz), 5.77 (t, 1H, J 
= 6.0 Hz), 5.62 (d, 1H, J = 6.4 Hz), 5.53 (t, 1H, J = 6.4 Hz), 3.65 (t, 2H, J = 6.8 Hz), 2.80 (t, 2H, J 
= 6.8 Hz), 2.46 (t, 2H, J = 6.8 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 233.2, 149.4, 128.0, 112.3, 
111.0 104.4, 95.8, 95.5, 93.2, 89.9, 42.1, 27.6, 22.4, 17.5; ESI-MS [m/z (%)] 723 (2M+K, 4), 
373(M+Na, 92), 351(M+H, 17), 251 (6), 237 (100), 215 (56); HR-MS (FAB+) calcd. for 
C16H14CrN2O4+H: 351.0431; found: 351.0450. 
 
(+)-Tricarbonyl[(2Sp-(methyl)-η
6
-phenyl)-6,7-dihydro-2H-pyrrolo[1,2-c]imidazol-3(5H)-one] 
chromium(0) (ent-151a). To a solution of 150a (115 mg, 0.28 mmol) in 
CH2Cl2 (6 mL) was added p-toluenesulfonic acid (106 mg, 0.56 mmol). 
The solution was stirred at reflux for approximately 3-5 min. The acid 
was neutralized by the addition of a sat. aq. NaHCO3 solution (10 mL). The reaction mixture was 
then extracted with EtOAc (10 mL). The organic extract was washed with water, brine, dried over 
anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography 
(EtOAc Rf = 0.17) gave ent-151a (76 mg, 77%) as a yellow oil; [ ] 
   +133.2 (c 1.0, acetone); IR 
(ATR, solid) νmax 3138, 4000, 3068, 2979, 2960, 2929, 2903, 1954, 1863, 1683, 1631, 1529, 1405 
cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 6.15 (s, 1H), 5.88 (d, 1H, J = 6.8 Hz), 5.76 (t, 1H J = 6.8 
Hz, 5.60 (d, 1H, J = 6.8 Hz, 5.52 (t, 1H, J = 6.0 Hz), 3.64 (t, 2H, J = 6.8 Hz), 2.78 (t, 2H, J = 6.8 
Hz), 2.44 (t, 2H, J = 6.8 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 233.2, 149.3, 128.0, 112.3, 111.0, 
104.4, 95.8, 95.5, 93.2, 89.8, 42.1, 27.6, 22.4, 17.5; ESI-MS [m/z (%)] 389 (M+K, 4), 373 (M+Na, 
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100), 351 (M+H, 18), 237 (40), 215 (23); HR-MS (FAB+) calcd. for C16H14CrN2O4+H: 351.0431; 
found: 351.0411. 
 
(−)-Tricarbonyl[(2Sp-(thiomethyl)-η
6
-phenyl)-6,7-dihydro-2H-pyrrolo[1,2-c]imidazol-3(5H)-
one]chromium(0) (151b). To a solution of 149g (115 mg, 0.28 mmol) 
in CH2Cl2 (6 mL) was added p-toluenesulfonic acid (106 mg, 0.56 
mmol). The solution was stirred at reflux for approximately 3-5 min. 
The acid was neutralized by the addition of a sat. aq. NaHCO3 solution (10 mL). The reaction 
mixture was then extracted with EtOAc (10 mL). The organic extract was washed with water, 
brine, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 30:70 acetone/EtOAc Rf = 0.17) gave 151b (51 mg, 78%) as a yellow 
oil; [ ] 
   = −174.7 (c 0.75, acetone); IR (ATR, solid) νmax 3438, 3153, 3079, 2982, 2965, 2924, 
1955, 1866, 1682, 1634, 1512, 1406 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 6.19 (s, 1H), 6.08 (d, 
1H, J = 6.8 Hz), 5.86 (t, 1H, J = 6.4 Hz), 5.73 (d, 1H, J = 6.4 Hz), 5.47 (t, 1H, J = 6.4 Hz), 3.64 (t, 
2H, J = 6.8 Hz), 2.78 (t, 2H, J = 6.8 Hz), 2.49 (s, 3H), 2.44 (t, 2H, J = 6.8 Hz); 
13
C NMR (100 
MHz, acetone-d6) δ 232.8, 149.4, 127.1, 116.3, 110.1, 105.2, 97.9, 95.0, 88.6, 88.0, 42.1, 27.6, 
22.3, 14.8; ESI-MS [m/z (%)] 381(25), 320(12), 269(100), 247(39), 227(4); HR-MS (FAB+) 
calcd. for C16H14CrN2O4S+H: 383.0152; found: 383.0152. 
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(+)-Tricarbonyl[(2Rp-(thiomethyl)-η
6
-phenyl)-6,7-dihydro-2H-pyrrolo[1,2-c]imidazol-3(5H)-
one]chromium(0) (ent-151b).  To a solution of 149d (48 mg, 0.11 
mmol) in CH2Cl2 (5 mL) was added p-toluenesulfonic acid (41 mg, 0.22 
mmol). The solution was stirred at reflux for approximately 3-5 min. 
The acid was neutralized by the addition of a sat. aq. NaHCO3 solution (10 mL). The reaction 
mixture was then extracted with EtOAc (10 mL). The organic extract was washed with water, 
brine, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (EtOAc Rf = 0.17) gave ent-151b (39 mg, 94%) as a yellow oil; [ ] 
   +179.6 (c 
1.0, acetone); IR (ATR, solid) νmax 3153, 3080, 2981, 2964, 2923, 1955, 1866, 1676, 1634, 1408 
cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 6.19 (s, 1H), 6.08 (d, 1H, J = 5.6 Hz), 5.85 (t, 1H, J = 6.4 
Hz), 5.732 (d, 1H, J = 5.6 Hz), 5.47 (dt, 1H, J = 6.4, 0.8 Hz), 3.64 (t, 2H, J = 6.8 Hz), 2.78 (t, 2H, J 
= 6.8 Hz), 2.49 (s, 3H), 2.45 (t, 2H, J = 6.8 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 232.8, 149.4, 
127.1, 116.3, 105.2, 97.8, 95.0, 88.6, 88.0, 42.1, 27.6, 22.3, 14.8; ESI-MS [m/z (%)] 421 (M+K, 5), 
405 (M+Na, 99), 383 (M+H, 18), 285 (7), 269 (100), 247 (34), 212 (5);  HR-MS (FAB+) calcd. for 
C16H14CrN2O4S+H: 383.0152; found: 383.0186. 
 
(−)-(1S,7aS)-1-ethoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (anti-152) 
and (−)-(1R,7aS)-1-ethoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (syn-
152). To a stirred solution of hemiaminal 146 (1.07 g, 4.89 mmol) in EtOH (10 mL) and CH2Cl2 
(10 mL) was added p-toluenesulfonic acid (1.74 g, 9.17 mmol). After stirring for 5 minutes at 
room temperature, the acid was neutralized with sat. aq. NaHCO3 solution (20 mL) and the 
reaction mixture was extracted with EtOAc (15 mL). The organic extract was washed with water, 
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brine, dried over anhyd Na2SO4, filtered and concentrated under reduced pressure. Flash column 
chromatography (30:70 EtOAc/hexane Rf = 0.32) gave, sequentially, anti-152 (1010 mg, 84 %) 
and syn-152 (195 mg, 16%, Rf = 0.23).  
(anti-152); thick colourless oil; [ ] 
   −9.7 (c 0.98, acetone); IR (ATR, solid) νmax 2971, 2930, 
2900, 2874, 1707, 1603, 1391, 1040 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 
7.68 (d, 2H, J = 8.0 Hz), 7.33 (t, 2H, J = 8.0 Hz), 7.08 (t, 1H, J = 7.2 Hz), 
5.54 (s, 1H), 3.65-3.50 (m, 4H), 3.08 (dt, 1H, J = 9.2, 4.1 Hz), 2.09-2.07 (m, 
1H), 1.96-1.90 (m, 2H), 1.43 (pent, 1H, J = 9.2 Hz), 1.12 (t, 3H, J = 7.2 Hz); 
13
C NMR (100 MHz, 
acetone-d6) δ 160.7, 139.4, 128.5, 123.4, 120.1, 87.7, 62.6, 59.7, 45.4, 28.3, 24.4, 14.6; EI-MS[m/z 
(%)] 246 (M
+
, 100), 217 (17), 201 (95), 171 (67), 149 (29), 121 (56), 105 (15), 77 (48), 70 (34); 
HR-MS (EI) calcd for C14H18N2O2 : 246.1368; found: 246.1359. 
 
(syn-152). colourless crystals; mp 81-83 °C; [ ] 
   −99.8 (c 1.0, acetone); IR (ATR, solid) νmax 
2973, 2928, 2879, 1775, 1704, 1597, 1397, 2088 cm
-1
; 
1
H NMR (400 MHz, 
acetone-d6) δ 7.61 (d, 2H, J = 8.0 Hz), 7.34 (t, 2H, J = 6.0 Hz), 7.08 (t, 1H, J 
= 7.2 Hz), 5.49 (d, 1H, J = 6.4 Hz), 4.12-4.10 (q, 1H, J = 6.8Hz), 3.67-3.52 
(m, 2H), 3.50-3.47 (m, 1H), 3.11-3.07 (m, 1H), 2.02-1.94 (m, 4H), 1.16 (t, 3H, J = 6.8 Hz); EI-
MS[m/z (%)] 246 (M
+
, 38), 216 (54), 173 (21), 171 (40), 119 (100), 104 (18), 77 (39), 70 (24); 
HR-MS (EI) calcd for C14H18N2O2 : 246.1368; found: 246.1357. 
 
 (+)-Tricarbonyl[(1S,7aS)-1-ethoxy-2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-
one]chromium(0) (153).  A solution of anti-152 (500 mg, 2.03 mmol), 
Cr(CO)6 (490 mg, 2.23 mmol) and n-BuOAc (1.87 mL, 14.2 mmol) in 
octane (14 mL) was heated in a round bottomed flask equipped under 
nitrogen at 145 °C for 24 hours. The sublimed solids were mechanically pushed back into the 
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solution periodically using a needle for the first 8 hours. The reaction mixture was cooled to room 
temperature, filtered through Celite with EtOAc, and concentrated under reduced pressure. Flash 
column chromatography (70:20:10 CH2Cl2/EtOAc/hexane Rf = 0.45) gave 153 (328 mg, 42%) as a 
bright yellow oil that crystallizes upon standing; mp 183-185 °C (EtOAc); [ ] 
   +54.8 (c 1.0, 
acetone); IR (ATR, solid) νmax 3121, 2984, 2944, 2897, 2877, 1938, 1876, 1843, 1713, 1529 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 6.70 (d, 1H, J = 7.2 Hz), 5.88-5.84 (m, 3H), 5.35 (s, 1H), 5.28 
(t, 1H, J = 4.8 Hz), 3.70-3.59 (m, 4H), 3.13-3.07 (m, 1H), 2.13-2.08 (m, 1), 1.98-1.89 (m, 2H), 
1.45 (pent, 1H, J = 6.8 Hz), 1.23 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 MHz, acetone-d6) δ 234.2, 
159.8, 120.6, 95.7, 95.6, 88.6, 87.2, 83.9, 82.3, 62.0, 59.4, 45.4, 28.2, 24.3, 14.5; ESI-MS[m/z (%)] 
405 (M
+
 + Na, 100), 383 (M
+
 + H, 13), 337 (19), 269 (8), 247 (5), 201 (5); HR-MS (FAB) calcd 
for C17H19O5CrN2: 383.0694; found: 383.0685. 
 
 (+)-Tricarbonyl[(1S,7aS)-2-(2Rp-(thiomethyl)-η
6
-phenyl)-1-ethoxytetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one]chromium(0) (154).  A solution of 153 (143 mg, 
0.37 mmol) in THF (3 mL) at −78 °C was treated with t-BuLi (0.35 mL, 
1.65 M, 0.56 mmol). After 30 min, dimethyldisulfide (0.06 mL) was 
added by syringe, and the reaction was allowed to warm to room temperature (ca. 25 min). Water 
(10 mL) was added and the reaction mixture was extracted with EtOAc (10 mL). The organic 
extract was washed with water, brine, dried over anhyd. Na2SO4, filtered and concentrated under 
reduced pressure. Flash column chromatography (50:50 EtOAc/hexane Rf = 0.36) gave 143 (151 
mg, 96%) as a bright yellow oil; [ ] 
   +163.3 (c 1.0, acetone); IR (ATR, solid) νmax  3086, 2974, 
2928, 2898, 2879, 1952, 1859, 1705, 1431, 1390 cm
-1
; 
1
H NMR (400 MHz, acetone-d6) δ 5.94-
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5.89 (m, 2H), 5.54 (d, 1H, J = 6.0 Hz), 5.36 (t, 1H, J = 6.4 Hz), 5.07 (s, 1H), 3.70-3.59 (m, 4H), 
3.07-3.03 (m, 1H), 2.45 (s, 3H), 2.11-2.07 (m, 1H), 1.99-1.92 (m, 2H), 1.64 (pent, 1H, J = 6.8 Hz), 
1.28 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 MHz, acetone-d6)  δ 232.9, 161.5, 121.0, 109.1, 99.7, 96.3, 
90.8, 87.4, 86.0, 63.6, 60.8, 45.8, 27.9, 24.7, 14.6, 14.5; ESI-MS[m/z (%)] 451 (M
+
 + Na, 100), 388 
(9), 315 (43), 247 (7), 150 (13); HR-MS (FAB) calcd for C18H21O5CrN2S: 429.0571; found: 
429.0582. 
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